Processing 00000000.tx.1: 1995 by The American Society for Biochemistry and Molecular Biology, Inc. 

Phrase: "1995 by The American Society"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037455:society [Organization]
   760   C0596070:American [Population Group]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Inc."
Processing 00000000.tx.2: Insulin Regulates Transcription of the CCAAT/Enhancer Binding Protein (C/EBP) , , and Genes in Fully-differentiated 3T3-L1 Adipocytes (*) (Received for publication, August 19, 1994; and in revised form, October 17, 1994) Ormond A. 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "Regulates"

Phrase: "Transcription of the CCAAT/Enhancer Binding Protein (C/EBP) ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   800   C0086222:Enhancer of transcription [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0040649:Transcription [Genetic Function]

Phrase: ","

Phrase: "and"

Phrase: "Genes in Fully-differentiated 3T3-L1 Adipocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0017337:Genes [Gene or Genome]

Phrase: "("

Phrase: "*"

Phrase: ")"

Phrase: "("

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "August 19,"

Phrase: "1994"

Phrase: ";"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "October 17,"

Phrase: "1994"

Phrase: ")"

Phrase: "Ormond A."
Processing 00000000.tx.3: MacDougald (),, Peter Cornelius(),(),, Raymond Liu (**),, M. 

Phrase: "MacDougald"

Phrase: "("

Phrase: ")"

Phrase: ","

Phrase: ", Peter Cornelius"

Phrase: "("

Phrase: ")"

Phrase: ","

Phrase: "("

Phrase: ")"

Phrase: ","

Phrase: ", Raymond Liu"

Phrase: "("

Phrase: "*"

Phrase: "*"

Phrase: ")"

Phrase: ","

Phrase: ", M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.4: Daniel Lane () From theDepartment of Biological Chemistry, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205 ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION FOOTNOTES REFERENCES ABSTRACT The effect of insulin on expression of CCAAT/enhancer binding protein (C/EBP) , , and was investigated in fully-differentiated 3T3-L1 adipocytes. 

Phrase: "Daniel Lane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "("

Phrase: ")"

Phrase: "From theDepartment"

Phrase: "of Biological Chemistry,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0005477:Chemistry, Biological [Occupation or Discipline]
   861   C0005532:Biological [Biomedical Occupation or Discipline]
   861   C0007996:Chemistry [Occupation or Discipline]
   861   C0079107:chemistry [Classification]
   861   C0201682:Chemistry [Laboratory Procedure]
   861   C0205460:biological [Qualitative Concept]

Phrase: "The Johns Hopkins University School of Medicine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0036375:School [Manufactured Object,Organization]
   748   C0041740:University [Manufactured Object,Organization]

Phrase: "Baltimore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004716:Baltimore [Geographic Area]

Phrase: "Maryland 21205 ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   758   C2825232:Footnote [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "ABSTRACT"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "The effect of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of CCAAT/enhancer binding protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "(C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: ")"

Phrase: ","

Phrase: ","

Phrase: "and"

Phrase: "was"

Phrase: "investigated in fully-differentiated 3T3-L1 adipocytes."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0007589:Differentiated [Cell Function]
   748   C0205615:Differentiated [Qualitative Concept]
   748   C0206131:Adipocytes [Cell]
   748   C0441918:L1 [Finding]
   748   C1179698:L1 [Body Location or Region]
   748   C1292732:investigated [Functional Concept]
   748   C1416177:L1 [Gene or Genome]
   721   C1159884:adipocyte differentiation [Cell Function]
Processing 00000000.tx.5: Treatment of adipocytes with insulin stimulated rapid dephosphorylation of C/EBP, and repressed the expression of C/EBP within 2-4 h, with >90% suppression occurring at 24 h. 

Phrase: "Treatment of adipocytes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "with insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "rapid dephosphorylation of C/EBP,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C1158884:Protein dephosphorylation [Molecular Function]
           Dephosphorylation
   748   C3160734:Dephosphorylation [Molecular Function]

Phrase: "and"

Phrase: "repressed"

Phrase: "the expression of C/EBP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1171362:expression protein [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "within 2-4 h,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0011744:2 H [Element, Ion, or Isotope]
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "with"

Phrase: ">90% suppression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0221103:Suppression [Pathologic Function]
   861   C0301625:Suppression [Organism Function]
   861   C0439181:% suppression [Quantitative Concept]
   861   C0728721:suppression [Mental Process]

Phrase: "occurring at 24 h."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   737   C1709305:Occur [Activity]
   737   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.6: While insulin induced expression of C/EBP and C/EBP within 1 h and caused a >20-fold increase by 4 h, expression returned to nearly pretreatment levels by 24 h. 

Phrase: "While"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "expression of C/EBP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1171362:expression protein [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   716   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "C/EBP within 1 h"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   853   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   814   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C2752241:enhancer binding [Genetic Function]
   774 E C0033618:Protein Binding [Molecular Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a >20-fold increase by 4 h,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "returned"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0332156:Return [Qualitative Concept]

Phrase: "to nearly pretreatment levels by 24 h."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   748   C0441889:Levels [Qualitative Concept]
   748   C1550147:Pretreatment [Substance]
   748   C2709094:pre treatment [Temporal Concept]
   748   C3539075:Pretreatment [Temporal Concept]
   748   C3539076:Pretreatment [Activity]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.7: The insulin concentration dependence of these effects was consistent with involvement of the insulin receptor. 

Phrase: "The insulin concentration dependence of these effects"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0011546:Dependence [Mental Process]
   748   C0439857:Dependence [Mental or Behavioral Dysfunction]
   748   C2698668:DEPENDENCE [Regulation or Law]

Phrase: "was"

Phrase: "consistent with involvement of the insulin receptor."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0332290:Consistent with [Idea or Concept]
           Consistent
Processing 00000000.tx.8: Gel shift analysis revealed that 6 h of insulin treatment decreased the binding of nuclear C/EBP while increasing binding of nuclear C/EBP and C/EBP. 

Phrase: "Gel shift analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0598490:Gel Shift Analysis [Laboratory Procedure]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that 6 h of insulin treatment"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0444953:H 6 [Intellectual Product]
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "the binding of nuclear C/EBP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "while"

Phrase: "increasing binding of nuclear C/EBP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "C/EBP."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
Processing 00000000.tx.9: The reciprocal effects of insulin on the steady-state levels of C/EBP transcription factors can be accounted for kinetically and quantitatively by changes in their mRNA levels, which can be accounted for by effects on gene transcription. 

Phrase: "The reciprocal effects of insulin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on the steady-state levels"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   901   C0678587:steady state [Natural Phenomenon or Process]
   884   C0683927:state level [Spatial Concept]
   827   C0205361:Steady [Qualitative Concept]
   827   C0441889:Levels [Qualitative Concept]
   827   C1301808:State [Geographic Area]
   827   C1442792:State [Functional Concept]
   827   C3148680:State [Geographic Area]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "of C/EBP transcription factors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   896   C0526260:Transcription Factor, CCAAT-Binding [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           CCAAT-Binding Factor
   827   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0040649:Transcription [Genetic Function]
   766   C1521761:Factor [Functional Concept]
   766   C2827422:Factor [Conceptual Entity]
   734   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "can"

Phrase: "be"

Phrase: "accounted for kinetically"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1551359:account [Idea or Concept]
   756   C2741673:Account # [Clinical Attribute]
   756   C2981730:Account [Classification]

Phrase: "and"

Phrase: "quantitatively by changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0392747:changes [Functional Concept]
   790   C0443172:changes [Quantitative Concept]
   756 E C1705241:Change [Quantitative Concept]

Phrase: "in their mRNA levels,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "which"

Phrase: "can"

Phrase: "be"

Phrase: "accounted for"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1551359:account [Idea or Concept]
   799   C2741673:Account # [Clinical Attribute]
   799   C2981730:Account [Classification]

Phrase: "by effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "on gene transcription."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040649:Gene Transcription [Genetic Function]
           Transcription
Processing 00000000.tx.10: The effects of insulin on adipocyte gene transcription (e.g. GLUT4) may be mediated, at least in part, by down-regulation of C/EBP and/or its dephosphorylation. 

Phrase: "The effects of insulin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "on adipocyte gene transcription"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0040649:Gene Transcription [Genetic Function]
           Transcription

Phrase: "("

Phrase: "e.g. GLUT4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0166441:GLUT-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420175:GLUT4 [Gene or Genome]
  1000   C2982484:GLUT4 [Gene or Genome]

Phrase: ")"

Phrase: "may"

Phrase: "be"

Phrase: "mediated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086597:mediated [Social Behavior]
  1000   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: ","

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "in part,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "by down-regulation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013081:Down-Regulation [Cell Function,Molecular Function]
   861   C0851285:Regulation [Governmental or Regulatory Activity]
   861   C1327622:Regulation [Biologic Function]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "of C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "and/or"

Phrase: "its dephosphorylation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1158884:Dephosphorylation [Molecular Function]
  1000   C3160734:Dephosphorylation [Molecular Function]
Processing 00000000.tx.11: INTRODUCTION A large body of evidence has shown that differentiation of 3T3 preadipocytes into adipocytes in cell culture serves as a faithful model of the differentiation process in vivo (reviewed in (1) ). 

Phrase: "INTRODUCTION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1293116:Introduction [Health Care Activity]
  1000   C1875307:INTRODUCTION [Manufactured Object]

Phrase: "A large body of evidence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0242821:body [Human]
   760   C0460148:Body [Anatomical Structure]
   760   C1268086:Body [Anatomical Structure]

Phrase: "has"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that differentiation of 3T3 preadipocytes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0007589:Differentiation [Cell Function]
   760   C1511938:Differentiation [Clinical Attribute]
   760   C2945687:Differentiation [Functional Concept]

Phrase: "into adipocytes in cell culture"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0007585:Cell Culture [Laboratory Procedure]
   812   C0010453:Culture [Idea or Concept]
   812   C0220814:culture [Functional Concept]
   812   C0430400:Culture [Laboratory Procedure]
   812   C2242979:Culture [Laboratory Procedure]

Phrase: "serves as a faithful model of the differentiation process"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0007589:Differentiation [Cell Function]
   742   C1184743:Process [Body Part, Organ, or Organ Component]
   742   C1511938:Differentiation [Clinical Attribute]
   742   C1522240:Process [Phenomenon or Process]
   742   C2945687:Differentiation [Functional Concept]
   742   C3161035:Model [Intellectual Product]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "("

Phrase: "reviewed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0282443:reviewed [Intellectual Product]
  1000   C1709940:Reviewed [Qualitative Concept]
   966 E C1552617:Review [Idea or Concept]

Phrase: "in (1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]

Phrase: ")"

Phrase: ")."
Processing 00000000.tx.12: Two cell lines, i.e. the 3T3-L1 and 3T3-F442A, have been most extensively characterized and are now widely used for the study of preadipocyte differentiation(2, 3, 4, 5, 6, 7) . When subjected to an appropriate differentiation protocol, 3T3 preadipocytes lose their fibroblastic features, round-up, and acquire the morphological and biochemical phenotype of adipocytes. 

Phrase: "Two cell lines,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0007600:Cell lines [Cell]
   827   C0205132:lines [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "the 3T3-L1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441918:L1 [Finding]
   861   C1179698:L1 [Body Location or Region]
   861   C1416177:L1 [Gene or Genome]

Phrase: "and"

Phrase: "3T3-F442A,"

Phrase: "have"

Phrase: "been"

Phrase: "most extensively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205393:Most [Quantitative Concept]

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: "and"

Phrase: "are"

Phrase: "now widely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1948052:Now [Temporal Concept]

Phrase: "used for the study of preadipocyte differentiation"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   757   C0869040:study use [Research Activity]
   757   C1524063:Use of [Functional Concept]
   748   C0007589:Differentiation [Cell Function]
   748   C0557651:Study [Manufactured Object]
   748   C1273517:used [Finding]
   748   C1511938:Differentiation [Clinical Attribute]
   748   C2603343:Study [Research Activity]
   748   C2945687:Differentiation [Functional Concept]
   714 E C0042153:use [Functional Concept]
   714 E C0457083:Use [Functional Concept]
   714 E C1947944:Use [Intellectual Product]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4,"

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "6,"

Phrase: "7"

Phrase: ") ."

Phrase: "When"

Phrase: "subjected to an appropriate differentiation protocol,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   753   C0007589:Differentiation [Cell Function]
   753   C0442711:Protocol [Intellectual Product]
   753   C1507394:Protocol [Intellectual Product]
   753   C1511938:Differentiation [Clinical Attribute]
   753   C1522729:Protocol [Intellectual Product]
   753   C1548787:Appropriate [Qualitative Concept]
   753   C2348563:Protocol [Intellectual Product]
   753   C2945687:Differentiation [Functional Concept]
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]

Phrase: "3T3 preadipocytes"

Phrase: "lose"

Phrase: "their fibroblastic features,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1521970:Feature [Qualitative Concept]
   827   C1706388:Feature [Conceptual Entity]
   827   C2346469:Feature [Qualitative Concept]
   827   C2348519:Feature [Qualitative Concept]

Phrase: "round-up,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332490:Round [Spatial Concept]

Phrase: "and"

Phrase: "acquire"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1706701:Acquire [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the morphological"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0543482:morphological [Spatial Concept]
   928 E C0332437:Morphology [Qualitative Concept]
   928 E C0700329:Morphology, NOS [Finding]
   928 E C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "biochemical phenotype of adipocytes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031437:Phenotype [Organism Attribute]
   770   C1285572:Phenotype [Laboratory Procedure]
Processing 00000000.tx.13: Concomitant with the accumulation of cytoplasmic triacylglycerol is the coordinate expression of virtually every enzyme of the pathways of de novo fatty acid and triacylglycerol biosynthesis. 

Phrase: "Concomitant with the accumulation of cytoplasmic triacylglycerol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0521115:Concomitant [Temporal Concept]

Phrase: "is"

Phrase: "the coordinate expression of virtually"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "every enzyme of the pathways of de novo fatty acid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   741   C0598390:enzyme pathway [Molecular Function]
   739   C0014442:Enzyme [Enzyme,Organic Chemical]

Phrase: "and"

Phrase: "triacylglycerol biosynthesis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1157337:triacylglycerol biosynthesis [Molecular Function]
   861   C0005572:biosynthesis [Functional Concept]
   861   C0220781:Biosynthesis [Biologic Function]
Processing 00000000.tx.14: In addition, differentiating preadipocytes acquire the complement of proteins for lipolysis of triacylglycerol, uptake, and intracellular translocation of fatty acids, as well as responsiveness to lipogenic and lipolytic hormones (1) . It has been established that these coordinate changes in the cellular levels of proteins that give rise to the adipocyte phenotype are almost entirely due to changes in the transcription rates of the corresponding genes(8, 9) . Although the sequence of events which prompt preadipocyte differentiation is not fully understood, compelling evidence indicates that C/EBP ()plays an essential role in this process(10, 11, 12, 13, 14, 15) . C/EBP appears to function both by inhibiting the clonal expansion that precedes terminal differentiation (16) and by activating the coordinate expression of a group of adipocyte genes whose promoters possess C/EBP-binding sites(10, 11, 17, 18) . Unequivocal proof that C/EBP is essential for differentiation was obtained using the antisense RNA approach(13, 19) . Expression of a truncated C/EBP antisense RNA in 3T3-L1 preadipocytes blocked expression of C/EBP, transcription of several adipocyte genes (i.e. 422/aP2, SCD1, and GLUT4), and accumulation of cytoplasmic triacylglycerol(13) . More recently it was shown that expression of C/EBP is not only necessary, but is sufficient, to induce preadipocyte differentiation(14, 15) . Thus, isopropyl-1-thio--D-galactopyranoside-induced expression of C/EBP by 3T3-L1 preadipocytes harboring a LacSwitch C/EBP expression vector system caused expression of adipocyte markers and acquisition of the adipocyte phenotype(14) . In addition, ectopic expression of C/EBP using a retroviral expression vector was shown to induce adipogenesis in a variety of cell lines(15) . C/EBP mRNA has been shown to give rise to two major alternative translation products, p42 and p30(18, 20) , both of which are expressed by 3T3-L1 adipocytes, liver, and white adipose tissue. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "differentiating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205615:differentiating [Qualitative Concept]

Phrase: "preadipocytes"

Phrase: "acquire"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1706701:Acquire [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the complement of proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0009498:Complement Proteins [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Complement

Phrase: "for lipolysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023796:Lipolysis [Organism Function]

Phrase: "of triacylglycerol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041004:Triacylglycerol [Biologically Active Substance,Lipid]

Phrase: "uptake,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243144:Uptake [Physiologic Function]
  1000   C0347980:% uptake [Quantitative Concept]

Phrase: "and"

Phrase: "intracellular translocation of fatty acids,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0599813:Intracellular translocation [Cell Function]
   760   C0040715:Translocation [Cell or Molecular Dysfunction]
   760   C2987521:Translocation [Activity]

Phrase: "as well as"

Phrase: "responsiveness to lipogenic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C0205342:Responsive [Functional Concept]

Phrase: "and"

Phrase: "lipolytic hormones"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0019932:Hormones [Hormone]
   777 E C0458083:Hormonal [Qualitative Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ") ."

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "that"

Phrase: "these coordinate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0427184:coordinate [Finding]
  1000   C0700114:coordinate [Functional Concept]
  1000   C1707511:Coordinate [Spatial Concept]

Phrase: "changes in the cellular levels of proteins"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   748   C0007634:Cellular [Cell]
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0178539:Cellular [Functional Concept]
   748   C0392747:Change [Functional Concept]
   748   C0441889:Levels [Qualitative Concept]
   748   C0443172:change [Quantitative Concept]
   748   C1705241:Change [Quantitative Concept]
   741   C0428479:Protein level [Laboratory or Test Result]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "that"

Phrase: "give"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "rise to the adipocyte phenotype"

Phrase: "are"

Phrase: "almost entirely due to changes"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   760   C3146286:Due [Idea or Concept]
   726 E C1705241:Change [Quantitative Concept]

Phrase: "in the transcription rates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]

Phrase: "of the corresponding genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "(8,"

Phrase: "9"

Phrase: ") ."

Phrase: "Although"

Phrase: "the sequence of events"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004793:Sequence [Nucleotide Sequence]
   770   C0162326:Sequence [Nucleotide Sequence]
   770   C0162327:Sequence [Nucleotide Sequence]
   770   C1519249:Sequence [Functional Concept]

Phrase: "which"

Phrase: "prompt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0871157:prompt [Functional Concept]
  1000   C1602245:Prompt [Pharmacologic Substance]

Phrase: "preadipocyte differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0007589:Differentiation [Cell Function]
   861   C1511938:Differentiation [Clinical Attribute]
   861   C2945687:Differentiation [Functional Concept]
   789 E C0205615:Differentiated [Qualitative Concept]

Phrase: "is"

Phrase: "not fully"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "understood"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0162340:Understand [Mental Process]

Phrase: ","

Phrase: "compelling evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "indicates"

Phrase: "that C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "("

Phrase: ")"

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "an essential role in this process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "(10,"

Phrase: "11,"

Phrase: "12,"

Phrase: "13,"

Phrase: "14,"

Phrase: "15"

Phrase: ") . C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "function"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]

Phrase: "both by inhibiting"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   790   C0238767:Both [Spatial Concept]
   790   C1706086:Both [Qualitative Concept]
   790   C3463820:Inhibiting [Activity]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]

Phrase: "the clonal expansion"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1516670:Clonal Expansion [Pathologic Function]
   861   C1522642:Clonal [Tissue]
   861   C1704387:Clonal [Qualitative Concept]
   789 E C0009013:Clone [Cell]
   789 E C0796368:clonality [Diagnostic Procedure]

Phrase: "that"

Phrase: "precedes"

Phrase: "terminal differentiation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C2752630:terminal differentiation [Cell Function]
   861   C0007589:Differentiation [Cell Function]
   861   C1511938:Differentiation [Clinical Attribute]
   861   C2945687:Differentiation [Functional Concept]
   789 E C0205615:Differentiated [Qualitative Concept]

Phrase: "(16"

Phrase: ")"

Phrase: "and by activating"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1515981:And [Idea or Concept]
   790   C1879547:activating [Activity]
   756 E C1515877:Activate [Functional Concept]

Phrase: "the coordinate expression of a group of adipocyte genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   745   C0017262:Gene Expression [Genetic Function]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "whose promoters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086860:promoters [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "possess"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0850310:possess [Mental or Behavioral Dysfunction]
  1000   C3154893:Possess [Idea or Concept]

Phrase: "C/EBP-binding sites"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   858   C0005456:Binding Sites [Receptor]
   841 E C0682969:Binding Site [Amino Acid Sequence]
   827   C0033618:Protein Binding [Molecular Function]
   799   C0205145:Sites [Spatial Concept]
   766 E C1515974:Site [Body Location or Region]
   766 E C2825164:Site [Spatial Concept]
   734   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(10,"

Phrase: "11,"

Phrase: "17,"

Phrase: "18"

Phrase: ") . Unequivocal proof"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0556981:% proof [Quantitative Concept]

Phrase: "that C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "is"

Phrase: "essential for differentiation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205224:Essential [Qualitative Concept]

Phrase: "was"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the antisense RNA approach"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449445:Approach [Spatial Concept]
   734   C0080124:Anti-Sense RNA [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(13,"

Phrase: "19"

Phrase: ") . Expression of a truncated C/EBP antisense RNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0040649:RNA Expression [Genetic Function]
   757   C1171362:expression protein [Genetic Function]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in 3T3-L1 preadipocytes"

Phrase: "blocked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:Blocked [Pathologic Function]
  1000   C0332206:Blocked [Functional Concept]
  1000   C2983591:BLOCKED [Research Activity]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "expression of C/EBP,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1171362:expression protein [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   716   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "transcription of several adipocyte genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0040649:genes transcription [Genetic Function]
           Transcription

Phrase: "(i.e. 422/aP2,"

Phrase: "SCD1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1419846:SCD1 [Gene or Genome]
  1000   C3540808:SCD1 [Gene or Genome]

Phrase: "and"

Phrase: "GLUT4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0166441:GLUT-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420175:GLUT4 [Gene or Genome]
  1000   C2982484:GLUT4 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "accumulation of cytoplasmic triacylglycerol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   819   C0544951:Cytoplasmic accumulation [Cell or Molecular Dysfunction]

Phrase: "(13"

Phrase: ") . More recently"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205172:More [Functional Concept]
   861   C0332185:Recently [Temporal Concept]

Phrase: "it"

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that expression of C/EBP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1171362:expression protein [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "not only necessary,"

Phrase: "but"

Phrase: "is"

Phrase: "sufficient, to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "preadipocyte differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0007589:Differentiation [Cell Function]
   861   C1511938:Differentiation [Clinical Attribute]
   861   C2945687:Differentiation [Functional Concept]
   789 E C0205615:Differentiated [Qualitative Concept]

Phrase: "(14,"

Phrase: "15"

Phrase: ") . Thus,"

Phrase: "isopropyl-1-thio"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1412102:THIO [Gene or Genome]

Phrase: "-"

Phrase: "-"

Phrase: "D-"

Phrase: "galactopyranoside-induced expression of C/EBP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1171362:expression protein [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "by 3T3-L1 preadipocytes"

Phrase: "harboring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0475311:Harbor [Manufactured Object]

Phrase: "a LacSwitch C/EBP expression vector system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   793   C0449913:System [Functional Concept]
   793   C1553451:System [Manufactured Object]
   793   C1704459:System [Medical Device]
   721 E C0205373:Systemic [Functional Concept]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "expression of adipocyte markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "acquisition of the adipocyte phenotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1706701:Acquisition [Activity]

Phrase: "(14"

Phrase: ") ."

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "ectopic expression of C/EBP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1512167:Ectopic Expression [Genetic Function]
   774   C1171362:expression protein [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a retroviral expression vector"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C1514926:Retroviral Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   901   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0442335:Vector [Spatial Concept]
   827   C1705099:Vector [Idea or Concept]

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "adipogenesis in a variety of cell lines"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0596843:Adipogenesis [Molecular Function]

Phrase: "(15"

Phrase: ") . C/EBP mRNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   771   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "give"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "rise to two major alternative translation products,"

Phrase: "p42"

Phrase: "and"

Phrase: "p30"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0069919:P30 [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1538722:p30 [Gene or Genome]

Phrase: "(18,"

Phrase: "20"

Phrase: ")"

Phrase: ","

Phrase: "both of which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0238767:Both [Spatial Concept]
   790   C1706086:Both [Qualitative Concept]

Phrase: "are"

Phrase: "expressed by 3T3-L1 adipocytes,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0206131:Adipocytes [Cell]
   760   C0441918:L1 [Finding]
   760   C1179698:L1 [Body Location or Region]
   760   C1416177:L1 [Gene or Genome]

Phrase: "liver,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "and"

Phrase: "white adipose tissue."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C1704223:White Adipose Tissue [Tissue]
   901   C0001527:Adipose tissue [Tissue]
   827   C0007457:White [Population Group]
   827   C0040300:Tissue [Tissue]
   827   C0043157:White [Population Group]
   827   C0220938:White [Qualitative Concept]
   827   C1547928:Tissue [Intellectual Product]
   755   C0028754:Adiposity [Disease or Syndrome]
   755   C1563743:adiposity [Organism Attribute]
Processing 00000000.tx.15: The two C/EBP isoforms possess some similar and some dissimilar functional properties. 

Phrase: "The two C/EBP isoforms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0597298:Protein Isoforms [Amino Acid, Peptide, or Protein]
           Isoforms
   734   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "possess"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0850310:possess [Mental or Behavioral Dysfunction]
  1000   C3154893:Possess [Idea or Concept]

Phrase: "some similar"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348205:Similar [Qualitative Concept]

Phrase: "and"

Phrase: "some dissimilar functional properties."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0871161:properties [Qualitative Concept]
   827   C1292721:properties [Functional Concept]
   793 E C1882134:Property [Conceptual Entity]
   793 E C2347695:Property [Entity]
Processing 00000000.tx.16: While both isoforms transactivate the promoters of certain adipocyte genes (18) , only p42 is antimitotic and capable of terminating clonal expansion. 

Phrase: "While"

Phrase: "both isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "transactivate"

Phrase: "the promoters of certain adipocyte genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0314621:gene promoters [Gene or Genome]
   753   C0086860:promoters [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(18"

Phrase: ")"

Phrase: ","

Phrase: "only p42"

Phrase: "is"

Phrase: "antimitotic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003379:antimitotic [Pharmacologic Substance]

Phrase: "and"

Phrase: "capable of terminating clonal expansion."
Processing 00000000.tx.17: Moreover, the relative levels of expression of the two isoforms differ during hepatic development and during the differentiation of 3T3-L1 preadipocytes raising the possibility that they play different roles during differentiation of these cell types. 

Phrase: "Moreover,"

Phrase: "the relative levels of expression of the two isoforms"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   745   C3244092:expression level [Idea or Concept]
   742   C0441889:Levels [Qualitative Concept]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "differ during hepatic development"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205054:Hepatic [Body Location or Region]
   770   C0243107:development [Physiologic Function]
   770   C0678723:Development [Organism Function]
   770   C1527148:Development [Functional Concept]

Phrase: "and during the differentiation of 3T3-L1 preadipocytes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0007589:Differentiation [Cell Function]
   744   C0441918:L1 [Finding]
   744   C1179698:L1 [Body Location or Region]
   744   C1416177:L1 [Gene or Genome]
   744   C1511938:Differentiation [Clinical Attribute]
   744   C1515981:And [Idea or Concept]
   744   C2945687:Differentiation [Functional Concept]

Phrase: "raising"

Phrase: "the possibility"

Phrase: "that"

Phrase: "they"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "different roles during differentiation of these cell types."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0035820:Roles [Social Behavior]
   711 E C1705810:Role [Conceptual Entity]
Processing 00000000.tx.18: Although expression of p30 precedes expression of p42 during development and differentiation, both isoforms are expressed by terminally differentiated adipocytes and hepatocytes. 

Phrase: "Although"

Phrase: "expression of p30"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "precedes"

Phrase: "expression of p42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "during development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "and"

Phrase: "differentiation,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "both isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "are"

Phrase: "expressed by terminally differentiated adipocytes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0007589:Differentiated [Cell Function]
   760   C0205615:Differentiated [Qualitative Concept]
   760   C0206131:Adipocytes [Cell]
   745   C1159884:adipocyte differentiation [Cell Function]

Phrase: "and"

Phrase: "hepatocytes."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0227525:Hepatocytes [Cell]
   966 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.19: The C/EBP family of transcription factors share amino acid sequence similarity within their C-terminal basic region/leucine zipper domain, which confers the capacity to dimerize and bind DNA (reviewed by McKnight(21) ). 

Phrase: "The C/EBP family of transcription factors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C1335532:Protein Family [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0015576:Family [Family Group]
   742   C1704727:Family [Conceptual Entity]

Phrase: "share"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "amino acid sequence similarity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1710052:Sequence Similarity [Quantitative Concept]
   812   C2348205:Similarity [Qualitative Concept]
   756   C0002518:Amino Acid Sequence [Amino Acid Sequence]

Phrase: "within their C-terminal basic region/leucine zipper domain,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   852   C1515557:Basic Leucine Zipper [Amino Acid Sequence]
   818   C0079686:Leucine Zipper [Amino Acid, Peptide, or Protein]
   795   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   795   C0453984:Zipper [Manufactured Object]
   795   C1880389:Domain [Functional Concept]
   795   C1883221:Domain [Conceptual Entity]
   795   C3541951:Domain [Intellectual Product]

Phrase: "which"

Phrase: "confers"

Phrase: "the capacity to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1516240:Capacity [Quantitative Concept]

Phrase: "dimerize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376525:Dimerize [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "("

Phrase: "reviewed by McKnight"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0282443:reviewed [Intellectual Product]
   790   C1709940:Reviewed [Qualitative Concept]
   756 E C1552617:Review [Idea or Concept]

Phrase: "(21"

Phrase: ")"

Phrase: ")."
Processing 00000000.tx.20: Members of the C/EBP family can form homo- and heterodimers, all of which can bind to the same cis-regulatory elements within the promoters/enhancers of genes regulated by the C/EBP's. 

Phrase: "Members of the C/EBP family"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   767   C0086282:Family Members [Family Group]
   750 E C1611821:Family Member [Intellectual Product]
   744   C0680022:members [Population Group]
   711 E C2698041:Member [Professional or Occupational Group]

Phrase: "can"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "homo-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1300203:Homo [Mammal]
  1000   C3245470:HOMO [Finding]

Phrase: "and"

Phrase: "heterodimers,"

Phrase: "all of which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0444868:All [Quantitative Concept]
   790   C3539085:All [Idea or Concept]

Phrase: "can"

Phrase: "bind to the same cis-regulatory elements"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   748   C0013879:Elements [Element, Ion, or Isotope]
   748   C0220905:regulatory [Regulation or Law]
   748   C0445247:Same [Qualitative Concept]
   748   C1145667:Bind [Activity]
   748   C1167622:bind [Molecular Function]
   748   C1504308:Cis [Eukaryote]
   748   C1704735:Regulatory [Conceptual Entity]
   745   C0034987:Regulatory Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   714 E C1705248:Element [Conceptual Entity]

Phrase: "within the promoters/enhancers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "of genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "regulated by the C/EBP's."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0851285:Regulated [Governmental or Regulatory Activity]
Processing 00000000.tx.21: The temporal expression of C/EBP and C/EBP during differentiation of 3T3-L1 preadipocytes, and the presence of a C/EBP-binding site within the C/EBP gene promoter, has led to the hypothesis that C/EBP and/or C/EBP may be responsible for the activation of expression of the C/EBP gene(12) . Further work will be required to clarify the roles of C/EBP and C/EBP in preadipocyte differentiation. 

Phrase: "The temporal expression of C/EBP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1171362:expression protein [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "C/EBP during differentiation of 3T3-L1 preadipocytes,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   806   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   782   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C2752241:enhancer binding [Genetic Function]
   757 E C0033618:Protein Binding [Molecular Function]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0243122:binding [Functional Concept]
   739   C1145667:Binding [Activity]
   739   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "the presence of a C/EBP-binding site"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "within the C/EBP gene promoter,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "led to the hypothesis"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   770   C1512571:Hypothesis [Idea or Concept]
   770   C1708698:LED [Manufactured Object]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C1522538:Lead [Functional Concept]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "that C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "and/or"

Phrase: "C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "may"

Phrase: "be"

Phrase: "responsible for the activation of expression of the C/EBP gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   735   C1273518:Responsible [Finding]

Phrase: "(12"

Phrase: ") . Further work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043227:Work [Occupational Activity]

Phrase: "will"

Phrase: "be"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "clarify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986669:Clarify [Activity]

Phrase: "the roles of C/EBP"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0035820:Roles [Social Behavior]
   714 E C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "C/EBP in preadipocyte differentiation."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   853   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   814   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C2752241:enhancer binding [Genetic Function]
   774 E C0033618:Protein Binding [Molecular Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
Processing 00000000.tx.22: While members of the C/EBP family have been implicated in the differentiation of 3T3-L1 preadipocytes, the role(s) of these transcription factors in the mature, fully-differentiated adipocyte has not been extensively investigated. 

Phrase: "While"

Phrase: "members of the C/EBP family"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   767   C0086282:Family Members [Family Group]
   750 E C1611821:Family Member [Intellectual Product]
   744   C0680022:members [Population Group]
   711 E C2698041:Member [Professional or Occupational Group]

Phrase: "have"

Phrase: "been"

Phrase: "implicated in the differentiation of 3T3-L1 preadipocytes,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0007589:Differentiation [Cell Function]
   744   C0441918:L1 [Finding]
   744   C1179698:L1 [Body Location or Region]
   744   C1416177:L1 [Gene or Genome]
   744   C1511938:Differentiation [Clinical Attribute]
   744   C2945687:Differentiation [Functional Concept]

Phrase: "the role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035820:Role [Social Behavior]
  1000   C1705810:Role [Conceptual Entity]

Phrase: "("

Phrase: "s) of these transcription factors"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0040649:Transcription [Genetic Function]
   760   C2603362:S' [Clinical Attribute]
   726   C1521761:Factor [Functional Concept]
   726   C2827422:Factor [Conceptual Entity]

Phrase: "in the mature, fully-differentiated adipocyte"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0206131:Adipocyte [Cell]

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "extensively"

Phrase: "investigated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]
Processing 00000000.tx.23: Recently, we reported that glucocorticoids exert rapid reciprocal effects on the expression of C/EBP, and , largely by altering transcription of the corresponding genes(22) . In view of the established roles of insulin and glucocorticoids on carbohydrate and lipid metabolism in the adipocyte (23, 24, 25, 26) and the fact that a number of genes which function in these processes are regulated by C/EBP, we examined the effect of insulin on the expression of C/EBP, and in terminally-differentiated 3T3-L1 adipocytes. 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "we"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that glucocorticoids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017710:Glucocorticoids [Hormone,Steroid]

Phrase: "exert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "rapid reciprocal effects on the expression of C/EBP,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   738   C1280500:effects [Qualitative Concept]
   704 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: ","

Phrase: "largely by altering transcription of the corresponding genes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0040649:genes transcription [Genetic Function]
           Transcription
   744   C0017337:Genes [Gene or Genome]

Phrase: "(22"

Phrase: ") ."

Phrase: "In view of the established roles"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0035820:Roles [Social Behavior]
   827 E C1705810:Role [Conceptual Entity]

Phrase: "of insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "glucocorticoids on carbohydrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0017710:Glucocorticoids [Hormone,Steroid]

Phrase: "and"

Phrase: "lipid metabolism in the adipocyte"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0598783:Lipid Metabolism [Molecular Function]
   806   C1517898:Lipid Metabolism [Molecular Function]
   760   C0023779:Lipid [Lipid]
   760   C0025519:Metabolism [Organism Function]
   760   C0025520:metabolism [Functional Concept]

Phrase: "(23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "24,"

Phrase: "25,"

Phrase: "26"

Phrase: ")"

Phrase: "and"

Phrase: "the fact"

Phrase: "that"

Phrase: "a number of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "which"

Phrase: "function in these processes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1705273:Function [Intellectual Product]
   737   C1184743:Process [Body Part, Organ, or Organ Component]
   737   C1522240:Process [Phenomenon or Process]

Phrase: "are"

Phrase: "regulated by C/EBP,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   882   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C2752241:enhancer binding [Genetic Function]
   783 E C0033618:Protein Binding [Molecular Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0243122:binding [Functional Concept]
   753   C0851285:Regulated [Governmental or Regulatory Activity]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the effect of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on the expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of C/EBP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "and in terminally-differentiated 3T3-L1 adipocytes."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0007589:Differentiated [Cell Function]
   748   C0205615:Differentiated [Qualitative Concept]
   748   C0206131:Adipocytes [Cell]
   748   C0441918:L1 [Finding]
   748   C1179698:L1 [Body Location or Region]
   748   C1416177:L1 [Gene or Genome]
   748   C1515981:And [Idea or Concept]
   721   C1159884:adipocyte differentiation [Cell Function]
Processing 00000000.tx.24: Our results suggest that insulin regulates C/EBP through at least three mechanisms: post-translational modification, transcription, and through induction of a dominant negative transcription factor (LIP). 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "regulates"

Phrase: "C/EBP through"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   926   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   862   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C2752241:enhancer binding [Genetic Function]
   797 E C0033618:Protein Binding [Molecular Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "at least three mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0441712:Mechanisms [Functional Concept]
   793 E C1706376:Mechanism [Manufactured Object]

Phrase: ":"

Phrase: "post-translational modification,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0033666:Post-Translational Modification [Molecular Function]
   827   C0392747:Modification [Functional Concept]
   827   C0687676:Post [Temporal Concept]
   827   C1519614:Translational [Genetic Function]
   827   C1554963:modification [Qualitative Concept]
   827   C1704687:Post [Manufactured Object]
   755 E C0040712:Translation [Intellectual Product]
   755 E C0597295:translation [Molecular Function]
   755 E C1514253:Postal [Functional Concept]

Phrase: "transcription,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040649:Transcription [Genetic Function]

Phrase: "and through induction of a dominant negative transcription factor"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   764   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   762   C0960756:factor A [Organic Chemical]
   742   C0040649:Transcription [Genetic Function]
   742   C0205160:Negative [Qualitative Concept]
   742   C0205263:Induction [Functional Concept]
   742   C0857127:induction [Therapeutic or Preventive Procedure]
   742   C1513916:Negative [Finding]
   742   C1515981:And [Idea or Concept]
   742   C1521761:Factor [Functional Concept]
   742   C1527180:Dominant [Functional Concept]
   742   C2825415:Negative [Conceptual Entity]
   742   C2825491:Negative [Qualitative Concept]
   742   C2827422:Factor [Conceptual Entity]

Phrase: "(LIP"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0023759:Lip [Body Part, Organ, or Organ Component]
  1000   C1278911:Lip [Body Part, Organ, or Organ Component]
   907 E C0227759:Labia [Body Part, Organ, or Organ Component]
   907 E C1070701:Labia [Eukaryote]
   907 E C2626732:Labium [Eukaryote]

Phrase: ")."
Processing 00000000.tx.25: EXPERIMENTAL PROCEDURES Cell Culture3T3-L1 preadipocytes were maintained and induced to differentiate into adipocytes as described previously(27) , except that insulin was withdrawn from the medium on day 4. 

Phrase: "EXPERIMENTAL PROCEDURES Cell Culture3T3-L1 preadipocytes"

Phrase: "were"

Phrase: "maintained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1314677:Maintained [Functional Concept]
   966 E C0024501:Maintain [Activity]

Phrase: "and"

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "differentiate into adipocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205615:differentiate [Qualitative Concept]
   790   C0206131:Adipocytes [Cell]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(27"

Phrase: ")"

Phrase: ","

Phrase: "except"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332300:except [Functional Concept]

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "withdrawn from the medium"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0009458:Medium [Intellectual Product]
   770   C0424092:Withdrawn [Finding]
   770   C0439536:Medium [Quantitative Concept]
   770   C1705217:Medium [Substance]
   770   C2349954:Withdrawn [Activity]
   770   C2825032:Withdrawn [Mental or Behavioral Dysfunction]
   770   C3244283:medium [Intellectual Product]

Phrase: "on day 4."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]
Processing 00000000.tx.26: Using this protocol, >95% of the cells begin to acquire the adipocyte phenotype 3-4 days after initiating differentiation. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "this protocol,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442711:Protocol [Intellectual Product]
  1000   C1507394:Protocol [Intellectual Product]
  1000   C1522729:Protocol [Intellectual Product]
  1000   C2348563:Protocol [Intellectual Product]

Phrase: ">95% of the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "begin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439659:Begin [Temporal Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "acquire"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1706701:Acquire [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the adipocyte phenotype 3-4 days after initiating differentiation."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   742   C0439228:days [Temporal Concept]
   708 E C0332173:/day [Temporal Concept]
   708 E C0439505:/day [Temporal Concept]
Processing 00000000.tx.27: Fully-differentiated 3T3-L1 adipocytes, 11-14 days after induction of differentiation, were switched to fresh media (Dulbecco's modified Eagle's media, 10% fetal bovine serum) 16-24 h before subjecting cells to insulin or IGF-1 treatment. 

Phrase: "Fully-differentiated 3T3-L1 adipocytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0206131:Adipocytes [Cell]

Phrase: "11-14 days after induction of differentiation,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   748   C0439228:days [Temporal Concept]
   714 E C0332173:/day [Temporal Concept]
   714 E C0439505:/day [Temporal Concept]

Phrase: "were"

Phrase: "switched to fresh media"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   770   C0009458:Media [Intellectual Product]
   770   C0162867:Media [Tissue]
   770   C0443224:Fresh [Qualitative Concept]
   770   C1254021:Media [Tissue]
   770   C2827486:Fresh [Body Substance]
   737 E C0439536:Medium [Quantitative Concept]
   737 E C1705217:Medium [Substance]
   737   C1707719:Switch [Manufactured Object]
   737 E C3244283:medium [Intellectual Product]

Phrase: "(Dulbecco's modified Eagle's media,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   812   C0009458:Media [Intellectual Product]
   812   C0162867:Media [Tissue]
   812   C1254021:Media [Tissue]
   779 E C0439536:Medium [Quantitative Concept]
   779 E C1705217:Medium [Substance]
   779 E C3244283:medium [Intellectual Product]

Phrase: "10% fetal bovine serum"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0007452:Bovine [Mammal]
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0521457:Fetal [Functional Concept]
   812   C1140701:bovine [Mammal]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]

Phrase: ")"

Phrase: "16-24 h before subjecting cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]

Phrase: "to insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "or"

Phrase: "IGF-1 treatment."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   895   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   839   C0679853:factor treatment [Intellectual Product]
   799   C0039798:treatment [Functional Concept]
   799   C0087111:Treatment [Therapeutic or Preventive Procedure]
   799   C1522326:Treatment [Functional Concept]
   799   C1533734:Treatment [Therapeutic or Preventive Procedure]
   799   C1705169:Treatment [Conceptual Entity]
   799   C3538994:TREATMENT [Research Activity]
   780   C0021665:Insulin-like growth factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   780   C0202220:Insulin-like Growth Factor-1 [Laboratory Procedure]
   734   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   734   C1753359:insulin-like growth factor [Molecular Function]
Processing 00000000.tx.28: Insulin was dissolved in 0.1 M HCl and IGF-1 was dissolved in 10 mM acetic acid. 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "dissolved in 0.1 M HCl"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]
   719   C1549535:Dissolve [Functional Concept]

Phrase: "and"

Phrase: "IGF-1"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
  1000   C0021665:Insulin-like growth factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0202220:Insulin-like Growth Factor-1 [Laboratory Procedure]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "dissolved in 10 mM acetic acid."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0000983:Acetic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   790   C0000985:Acetic acid [Organic Chemical]
   753   C0001128:Acid [Chemical]
   753   C0202406:Acid [Laboratory Procedure]
   753   C0981805:ACETIC [Organic Chemical,Pharmacologic Substance]
   719   C1549535:Dissolve [Functional Concept]
Processing 00000000.tx.29: Okadaic acid (Boehringer Mannheim) was dissolved in dimethyl sulfoxide. 

Phrase: "Okadaic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0069389:Ocadaic Acid [Hazardous or Poisonous Substance,Organic Chemical]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "(Boehringer Mannheim"

Phrase: ")"

Phrase: "was"

Phrase: "dissolved in dimethyl sulfoxide."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0012403:Dimethyl Sulfoxide [Organic Chemical,Pharmacologic Substance]
   770   C0038770:sulfoxide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C0038771:sulfoxide [Organic Chemical]
   770   C0851343:Sulfoxide [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   737   C1549535:Dissolve [Functional Concept]
Processing 00000000.tx.30: Analysis of RNACellular RNA was isolated from 3T3-L1 cells using guanidine thiocyanate followed by ultracentrifugation through CsCl(28) . The amount of C/EBP and C/EBP mRNA was assessed by Northern blot analysis(28) . Total RNA (20 g) was separated by electrophoresis in horizontal 1.2% agarose gels containing 6.5% formaldehyde. 

Phrase: "Analysis of RNACellular RNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C0872262:RNA Analysis [Laboratory Procedure,Research Activity]
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "isolated from 3T3-L1 cells"
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   862   C1257743:3T3-L1 Cells [Cell]
   797   C0085087:3T3 Cells [Cell]
   760   C0007634:Cells [Cell]
   760   C0205409:Isolated [Functional Concept]
   760   C0441918:L1 [Finding]
   760   C1179698:L1 [Body Location or Region]
   760   C1416177:L1 [Gene or Genome]
   760   C1548221:Isolated [Idea or Concept]
   760   C3282337:Cells [Cell]
   726 E C0370215:Isolate [Substance]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1875400:ISOLATE [Pharmacologic Substance]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "guanidine thiocyanate"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0061947:guanidine thiocyanate [Organic Chemical,Pharmacologic Substance]
   861   C0018320:guanidine [Organic Chemical]
   861   C0039887:thiocyanate [Organic Chemical]
   861   C0120446:Guanidine [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   861   C0220926:thiocyanate [Inorganic Chemical]

Phrase: "followed by ultracentrifugation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0041609:Ultracentrifugation [Laboratory Procedure]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "through CsCl"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0055134:CsCl [Inorganic Chemical,Pharmacologic Substance]

Phrase: "(28"

Phrase: ") ."

Phrase: "The amount of C/EBP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1265611:Amount [Quantitative Concept]

Phrase: "and"

Phrase: "C/EBP mRNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   771   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "assessed by Northern blot analysis"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0005861:Northern blot analysis [Molecular Biology Research Technique]
           Northern Blot
   806   C1621557:Northern Blot [Research Device]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1516048:Assessed [Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1709269:Northern [Spatial Concept]

Phrase: "(28"

Phrase: ") . Total RNA (20 g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439267:g% [Quantitative Concept]

Phrase: "was"

Phrase: "separated by electrophoresis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0013855:Electrophoresis [Laboratory Procedure]
   790   C0086972:Separated [Finding]
   790   C0443299:separated [Spatial Concept]
   790   C0687118:Separated [Functional Concept]

Phrase: "in horizontal 1.2% agarose gels"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   823   C1706746:Agarose Gel [Research Device]
   804   C0017243:Gels [Biomedical or Dental Material]
   771 E C1382104:Gel [Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "6.5% formaldehyde."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0016564:Formaldehyde [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   734   C0442749:6/5 [Finding]
Processing 00000000.tx.31: RNA was transferred to nylon membranes (Hybond-N; Amersham Corp.) overnight and covalently bonded to the membrane by exposure to ultraviolet light (UV Stratalinker 1800; Stratagene). 

Phrase: "RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "transferred to nylon membranes"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0025255:Membranes [Tissue]
   770   C0028736:Nylon [Biomedical or Dental Material,Organic Chemical]
   770   C0348011:transferred [Functional Concept]
   770   C0740034:Nylon [Biomedical or Dental Material]
   737 E C0040671:Transfer [Mental Process]
   737 E C0596901:Membrane [Cell Component]
   737 E C1705822:Transfer [Activity]
   737 E C1706182:Membrane [Manufactured Object]

Phrase: "(Hybond-N"

Phrase: "; Amersham Corp.)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0683758:Corp. [Organization]

Phrase: "overnight"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439583:Overnight [Temporal Concept]

Phrase: "and"

Phrase: "covalently"

Phrase: "bonded to the membrane"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0025255:Membrane [Tissue]
   770   C0596901:Membrane [Cell Component]
   770   C1706182:Membrane [Manufactured Object]

Phrase: "by exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0274281:Exposure, NOS [Injury or Poisoning]
  1000   C0332157:Exposure [Clinical Attribute]

Phrase: "to ultraviolet light"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0041625:Ultraviolet Light [Natural Phenomenon or Process]
   958 E C0181651:ultraviolet lights [Medical Device]
   861   C0023693:Light [Natural Phenomenon or Process]
   861   C1306462:Light [Functional Concept]
   861   C1532472:Ultraviolet [Qualitative Concept]
   861   C1881376:Light [Qualitative Concept]

Phrase: "(UV Stratalinker 1800"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0041625:UV [Natural Phenomenon or Process]
   827   C1961129:uV [Quantitative Concept]

Phrase: "; Stratagene"

Phrase: ")."
Processing 00000000.tx.32: Blots were prehybridized for at least 6 h (42 C) in a solution containing 50% formamide, 4 SSC, 5 Denhardt's solution, 50 mM phosphate buffer, pH 7.0, 100 g/ml yeast tRNA, 0.5 mg/ml sodium pyrophosphate, and 1% sodium dodecyl sulfate (SDS). 

Phrase: "Blots"

Phrase: "were"

Phrase: "prehybridized for"

Phrase: "at least 6 h (42 C) in"

Phrase: "a solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037633:Solution [Substance]
  1000   C0525069:Solution [Biomedical or Dental Material]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "50% formamide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016568:formamide [Organic Chemical]

Phrase: "4 SSC,"

Phrase: "5 Denhardt's solution,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037633:Solution [Substance]
   827   C0525069:Solution [Biomedical or Dental Material]

Phrase: "50 mM phosphate buffer,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   812   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   812   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031701:phosphate [Organophosphorus Compound]
   812   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "pH 7.0,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "100 g/ml yeast tRNA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0035711:tRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C1537998:trnA [Gene or Genome]

Phrase: "0.5 mg/ml sodium pyrophosphate,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   858   C0065530:Mg pyrophosphate [Biologically Active Substance,Inorganic Chemical]
   827   C0074764:sodium pyrophosphate [Inorganic Chemical,Pharmacologic Substance]
   799   C0034320:Pyrophosphate [Inorganic Chemical,Pharmacologic Substance]
   799   C3252566:Pyrophosphate [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "1% sodium dodecyl sulfate (SDS)."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   923   C0037506:Sodium Dodecyl Sulfate [Biomedical or Dental Material,Lipid,Pharmacologic Substance]
   875   C0074769:Sodium sulphate [Inorganic Chemical,Pharmacologic Substance]
   861   C0058632:dodecyl sulfate [Lipid,Pharmacologic Substance]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0038720:Sulfate [Inorganic Chemical]
   812   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C3536965:SULFATE [Element, Ion, or Isotope]
Processing 00000000.tx.33: Hybridization was carried out for at least 16 h at 42 C in an identical solution containing 4 10 dpm of labeled probe per ml. 

Phrase: "Hybridization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020202:Hybridisation [Genetic Function]
  1000   C1300517:Hybridization [Laboratory Procedure]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out for"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0439787:Out [Spatial Concept]
   833   C0849355:Out [Qualitative Concept]

Phrase: "at least 16 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "at 42 C in"

Phrase: "an identical solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037633:Solution [Substance]
   861   C0525069:Solution [Biomedical or Dental Material]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "4 10 dpm of labeled probe"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1512024:DPM [Intellectual Product]
   753   C1634619:dpm [Quantitative Concept]

Phrase: "per ml."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.34: In general, hybridized blots were washed three times in a solution containing 0.5 SSC, 0.1% SDS at 60 C. 

Phrase: "In general, hybridized blots"

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "three times in a solution"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0040223:times [Temporal Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.5 SSC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0444499:0/5 [Quantitative Concept]

Phrase: "0.1% SDS at 60 C."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   800   C0037506:Sodium Dodecyl Sulfate [Biomedical or Dental Material,Lipid,Pharmacologic Substance]
   770   C0058632:dodecyl sulfate [Lipid,Pharmacologic Substance]
   767   C0074769:Sodium sulphate [Inorganic Chemical,Pharmacologic Substance]
   767   C0597484:Sodium 1+ [Element, Ion, or Isotope,Pharmacologic Substance]
           Sodium+
   744   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   744   C0038720:Sulfate [Inorganic Chemical]
   744   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   744   C3536965:SULFATE [Element, Ion, or Isotope]
Processing 00000000.tx.35: Autoradiography was at -80 C with Kodak X-Omat AR film (Eastman Kodak Co.) and an intensifying screen for the times indicated in the figure legends. 

Phrase: "Autoradiography"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004400:Autoradiography [Laboratory Procedure]
   900 E C2986957:Autoradiograph [Manufactured Object]

Phrase: "was"

Phrase: "at -80 C with Kodak X-Omat AR film"

Phrase: "(Eastman Kodak Co.)"

Phrase: "and"

Phrase: "an intensifying screen for the times"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0220908:screen [Health Care Activity]
   753   C1305399:screen [Functional Concept]
   753   C1705053:Screen [Medical Device]

Phrase: "indicated in the figure legends."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1444656:Indicated [Finding]
   726   C2729544:Legend [Pharmacologic Substance]
Processing 00000000.tx.36: Results were quantified using a laser densitometer (LKB Ultroscan XL). 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "were"

Phrase: "quantified"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a laser densitometer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0180321:Densitometer [Medical Device]
   861   C1706216:Densitometer [Medical Device]

Phrase: "(LKB Ultroscan XL"

Phrase: ")."
Processing 00000000.tx.37: The DNA fragment used as a probe for C/EBP mRNA was an 900-base pair SacI/HindIII fragment complementary to the 3` end of the C/EBP coding region, as well as part of the 3`-untranslated region (+1175 to +2078 nucleotides relative to transcriptional start site). 

Phrase: "The DNA fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332255:fragment [Functional Concept]
   861   C1708096:Fragment [Qualitative Concept]

Phrase: "used as a probe"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0182400:Probe [Medical Device]
   770   C1273517:used [Finding]
   770   C1704681:Probe [Gene or Genome]
   770   C2347609:Probe [Chemical Viewed Functionally]
   770   C3536729:Probe [Manufactured Object]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "for C/EBP mRNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   771   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "an 900-base pair SacI/HindIII"

Phrase: "fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332255:fragment [Functional Concept]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "complementary to the 3` end"

Phrase: "of the C/EBP coding region,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   861   C0079941:Protein Coding Region [Gene or Genome]
           Coding Region
   839   C1514562:Protein Region [Amino Acid Sequence]
   799   C0009219:Coding [Occupational Activity]
   799   C0017446:Region [Geographic Area]
   799   C0205147:Region [Spatial Concept]
   766 E C0805701:Code [Intellectual Product]
   734   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   727 E C0205276:Regional [Spatial Concept]
   727 E C1947913:Regional [Spatial Concept]

Phrase: "as well as"

Phrase: "part of the 3`-untranslated region"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1292711:Part of [Spatial Concept]
   753   C0449719:Part [Spatial Concept]
   753   C1709471:Part [Quantitative Concept]

Phrase: "(+1175 to +2078 nucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "relative to transcriptional start site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0080103:Relative [Family Group]
   760   C0205345:Relative [Qualitative Concept]
   760   C1547039:*Relative [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.38: The cDNA fragment for C/EBP is full length and was cloned from a 3T3-L1 adipocyte library as reported previously(29) . The cDNA fragment used as a probe for C/EBP mRNA was as described(12) . Isolated C/EBP, C/EBP, or C/EBP DNA probes were labeled to high specific activity (1 10 dpm/g) by random hexamer priming(30) . Cell Lysates and Immunoblotting3T3-L1 adipocyte monolayers (10 cm) were washed once with 10 ml of phosphate-buffered saline and scraped in 1 ml of a lysis buffer containing 1% SDS, 60 mM Tris-Cl, pH 6.8. 

Phrase: "The cDNA fragment for C/EBP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   744   C0332255:fragment [Functional Concept]
   744   C1708096:Fragment [Qualitative Concept]

Phrase: "is"

Phrase: "full length"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0443225:Full [Qualitative Concept]
   861   C1444754:Length [Quantitative Concept]
   861   C1706316:LENGTH [Research Activity]
   789 E C0205166:Long [Qualitative Concept]
   789 E C1522425:Longest [Qualitative Concept]
   789 E C1706317:Long [Qualitative Concept]

Phrase: "and"

Phrase: "was"

Phrase: "cloned from a 3T3-L1 adipocyte library"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   748   C0009013:cloned [Cell]
   748   C0023621:Library [Manufactured Object,Organization]
   748   C0206131:Adipocyte [Cell]
   748   C0441918:L1 [Finding]
   748   C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C1179698:L1 [Body Location or Region]
   748   C1416177:L1 [Gene or Genome]
   714 E C1522642:Clone [Tissue]

Phrase: "as"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "previously"

Phrase: "(29"

Phrase: ") ."

Phrase: "The cDNA fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332255:fragment [Functional Concept]
   861   C1708096:Fragment [Qualitative Concept]

Phrase: "used as a probe"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0182400:Probe [Medical Device]
   770   C1273517:used [Finding]
   770   C1704681:Probe [Gene or Genome]
   770   C2347609:Probe [Chemical Viewed Functionally]
   770   C3536729:Probe [Manufactured Object]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "for C/EBP mRNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   771   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(12"

Phrase: ") . Isolated C/EBP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   937   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C2752241:enhancer binding [Genetic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0243122:binding [Functional Concept]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]

Phrase: "C/EBP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "or"

Phrase: "C/EBP DNA probes"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0012893:DNA Probes [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0182400:Probes [Medical Device]
   766 E C1704681:Probe [Gene or Genome]
   766 E C2347609:Probe [Chemical Viewed Functionally]
   766 E C3536729:Probe [Manufactured Object]
   734   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "labeled to high specific activity"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   760   C0205177:Activity [Functional Concept]
   760   C0205250:High [Qualitative Concept]
   760   C0205369:Specific [Qualitative Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1299351:High [Qualitative Concept]
   760   C1552740:specific [Intellectual Product]
   760   C1561536:*Activity [Idea or Concept]
   760   C1708632:Labeled [Qualitative Concept]
   760   C2700149:HIGH [Intellectual Product]
   726 E C0181496:Label [Manufactured Object]
   726 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "(1 10 dpm/g) by random hexamer priming"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0720544:G-1 [Organic Chemical,Pharmacologic Substance]
   744   C0439267:g% [Quantitative Concept]

Phrase: "(30"

Phrase: ") . Cell Lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "and"

Phrase: "Immunoblotting3T3-L1 adipocyte monolayers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0872351:monolayers [Clinical Drug]

Phrase: "(10 cm)"

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "once with 10 ml of phosphate-buffered saline"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   767   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   744   C0031701:phosphate [Organophosphorus Compound]
   744   C0036082:Saline [Substance]
   744   C0439526:/mL [Quantitative Concept]
   744   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   744   C1720092:Once [Intellectual Product]
   744   C1948045:Once [Temporal Concept]

Phrase: "and"

Phrase: "scraped in 1 ml of a lysis buffer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0024348:Lysis [Pathologic Function]
   744   C0184933:scraped [Therapeutic or Preventive Procedure]
   744   C0439526:/mL [Quantitative Concept]
   744   C0444082:scraped [Body Substance]
   744   C1536403:lysis [Cell Function]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1% SDS,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   923   C0037506:Sodium Dodecyl Sulfate [Biomedical or Dental Material,Lipid,Pharmacologic Substance]
   875   C0074769:Sodium sulphate [Inorganic Chemical,Pharmacologic Substance]
   861   C0058632:dodecyl sulfate [Lipid,Pharmacologic Substance]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0038720:Sulfate [Inorganic Chemical]
   812   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C3536965:SULFATE [Element, Ion, or Isotope]

Phrase: "60 mM Tris-Cl,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596019:Cl - [Element, Ion, or Isotope]

Phrase: "pH 6.8."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]
Processing 00000000.tx.39: Lysates were boiled for 3 min, vortexed, then boiled for an additional 7 min prior to storing at -35 C. 

Phrase: "Lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "boiled for 3 min,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0702093:/min [Temporal Concept]
   737   C0242301:Boil [Disease or Syndrome]
   737   C1546559:Boil [Intellectual Product]

Phrase: "vortexed,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0439648:vortexed [Spatial Concept]
  1000   C0724378:vortexed [Organic Chemical,Pharmacologic Substance]
   966 E C2719416:Vortex [Pharmacologic Substance]

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "boiled for an additional 7 min"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0702093:/min [Temporal Concept]
   753   C1524062:Additional [Functional Concept]
   719   C0242301:Boil [Disease or Syndrome]
   719   C1546559:Boil [Intellectual Product]

Phrase: "prior to storing at -35 C."
Processing 00000000.tx.40: Western analysis was performed as described previously(13) . Results were quantified using laser densitometry. 

Phrase: "Western analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(13"

Phrase: ") . Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "were"

Phrase: "quantified"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "laser densitometry."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0011321:Densitometry [Laboratory Procedure]
Processing 00000000.tx.41: When presented graphically for C/EBP, the results represent the sum of p30 and p42, and when presented for C/EBP, the results represent the sum of LAP and LIP. 

Phrase: "When"

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "graphically for C/EBP,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   882   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C2752241:enhancer binding [Genetic Function]
   783 E C0033618:Protein Binding [Molecular Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the sum of p30"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1515051:Sum [Quantitative Concept]

Phrase: "and"

Phrase: "p42,"

Phrase: "and"

Phrase: "when"

Phrase: "presented for C/EBP,"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   882   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C2752241:enhancer binding [Genetic Function]
   783 E C0033618:Protein Binding [Molecular Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0243122:binding [Functional Concept]
   753   C0449450:Presented [Idea or Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   719 E C0150312:Present [Quantitative Concept]

Phrase: "the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the sum of LAP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1515051:Sum [Quantitative Concept]

Phrase: "and"

Phrase: "LIP."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0023759:Lip [Body Part, Organ, or Organ Component]
  1000   C1278911:Lip [Body Part, Organ, or Organ Component]
   907 E C0227759:Labia [Body Part, Organ, or Organ Component]
   907 E C1070701:Labia [Eukaryote]
   907 E C2626732:Labium [Eukaryote]
Processing 00000000.tx.42: Preparation of AntibodiesPeptides corresponding to amino acids 278-295 (LRNLFKQLPEPLLASAGH) of C/EBP and 115-130 (ARGPLKREPDWGDGDA) of C/EBP were synthesized (Protein Peptide Facility; Department of Biological Chemistry, Johns Hopkins University School of Medicine) with an additional N-terminal cysteine residue and then cross-linked through the N-terminal-SH to keyhole limpet hemocyanin. 

Phrase: "Preparation of AntibodiesPeptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0455052:Preparation [Health Care Activity]
   790   C1521827:Preparation [Functional Concept]

Phrase: "corresponding to amino acids 278-295"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   756 E C2917660:Amino Acid [Pharmacologic Substance]
   753   C0001128:Acids [Chemical]
   719 E C0202406:Acid [Laboratory Procedure]

Phrase: "(LRNLFKQLPEPLLASAGH"

Phrase: ")"

Phrase: "of C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "115-130"

Phrase: "(ARGPLKREPDWGDGDA"

Phrase: ")"

Phrase: "of C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "were"

Phrase: "synthesized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883254:Synthesized [Activity]

Phrase: "(Protein Peptide Facility"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1547538:Facility [Idea or Concept]

Phrase: "; Department of Biological Chemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "Johns Hopkins University School of Medicine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0036375:School [Manufactured Object,Organization]
   753   C0041740:University [Manufactured Object,Organization]

Phrase: ")"

Phrase: "with an additional N-terminal cysteine residue"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C1709915:Residue [Conceptual Entity]
   804   C1882936:RESIDUE [Phenomenon or Process]
   733 E C1609982:Residual [Qualitative Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "cross-linked through the N-terminal-SH"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0178576:Cross Linked [Natural Phenomenon or Process]
   778   C0332220:cross linked [Functional Concept]
   748   C0038108:SH [Geographic Area]
   748   C0205088:Terminal [Temporal Concept]
   748   C1705314:Terminal [Manufactured Object]
   748   C1705315:Terminal [Spatial Concept]
   748   C2828360:Cross [Conceptual Entity]
   714   C1517892:Link [Intellectual Product]
   714   C1704666:Link [Intellectual Product]

Phrase: "to keyhole limpet hemocyanin."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0064332:keyhole-limpet haemocyanin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018999:Haemocyanin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0324030:Limpet [Eukaryote]
   827   C2350000:Limpet [Food]
Processing 00000000.tx.43: Immunization of rabbits and collection of preimmune and immune sera were performed by HRP (Denver, PA). 

Phrase: "Immunization of rabbits"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   790   C0042196:immunisation [Therapeutic or Preventive Procedure]
   790   C3244291:immunization [Functional Concept]

Phrase: "and"

Phrase: "collection of preimmune"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1516698:Collection [Functional Concept]
   790   C1704814:Collection [Idea or Concept]
   718 E C1516695:Collected [Idea or Concept]

Phrase: "and"

Phrase: "immune sera"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0020960:Immune Sera [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0229671:Sera [Body Substance]
   861   C0439662:Immune [Functional Concept]
   861   C1151254:SerA [Molecular Function]
   827 E C1546774:Serum [Intellectual Product]
   827 E C1550100:Serum [Body Substance]

Phrase: "were"

Phrase: "performed by HRP (Denver,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C1550369:Performed By [Qualitative Concept]
   770   C0019941:HRP [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   770   C0884358:Performed [Functional Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "PA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541314:PA [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.44: Antiserum used for Western blots or supershifting was specific for either C/EBP or C/EBP and interactions with other C/EBP isoforms were not observed. 

Phrase: "Antiserum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "used for Western blots"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   833   C0949466:Western Blots [Laboratory Procedure]
   799 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   770   C1273517:used [Finding]
   770   C1705493:Western [Spatial Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "or"

Phrase: "supershifting"

Phrase: "was"

Phrase: "specific for either C/EBP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205369:Specific [Qualitative Concept]
   748   C1552740:specific [Intellectual Product]

Phrase: "or"

Phrase: "C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "interactions with other C/EBP isoforms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0872079:interactions protein [Molecular Function]
   711   C1704675:Interaction [Functional Concept]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]
Processing 00000000.tx.45: Immune serum against a synthetic peptide corresponding to an internal amino acid sequence of C/EBP (present in both p42 and p30) was prepared as described previously(18) . In some experiments, immune sera to C/EBP and C/EBP were generously provided by Dr. 

Phrase: "Immune serum against a synthetic peptide"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0020960:immune serum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0229671:Serum [Body Substance]
   753   C0439662:Immune [Functional Concept]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]

Phrase: "corresponding to an internal amino acid sequence of C/EBP"
Meta Candidates (Total=28; Excluded=1; Pruned=0; Remaining=27)
   804   C0920679:aminoacid sequence of protein [Amino Acid Sequence]
   790   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   782   C0033618:protein amino acid binding [Molecular Function]
       E   Protein Binding
   770   C0002518:Amino Acid Sequence [Amino Acid Sequence]
           Protein Sequence
   770   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1148572:amino acid binding [Molecular Function]
   767   C1874187:amino acid protein [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   753   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C2752241:enhancer binding [Genetic Function]
   753   C2917660:Amino Acid [Pharmacologic Substance]
   751   C0014290:Sequence, Enhancer [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   736   C0001128:Acid [Chemical]
   736   C0004793:Sequence [Nucleotide Sequence]
   736   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   736   C0162326:Sequence [Nucleotide Sequence]
   736   C0162327:Sequence [Nucleotide Sequence]
   736   C0202406:Acid [Laboratory Procedure]
   736   C0205102:Internal [Spatial Concept]
   736   C0243122:binding [Functional Concept]
   736   C1145667:Binding [Activity]
   736   C1167622:Binding [Molecular Function]
   736   C1519249:Sequence [Functional Concept]
   736   C1553872:Internal [Intellectual Product]
   736   C1619620:Internal [Intellectual Product]

Phrase: "(present in both p42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "p30"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0069919:P30 [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1538722:p30 [Gene or Genome]

Phrase: ")"

Phrase: "was"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(18"

Phrase: ") ."

Phrase: "In some experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "immune sera to C/EBP"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   778   C0020960:Immune Sera [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   757   C0036825:Serum protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C1304893:Protein.serum [Laboratory or Test Result]
   748   C0229671:Sera [Body Substance]
   748   C0439662:Immune [Functional Concept]
   748   C1151254:SerA [Molecular Function]
   714 E C1546774:Serum [Intellectual Product]
   714 E C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "were"

Phrase: "generously"

Phrase: "provided by Dr."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0031831:DR [Professional or Occupational Group]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C1999230:Provided [Activity]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
Processing 00000000.tx.46: Steve McKnight(12) . Preparation of Nuclear ExtractsNuclei were purified from 3T3-L1 cells by a modification (31) of the procedure of Dignam et al.(32) . Nuclear extracts were prepared as described by Lavery and Schibler (33) using a 1 NUN solution (0.3 M NaCl, 1 M urea, 1% Nonidet P-40, 25 mM HEPES, pH 7.9, and 1 mM dithiothreitol). 

Phrase: "Steve McKnight"

Phrase: "(12"

Phrase: ") . Preparation of Nuclear ExtractsNuclei"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0455052:Preparation [Health Care Activity]
   770   C1521827:Preparation [Functional Concept]

Phrase: "were"

Phrase: "purified from 3T3-L1 cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   862   C1257743:3T3-L1 Cells [Cell]
   797   C0085087:3T3 Cells [Cell]
   760   C0007634:Cells [Cell]
   760   C0441918:L1 [Finding]
   760   C1179698:L1 [Body Location or Region]
   760   C1416177:L1 [Gene or Genome]
   760   C1998793:Purified [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "by a modification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392747:Modification [Functional Concept]
  1000   C1554963:modification [Qualitative Concept]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: "of the procedure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
  1000   C1948041:Procedure [Therapeutic or Preventive Procedure]
  1000   C2700391:Procedure [Activity]
  1000   C3274430:PROCEDURE [Health Care Activity]
  1000   C3538935:Procedure [Idea or Concept]
  1000   C3539779:Procedure [Intellectual Product]

Phrase: "of Dignam et al.(32"

Phrase: ") . Nuclear extracts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1518434:Nuclear Extract [Biomedical or Dental Material]
   861   C0521447:Nuclear [Spatial Concept]
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "as"

Phrase: "described by Lavery"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Schibler"

Phrase: "(33"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a 1 NUN solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037633:Solution [Substance]
   812   C0525069:Solution [Biomedical or Dental Material]

Phrase: "(0.3 M NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C1959973:% NaCl [Quantitative Concept]

Phrase: "1 M urea,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0041942:Urea [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   771 E C0728794:Ureaphil [Organic Chemical,Pharmacologic Substance]

Phrase: "1% Nonidet P-40,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0068941:Nonidet P-40 [Organic Chemical,Pharmacologic Substance]
   812   C0068940:nonidet [Organic Chemical,Pharmacologic Substance]
   812   C0439509:/40 [Temporal Concept]

Phrase: "25 mM HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "pH 7.9,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "1 mM dithiothreitol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.47: Protein concentration was determined using the BCA Protein Assay Reagent (Pierce Chemical Co.) and ranged from 8.5 to 10 mg/ml. 

Phrase: "Protein concentration"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0427716:Protein concentration [Laboratory Procedure]
  1000   C1304757:Protein concentration [Laboratory or Test Result]
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "was"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the BCA Protein Assay Reagent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Pierce Chemical Co.)"

Phrase: "and"

Phrase: "ranged from 8.5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1514721:Range [Quantitative Concept]
   737   C2348147:Range [Quantitative Concept]
   737   C3542016:Range [Intellectual Product]

Phrase: "to 10 mg/ml."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439294:mg ml [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.48: Gel Shift AnalysisA double stranded oligonucleotide corresponding to the C/EBP-binding site in the 422(aP2) promoter (10) was labeled using [-P]ATP and DNA polymerase (Klenow fragment; New England Biolabs). 

Phrase: "Gel Shift AnalysisA double stranded oligonucleotide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0028953:Oligonucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "corresponding to the C/EBP-binding site"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   818   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0033618:Protein Binding [Molecular Function]
   764   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C2752241:enhancer binding [Genetic Function]
   762   C0005456:Binding Site [Receptor]
   762   C0682969:Binding Site [Amino Acid Sequence]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0205145:Site [Spatial Concept]
   742   C0243122:binding [Functional Concept]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]
   742   C1515974:Site [Body Location or Region]
   742   C2825164:Site [Spatial Concept]

Phrase: "in the 422"

Phrase: "(aP2"

Phrase: ")"

Phrase: "promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(10"

Phrase: ")"

Phrase: "was"

Phrase: "labeled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708632:Labeled [Qualitative Concept]
   966 E C0181496:Label [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "[-P]ATP"

Phrase: "and"

Phrase: "DNA polymerase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0012892:DNA Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Klenow fragment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0012888:Klenow Fragment [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2257063:Klenow fragment [Genetic Function]
   861   C0332255:fragment [Functional Concept]
   861   C1708096:Fragment [Qualitative Concept]

Phrase: "; New England Biolabs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0027965:New England [Geographic Area]

Phrase: ")."
Processing 00000000.tx.49: The gel shift mixture (40 l) contained 0.33 M urea, 0.1 M NaCl, 0.33% Nonidet P-40, 25 mM HEPES, pH 7.9, 10 mM dithiothreitol, 10% glycerol, 5 g of acetylated bovine serum albumin, 3 g of poly[d(I-C)], and 3.0 10 dpm of P-labeled oligonucleotide. 

Phrase: "The gel shift mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439962:Mixture [Substance]

Phrase: "(40 l)"

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "0.33 M urea,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0041942:Urea [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   756 E C0728794:Ureaphil [Organic Chemical,Pharmacologic Substance]

Phrase: "0.1 M NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C1959973:% NaCl [Quantitative Concept]

Phrase: "0.33% Nonidet P-40,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0068941:Nonidet P-40 [Organic Chemical,Pharmacologic Substance]
   804   C0068940:nonidet [Organic Chemical,Pharmacologic Substance]
   804   C0439509:/40 [Temporal Concept]

Phrase: "25 mM HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "pH 7.9,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "10 mM dithiothreitol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "10% glycerol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "5 g of acetylated bovine serum albumin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0439267:g% [Quantitative Concept]

Phrase: "3 g of poly["
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0032411:Poly G [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0439267:g% [Quantitative Concept]

Phrase: "d("

Phrase: "I-C)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "],"

Phrase: "and"

Phrase: "3.0 10 dpm of P-labeled oligonucleotide."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1512024:DPM [Intellectual Product]
   744   C1634619:dpm [Quantitative Concept]
Processing 00000000.tx.50: This mixture (including 6 l of antiserum and/or preimmune sera as indicated) was incubated on ice for 30 min, then at room temperature for 90 min prior to electrophoresis on 6% polyacrylamide gels. 

Phrase: "This mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439962:Mixture [Substance]

Phrase: "("

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "6 l of antiserum"

Phrase: "and/or"

Phrase: "preimmune sera as indicated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0229671:Sera [Body Substance]
   770   C1151254:SerA [Molecular Function]
   737 E C1546774:Serum [Intellectual Product]
   737 E C1550100:Serum [Body Substance]

Phrase: ")"

Phrase: "was"

Phrase: "incubated on ice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020746:Ice [Inorganic Chemical]
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 30 min,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "then at room temperature"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   770   C0005903:temperature [Organism Attribute]
   770   C0039476:*Temperature [Quantitative Concept]
   770   C1547703:Room [Spatial Concept]
   770   C1883708:Then [Temporal Concept]

Phrase: "for 90 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "prior to electrophoresis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013855:Electrophoresis [Laboratory Procedure]

Phrase: "on 6% polyacrylamide gels."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0071500:polyacrylamide gels [Biomedical or Dental Material,Pharmacologic Substance]
   827   C0017243:Gels [Biomedical or Dental Material]
   827   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   793 E C1382104:Gel [Substance]
Processing 00000000.tx.51: Nuclear Run-on Transcription AnalysisAfter the indicated treatments of 3T3-L1 adipocytes (day 12), nuclei were isolated from transcriptional run-on assays as described by Cornelius et al.(34) . Equal numbers of nuclei were incubated for 25 min at 28 C in the presence of [-P]UTP (6000 Ci/mmol; DuPont). 

Phrase: "Nuclear Run-on Transcription AnalysisAfter"

Phrase: "the indicated treatments of 3T3-L1 adipocytes"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   748   C0087111:Treatments [Therapeutic or Preventive Procedure]
   714 E C0039798:treatment [Functional Concept]
   714 E C1522326:Treatment [Functional Concept]
   714 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   714 E C1705169:Treatment [Conceptual Entity]
   714 E C3538994:TREATMENT [Research Activity]

Phrase: "(day 12"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "nuclei"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0007610:Nucleus [Cell Component]

Phrase: "were"

Phrase: "isolated from transcriptional run-on assays"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   833   C1519116:Run-On Assays [Molecular Biology Research Technique]
   753   C0035953:run [Daily or Recreational Activity]
   753   C0040649:Transcriptional [Genetic Function]
   753   C0205409:Isolated [Functional Concept]
   753   C0600140:run [Finding]
   753   C1548221:Isolated [Idea or Concept]
   753   C1704688:Run [Functional Concept]
   753   C2346414:Run [Finding]
   719   C0005507:Assay [Laboratory Procedure]
   719   C0243073:assay [Qualitative Concept]
   719 E C0370215:Isolate [Substance]
   719   C1510438:Assay [Laboratory Procedure]
   719 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "as"

Phrase: "described by Cornelius et al.(34"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1552738:described [Idea or Concept]

Phrase: ") . Equal numbers of nuclei"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "were"

Phrase: "incubated for 25 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0702093:/min [Temporal Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 28 C in"

Phrase: "the presence of [-P]UTP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "(6000 Ci/mmol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439190:MMOLE [Quantitative Concept]

Phrase: "; DuPont"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331805:DuPont [Health Care Related Organization]

Phrase: ")."
Processing 00000000.tx.52: Reactions were terminated by addition of RNase-free DNase, and then P-labeled RNA was isolated by guanidine thiocyanate extraction and CsCl density gradient centrifugation. 

Phrase: "Reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0443286:Reaction [Functional Concept]
   966   C1114821:Reaction [Clinical Attribute]

Phrase: "were"

Phrase: "terminated by addition of RNase-free DNase,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   748   C0011519:DNase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0011522:DNAase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   748   C0014241:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0035541:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0035542:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0332296:free [Functional Concept]
   748   C1553404:terminated [Idea or Concept]
   748   C1880497:Free [Qualitative Concept]
   748   C1883712:Addition [Functional Concept]
   748   C1996904:Free [Qualitative Concept]
   748   C2348570:Terminated [Functional Concept]

Phrase: "and"

Phrase: "then P-labeled RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "isolated by guanidine thiocyanate extraction"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   806   C0061947:guanidine thiocyanate [Organic Chemical,Pharmacologic Substance]
   760   C0018320:guanidine [Organic Chemical]
   760   C0039887:thiocyanate [Organic Chemical]
   760   C0120446:Guanidine [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   760   C0185115:Extraction [Therapeutic or Preventive Procedure]
   760   C0205409:Isolated [Functional Concept]
   760   C0220926:thiocyanate [Inorganic Chemical]
   760   C0684295:extraction [Laboratory Procedure]
   760   C1548221:Isolated [Idea or Concept]
   726 E C0370215:Isolate [Substance]
   726 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "CsCl density gradient centrifugation."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   923   C0007704:Centrifugation, Density Gradient [Laboratory Procedure]
   812   C0007703:Centrifugation [Laboratory Procedure]
   812   C0178587:density [Quantitative Concept]
   812   C0439182:% gradient [Quantitative Concept]
   812   C0812409:Gradient [Quantitative Concept]
   741 E C0439794:Dense [Qualitative Concept]
Processing 00000000.tx.53: After partial hydrolysis in 0.2 M NaOH, P-labeled RNA was extracted once with chloropane (35) and recovered by ethanol precipitation. 

Phrase: "After partial hydrolysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020291:Hydrolysis [Natural Phenomenon or Process]

Phrase: "in 0.2 M NaOH,"

Phrase: "P-labeled RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "extracted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0185115:Extracted [Therapeutic or Preventive Procedure]
  1000   C3541890:EXTRACTED [Finding]
   966 E C2828366:Extract [Substance]

Phrase: "once with chloropane"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1720092:Once [Intellectual Product]
   790   C1948045:Once [Temporal Concept]

Phrase: "(35"

Phrase: ")"

Phrase: "and"

Phrase: "recovered by ethanol precipitation."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0001962:Ethanol [Organic Chemical]
   770   C0032931:Precipitation [Natural Phenomenon or Process]
   770   C0032932:Precipitation [Molecular Function]
   770   C0521108:recovered [Qualitative Concept]
   770   C1642401:% precipitation [Quantitative Concept]
   770   C2584299:Precipitation [Natural Phenomenon or Process]
   737 E C2004454:recover [Organism Function]
Processing 00000000.tx.54: Labeled transcripts (20 10 dpm/ml) were hybridized for 72 h with cDNAs covalently linked to nylon membrane (Hybond-N; Amersham). 

Phrase: "Labeled transcripts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(20 10 dpm/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1512024:DPM [Intellectual Product]
   827   C1634619:dpm [Quantitative Concept]
   734   C1630409:20/10 [Finding]

Phrase: "ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439526:/mL [Quantitative Concept]

Phrase: "were"

Phrase: "hybridized for 72 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "with cDNAs covalently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "linked to nylon membrane"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0025255:Membrane [Tissue]
   770   C0028736:Nylon [Biomedical or Dental Material,Organic Chemical]
   770   C0596901:Membrane [Cell Component]
   770   C0740034:Nylon [Biomedical or Dental Material]
   770   C1706182:Membrane [Manufactured Object]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]

Phrase: "(Hybond-N"

Phrase: "; Amersham"

Phrase: ")."
Processing 00000000.tx.55: Blots were washed to high stringency, and hybridized RNA was visualized by autoradiography. 

Phrase: "Blots"

Phrase: "were"

Phrase: "washed to high stringency,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0205250:High [Qualitative Concept]
   770   C1299351:High [Qualitative Concept]
   770   C1548982:Washed [Idea or Concept]
   770   C2700149:HIGH [Intellectual Product]
   737 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "hybridized RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "visualized by autoradiography."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0004400:Autoradiography [Laboratory Procedure]
   790   C0234621:Visualized [Functional Concept]
Processing 00000000.tx.56: RESULTS Effects of Insulin on the Cellular Levels of C/EBP, C/EBP, and C/EBPIn view of the well documented effects of insulin on adipose tissue metabolism and of the activating effect of C/EBP on adipocyte gene transcription during preadipocyte differentiation, it was of interest to assess the effect of insulin on the expression of C/EBP family members in fully-differentiated 3T3-L1 adipocytes. 

Phrase: "RESULTS Effects of Insulin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "on the Cellular Levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "of C/EBP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "C/EBP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "C/EBPIn view of the well documented effects of insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0449911:View [Spatial Concept]

Phrase: "on adipose tissue metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]
   734   C0001527:Adipose tissue [Tissue]

Phrase: "and of the activating effect of C/EBP"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   806   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   782   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C2752241:enhancer binding [Genetic Function]
   757 E C0033618:Protein Binding [Molecular Function]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0243122:binding [Functional Concept]
   739   C1145667:Binding [Activity]
   739   C1167622:Binding [Molecular Function]
   739   C1280500:Effect [Qualitative Concept]
   739   C1515981:And [Idea or Concept]
   739   C1879547:activating [Activity]
   739   C2348382:Effect [Qualitative Concept]
   706 E C1515877:Activate [Functional Concept]

Phrase: "on adipocyte gene transcription"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0040649:Gene Transcription [Genetic Function]
           Transcription

Phrase: "during preadipocyte differentiation,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0007589:Differentiation [Cell Function]
   861   C1511938:Differentiation [Clinical Attribute]
   861   C2945687:Differentiation [Functional Concept]
   789 E C0205615:Differentiated [Qualitative Concept]

Phrase: "it"

Phrase: "was of interest to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0043194:WAS [Disease or Syndrome]
   770   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0543488:Interest [Mental Process]
   770   C1421478:WAS [Gene or Genome]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "the effect of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on the expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of C/EBP family members"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   827   C0086282:Family Members [Family Group]
   827   C1335532:Protein Family [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0015576:Family [Family Group]
   799   C0680022:members [Population Group]
   799   C1704727:Family [Conceptual Entity]
   793 E C1611821:Family Member [Intellectual Product]
   766 E C2698041:Member [Professional or Occupational Group]
   734   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   727 E C0241888:Familial [Functional Concept]

Phrase: "in fully-differentiated 3T3-L1 adipocytes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0206131:Adipocytes [Cell]
Processing 00000000.tx.57: As shown in Fig.1, A and B, treatment of adipocytes with insulin suppressed expression of both the 42- and 30-kDa C/EBP isoforms. 

Phrase: "As"

Phrase: "shown in Fig.1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0349966:Fig [Food]
   770   C1337208:FIG [Food]
   737   C1547282:Show [Intellectual Product]

Phrase: "A"

Phrase: "and"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "treatment of adipocytes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "with insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "suppressed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:Suppressed [Functional Concept]

Phrase: "expression of both"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "the 42-"

Phrase: "and"

Phrase: "30-kDa C/EBP isoforms."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   818   C0597298:Protein Isoforms [Amino Acid, Peptide, or Protein]
           Isoforms
   710   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.58: A decrease was first observed between 2 and 4 h after the addition of insulin, with repression of C/EBP continuing for at least 24 h. 

Phrase: "A decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "was"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "observed between 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1441672:Observed [Functional Concept]

Phrase: "and"

Phrase: "4 h after the addition of insulin,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0033727:H+ [Element, Ion, or Isotope]
   748   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441932:H+ [Classification]
   748   C0564385:/h [Quantitative Concept]

Phrase: "with repression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035143:Repression [Mental Process]

Phrase: "of C/EBP continuing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0549178:Continuing [Idea or Concept]
   771   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "for"

Phrase: "at least 24 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.59: In contrast, insulin caused an increase in C/EBP (LAP and LIP; (36) and (37) ) that was observed at 2 h and was maximal at 4 h. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "an increase in C/EBP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "(LAP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540509:LAP [Gene or Genome]

Phrase: "and"

Phrase: "LIP"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0023759:Lip [Body Part, Organ, or Organ Component]
  1000   C1278911:Lip [Body Part, Organ, or Organ Component]
   907 E C0227759:Labia [Body Part, Organ, or Organ Component]
   907 E C1070701:Labia [Eukaryote]
   907 E C2626732:Labium [Eukaryote]

Phrase: ";"

Phrase: "(36"

Phrase: ")"

Phrase: "and ("

Phrase: "37"

Phrase: ")"

Phrase: ")"

Phrase: "that"

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "at 2 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "was"

Phrase: "maximal at 4 h."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C2946875:Maximum-H [Pharmacologic Substance]
   770   C0205289:Maximal [Qualitative Concept]
   770   C0806909:Maximal [Quantitative Concept]
Processing 00000000.tx.60: Expression of C/EBP was also induced by insulin within 2 h and was sustained for 10 h. 

Phrase: "Expression of C/EBP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1171362:expression protein [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   716   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "also"

Phrase: "induced by insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C0205263:Induced [Functional Concept]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "within 2 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "was"

Phrase: "sustained for 10 h."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0443318:Sustained [Functional Concept]
   770   C0564385:/h [Quantitative Concept]
   737 E C2732140:Sustain [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.61: Induction of both C/EBP and C/EBP by insulin was transient, with expression decreasing toward pretreatment levels by 24 h. 

Phrase: "Induction of both C/EBP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205263:Induction [Functional Concept]
   748   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "C/EBP by insulin"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   882   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C2752241:enhancer binding [Genetic Function]
   783 E C0033618:Protein Binding [Molecular Function]
   783   C1623517:insulin binding [Molecular Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "transient,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040704:Transient [Population Group]
  1000   C0205374:Transient [Temporal Concept]

Phrase: "with expression decreasing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0442797:Decreasing [Qualitative Concept]
   827 E C0392756:Decrease [Qualitative Concept]
   827 E C0547047:Decrease [Quantitative Concept]

Phrase: "toward pretreatment levels"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0441889:Levels [Qualitative Concept]
   861   C1550147:Pretreatment [Substance]
   861   C2709094:pre treatment [Temporal Concept]
   861   C3539075:Pretreatment [Temporal Concept]
   861   C3539076:Pretreatment [Activity]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "by 24 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.62: These results show that insulin reciprocally regulates expression of at least 3 members of the C/EBP family of transcription factors in fully differentiated 3T3-L1 adipocytes. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that insulin reciprocally"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "regulates"

Phrase: "expression of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "at least 3 members"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0680022:members [Population Group]
   793 E C2698041:Member [Professional or Occupational Group]

Phrase: "of the C/EBP family"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   840   C1335532:Protein Family [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0015576:Family [Family Group]
   804   C1704727:Family [Conceptual Entity]
   771   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   733 E C0241888:Familial [Functional Concept]
   717   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "of transcription factors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0040649:Transcription [Genetic Function]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "in fully differentiated 3T3-L1 adipocytes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0206131:Adipocytes [Cell]
Processing 00000000.tx.63: Figure 1: Effect of insulin on the expression of C/EBP. 

Phrase: "Figure 1"

Phrase: ":"

Phrase: "Effect of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on the expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of C/EBP."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
Processing 00000000.tx.64: A, 3T3-L1 adipocytes in monolayer culture were treated with 167 nM insulin (INS) for the indicated times. 

Phrase: "A,"

Phrase: "3T3-L1 adipocytes in monolayer culture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0206131:Adipocytes [Cell]

Phrase: "were"

Phrase: "treated with 167 nM insulin (INS)"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0312860:NM [Cell Function]
   760   C1522326:Treated [Functional Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   726 E C1292734:TREAT [Functional Concept]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "for the indicated times."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]
Processing 00000000.tx.65: Whole cell lysates containing equal cell equivalents (200 g of protein) were subjected to SDS-PAGE, and immunoblotted using antisera against C/EBP, C/EBP, and C/EBP. 

Phrase: "Whole cell lysates"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   884   C1881488:Cell Lysate [Physical Object]
           Lysate
   827   C0007634:Cell [Cell]
   827   C0444667:Whole [Quantitative Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "equal cell equivalents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439185:Equivalents [Quantitative Concept]
   793 E C0205163:Equivalent [Qualitative Concept]

Phrase: "(200 g of protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0060916:protein g [Amino Acid, Peptide, or Protein]
   819   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "subjected to SDS-PAGE,"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   882   C0600209:Sodium Dodecyl Sulfate-PAGE [Laboratory Procedure,Research Activity]
   833   C0037506:Sodium Dodecyl Sulfate [Biomedical or Dental Material,Lipid,Pharmacologic Substance]
   790   C0058632:dodecyl sulfate [Lipid,Pharmacologic Substance]
   783   C0074769:Sodium sulphate [Inorganic Chemical,Pharmacologic Substance]
   753   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   753   C0038720:Sulfate [Inorganic Chemical]
   753   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   753   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C1704732:Page [Intellectual Product]
   753   C3536965:SULFATE [Element, Ion, or Isotope]
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "immunoblotted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antisera against C/EBP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0020960:Antisera [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   716   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "C/EBP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "C/EBP."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
Processing 00000000.tx.66: These results are representative of at least six independent time course experiments. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "representative of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1882932:Representative [Activity]

Phrase: "at least six independent time course experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   799   C0681814:Experiments [Research Activity]
   766 E C1706386:Experiment [Conceptual Entity]
   716 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.67: 42 and 30 refer to p42 and p30 isoforms, respectively. 

Phrase: "42"

Phrase: "and"

Phrase: "30"

Phrase: "refer to p42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205543:refer [Functional Concept]

Phrase: "and"

Phrase: "p30 isoforms,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "respectively."
Processing 00000000.tx.68: LAP and LIP refer to the liver activator protein and liver inhibitory protein of C/EBP, respectively; 

Phrase: "LAP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540509:LAP [Gene or Genome]

Phrase: "and"

Phrase: "LIP"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0023759:Lip [Body Part, Organ, or Organ Component]
  1000   C1278911:Lip [Body Part, Organ, or Organ Component]
   907 E C0227759:Labia [Body Part, Organ, or Organ Component]
   907 E C1070701:Labia [Eukaryote]
   907 E C2626732:Labium [Eukaryote]

Phrase: "refer to the liver activator protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0209548:Liver Activator Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1413323:LIVER ACTIVATOR PROTEIN [Gene or Genome]
   756   C1840635:HEPATIC PROTEIN [Gene or Genome]
   753   C0023884:Liver [Body Part, Organ, or Organ Component]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0205543:refer [Functional Concept]
   753   C0736268:LIVER [Body Part, Organ, or Organ Component]
   753   C1278929:Liver [Body Part, Organ, or Organ Component]
   753   C2346688:LIVER [Food]

Phrase: "and"

Phrase: "liver inhibitory protein of C/EBP,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   800   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   765   C0062522:hepatic-binding protein [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "respectively"

Phrase: ";"
Processing 00000000.tx.69: and refers to C/EBP. 

Phrase: "and"

Phrase: "refers to C/EBP."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   882   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C2752241:enhancer binding [Genetic Function]
   783 E C0033618:Protein Binding [Molecular Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0205543:refer [Functional Concept]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
Processing 00000000.tx.70: B, results in A were quantified by laser densitometry and the results are shown graphically relative to the maximal level of expression of each C/EBP. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "results in A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1274040:Result [Functional Concept]
   790   C1546471:Result [Idea or Concept]
   790   C2825142:Result [Finding]

Phrase: "were"

Phrase: "quantified by laser densitometry"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0011321:Densitometry [Laboratory Procedure]
   770   C0023089:Laser [Manufactured Object]
   770   C0458142:Laser [Phenomenon or Process]
   770   C1023865:Laser [Plant]
   770   C1706315:Laser [Medical Device]
   737   C1709793:Quantify [Quantitative Concept]

Phrase: "and"

Phrase: "the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "graphically relative to the maximal level of expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0080103:Relative [Family Group]
   744   C0205345:Relative [Qualitative Concept]
   744   C1547039:*Relative [Quantitative Concept]

Phrase: "of each C/EBP."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
Processing 00000000.tx.71: Axel Kahn and colleagues (38) have found that insulin can alter hepatic gene expression by glucose-dependent or glucose-independent mechanisms. 

Phrase: "Axel Kahn"

Phrase: "and"

Phrase: "colleagues"

Phrase: "(38"

Phrase: ")"

Phrase: "have"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "can"

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "hepatic gene expression by glucose-dependent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0017262:Gene Expression [Genetic Function]
   753   C0017337:Gene [Gene or Genome]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "glucose-independent mechanisms."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0441712:Mechanisms [Functional Concept]
   793 E C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.72: To ascertain whether glucose is required for the regulation of C/EBP by insulin, cells were incubated overnight in glucose-free media (with or without pyruvate) prior to insulin treatment. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "ascertain"

Phrase: "whether"

Phrase: "glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "is"

Phrase: "required for the regulation of C/EBP"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   818   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1655411:regulation of protein binding [Molecular Function]
   790   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   784   C1523122:regulation of binding [Molecular Function]
   764   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C2752241:enhancer binding [Genetic Function]
   762 E C0033618:Protein Binding [Molecular Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0243122:binding [Functional Concept]
   742   C0851285:Regulation [Governmental or Regulatory Activity]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]
   742   C1327622:Regulation [Biologic Function]
   742   C1514873:Required [Functional Concept]

Phrase: "by insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "overnight in glucose-free media"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   760   C0009458:Media [Intellectual Product]
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0162867:Media [Tissue]
   760   C0332296:free [Functional Concept]
   760   C0439583:Overnight [Temporal Concept]
   760   C1254021:Media [Tissue]
   760   C1880497:Free [Qualitative Concept]
   760   C1996904:Free [Qualitative Concept]
   726 E C0439536:Medium [Quantitative Concept]
   726 E C1705217:Medium [Substance]
   726 E C3244283:medium [Intellectual Product]

Phrase: "("

Phrase: "with"

Phrase: "or without pyruvate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0034354:pyruvate [Organic Chemical]
   790   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]

Phrase: ")"

Phrase: "prior to insulin treatment."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.73: Western blot analysis showed that while overall expression of C/EBP was repressed by incubation in glucose-free medium, regulation of C/EBP by insulin was identical to that shown in Fig.1. 

Phrase: "Western blot analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   827   C1705493:Western [Spatial Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "while"

Phrase: "overall expression of C/EBP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1171362:expression protein [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "repressed by incubation"

Phrase: "in glucose-free medium,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0009458:Medium [Intellectual Product]
   827   C0439536:Medium [Quantitative Concept]
   827   C1705217:Medium [Substance]
   827   C3244283:medium [Intellectual Product]

Phrase: "regulation of C/EBP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   851   C1655411:regulation of protein binding [Molecular Function]
   820   C1523122:regulation of binding [Molecular Function]
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]
   716   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "by insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "identical to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205280:Identical [Qualitative Concept]

Phrase: "shown in Fig.1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0349966:Fig [Food]
   770   C1337208:FIG [Food]
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.74: This includes the rapid effect of insulin on post-translational modification and the subsequent suppression of C/EBP protein. 

Phrase: "This"

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "the rapid effect of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on post-translational modification"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0033666:Post-Translational Modification [Molecular Function]
   827   C0392747:Modification [Functional Concept]
   827   C0687676:Post [Temporal Concept]
   827   C1519614:Translational [Genetic Function]
   827   C1554963:modification [Qualitative Concept]
   827   C1704687:Post [Manufactured Object]
   755 E C0040712:Translation [Intellectual Product]
   755 E C0597295:translation [Molecular Function]
   755 E C1514253:Postal [Functional Concept]

Phrase: "and"

Phrase: "the subsequent suppression of C/EBP protein."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0221103:Suppression [Pathologic Function]
   742   C0301625:Suppression [Organism Function]
   742   C0439181:% suppression [Quantitative Concept]
   742   C0728721:suppression [Mental Process]
Processing 00000000.tx.75: Therefore, insulin regulates C/EBP through glucose-independent mechanisms. 

Phrase: "Therefore,"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "regulates"

Phrase: "C/EBP through glucose-independent mechanisms."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   833   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   800   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C2752241:enhancer binding [Genetic Function]
   767 E C0033618:Protein Binding [Molecular Function]
   767   C1148590:glucose binding [Molecular Function]
   767   C2599779:Glucose & Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Carbohydrate]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
Processing 00000000.tx.76: Inspection of Fig.1A reveals that p30 consists of two bands, and that the top band is absent after 2 h of insulin treatment. 

Phrase: "Inspection of Fig.1A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0199219:Inspection [Functional Concept]

Phrase: "reveals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "that p30"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0069919:P30 [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1538722:p30 [Gene or Genome]

Phrase: "consists of two bands,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0175723:Bands [Medical Device]
   770   C0205448:Two [Quantitative Concept]
   770   C0332529:CONSIST [Qualitative Concept]
   737 E C0439645:Band [Spatial Concept]
   737 E C1521913:band [Cell Component]

Phrase: "and"

Phrase: "that"

Phrase: "the top band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0175723:Band [Medical Device]
   861   C0439645:Band [Spatial Concept]
   861   C1521913:band [Cell Component]

Phrase: "is"

Phrase: "absent after 2 h of insulin treatment."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332197:Absent [Quantitative Concept]
   748   C2699517:ABSENT [Finding]
Processing 00000000.tx.77: A more extensive time course of insulin effects on expression of C/EBP in 3T3-L1 adipocytes reveals that the top band of p30 is about 50% depleted by 15 min, and is completely absent at 30 min (Fig.2). 

Phrase: "A more extensive time course of insulin effects"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0449247:Time course [Temporal Concept]
   744   C0040223:Time [Temporal Concept]
   744   C0750729:Course [Temporal Concept]
   744   C3541383:Time [Temporal Concept]

Phrase: "on expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "in 3T3-L1 adipocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206131:Adipocytes [Cell]

Phrase: "reveals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "that"

Phrase: "the top band of p30"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0175723:Band [Medical Device]
   760   C0439645:Band [Spatial Concept]
   760   C1521913:band [Cell Component]

Phrase: "is"

Phrase: "about 50%"

Phrase: "depleted by 15 min,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0333668:Depleted [Functional Concept]
   770   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "is"

Phrase: "completely absent at 30 min (Fig.2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332197:Absent [Quantitative Concept]
   748   C2699517:ABSENT [Finding]

Phrase: ")."
Processing 00000000.tx.78: The corresponding increase in the bottom band suggests that these mobilities might reflect structural differences within p30, perhaps due to post-translational modification. 

Phrase: "The corresponding increase in the bottom band"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "these mobilities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0449580:mobilities [Qualitative Concept]
   966 E C0425245:Mobility [Finding]
   916 E C0231435:Mobile [Functional Concept]
   916 E C1552449:Mobile [Health Care Related Organization,Manufactured Object]

Phrase: "might"

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "structural differences within p30,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "perhaps due to post-translational modification."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0033666:Post-Translational Modification [Molecular Function]
   790   C0678226:Due to [Functional Concept]
           due
   753   C0392747:Modification [Functional Concept]
   753   C0687676:Post [Temporal Concept]
   753   C1519614:Translational [Genetic Function]
   753   C1554963:modification [Qualitative Concept]
   753   C1704687:Post [Manufactured Object]
   753   C3146286:Due [Idea or Concept]
Processing 00000000.tx.79: A similar, although less obvious, shift in mobility of p42 occurs with similar kinetics (Fig.2). 

Phrase: "A similar,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348205:Similar [Qualitative Concept]

Phrase: "although"

Phrase: "less obvious, shift in mobility of p42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0333051:Shift [Functional Concept]
   748   C2347509:Shift [Phenomenon or Process]

Phrase: "occurs with similar kinetics"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0022702:Kinetics [Natural Phenomenon or Process]
   770   C0220865:kinetics [Functional Concept]
   770   C1709305:Occur [Activity]
   770   C2348205:Similar [Qualitative Concept]
   770   C2745955:OCCUR [Temporal Concept]
   770   C2825046:Kinetics [Occupation or Discipline]

Phrase: "(Fig.2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.80: Evidence described in a later section suggests that insulin treatment alters the phosphorylation of the two C/EBP isoforms. 

Phrase: "Evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "described in a later section"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0205155:Section [Spatial Concept]
   760   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   760   C1522472:Section [Substance]
   760   C1552738:described [Idea or Concept]
   760   C1552923:Section [Quantitative Concept]
   760   C1705191:Section [Physical Object]
   726   C0205087:Late [Temporal Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that insulin treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the phosphorylation of the two C/EBP isoforms."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   739   C0031715:Phosphorylation [Molecular Function]
Processing 00000000.tx.81: Figure 2: Rapid effect of insulin on C/EBP. 

Phrase: "Figure 2"

Phrase: ":"

Phrase: "Rapid effect of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on C/EBP."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
Processing 00000000.tx.82: 3T3-L1 adipocytes in monolayer culture were treated with insulin (167 nM) for the indicated times. 

Phrase: "3T3-L1 adipocytes in monolayer culture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0206131:Adipocytes [Cell]

Phrase: "were"

Phrase: "treated with insulin"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   756 E C1292734:TREAT [Functional Concept]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(167 nM) for the indicated times."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0312860:NM [Cell Function]
Processing 00000000.tx.83: Whole cell lysates containing equal cell equivalents 200 g of protein) were subjected to SDS-PAGE, and immunoblotted using antisera against C/EBP. 

Phrase: "Whole cell lysates"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   884   C1881488:Cell Lysate [Physical Object]
           Lysate
   827   C0007634:Cell [Cell]
   827   C0444667:Whole [Quantitative Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "equal cell equivalents 200 g of protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0060916:protein g [Amino Acid, Peptide, or Protein]
   774   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   774   C0524983:G cell [Cell]
   748   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "subjected to SDS-PAGE,"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   882   C0600209:Sodium Dodecyl Sulfate-PAGE [Laboratory Procedure,Research Activity]
   833   C0037506:Sodium Dodecyl Sulfate [Biomedical or Dental Material,Lipid,Pharmacologic Substance]
   790   C0058632:dodecyl sulfate [Lipid,Pharmacologic Substance]
   783   C0074769:Sodium sulphate [Inorganic Chemical,Pharmacologic Substance]
   753   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   753   C0038720:Sulfate [Inorganic Chemical]
   753   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   753   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C1704732:Page [Intellectual Product]
   753   C3536965:SULFATE [Element, Ion, or Isotope]
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "immunoblotted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antisera against C/EBP."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0020960:Antisera [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   716   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.84: Effect of Insulin on the Binding of C/EBP Isoforms to a C/EBP Binding-site OligonucleotideGel shift experiments were performed to verify that the insulin-induced changes in C/EBP isoform levels described above correlate with changes in their DNA binding capacity. 

Phrase: "Effect of Insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on the Binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "of C/EBP Isoforms"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0597298:Protein Isoforms [Amino Acid, Peptide, or Protein]
           Isoforms
   771   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "to a C/EBP Binding-site OligonucleotideGel shift experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   791   C0681814:Experiments [Research Activity]
   758 E C1706386:Experiment [Conceptual Entity]
   708 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "verify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711411:Verify [Functional Concept]

Phrase: "that"

Phrase: "the insulin-induced changes in C/EBP isoform levels"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   738   C0392747:changes [Functional Concept]
   738   C0443172:changes [Quantitative Concept]
   737   C0025320:The change [Physiologic Function]
   704 E C1705241:Change [Quantitative Concept]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "above"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]

Phrase: "correlate with changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0392747:changes [Functional Concept]
   790   C0443172:changes [Quantitative Concept]
   756 E C1705241:Change [Quantitative Concept]

Phrase: "in their DNA binding capacity."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0439155:Binding capacity [Quantitative Concept]
   827   C1516240:Capacity [Quantitative Concept]
   734   C1148673:DNA Binding [Genetic Function]
Processing 00000000.tx.85: Thus, nuclear extracts, prepared from 3T3-L1 adipocytes that had been treated or not with insulin for 6 h, were subjected to gel shift analysis using an oligonucleotide probe corresponding to the C/EBP-binding site in the 422(aP2) promoter(10) . All three C/EBP isoforms (, , and ) bind at this site. 

Phrase: "Thus,"

Phrase: "nuclear extracts,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1518434:Nuclear Extract [Biomedical or Dental Material]
   861   C0521447:Nuclear [Spatial Concept]
   827   C2828366:Extract [Substance]

Phrase: "prepared from 3T3-L1 adipocytes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0206131:Adipocytes [Cell]
   760   C0441918:L1 [Finding]
   760   C1179698:L1 [Body Location or Region]
   760   C1416177:L1 [Gene or Genome]
   726   C1521827:Prepare [Functional Concept]

Phrase: "that"

Phrase: "had"

Phrase: "been"

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "or"

Phrase: "not with insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1518422:Not [Functional Concept]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "for 6 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "were"

Phrase: "subjected to gel shift analysis"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   862   C0598490:Gel Shift Analysis [Laboratory Procedure]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0017243:Gel [Biomedical or Dental Material]
   760   C0333051:Shift [Functional Concept]
   760   C0936012:Analysis [Research Activity]
   760   C1382104:Gel [Substance]
   760   C1524024:analysis [Functional Concept]
   760   C2347509:Shift [Phenomenon or Process]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an oligonucleotide probe"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0028953:Oligonucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0182400:Probe [Medical Device]
   861   C1704681:Probe [Gene or Genome]
   861   C2347609:Probe [Chemical Viewed Functionally]
   861   C3536729:Probe [Manufactured Object]

Phrase: "corresponding to the C/EBP-binding site"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   818   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0033618:Protein Binding [Molecular Function]
   764   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C2752241:enhancer binding [Genetic Function]
   762   C0005456:Binding Site [Receptor]
   762   C0682969:Binding Site [Amino Acid Sequence]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0205145:Site [Spatial Concept]
   742   C0243122:binding [Functional Concept]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]
   742   C1515974:Site [Body Location or Region]
   742   C2825164:Site [Spatial Concept]

Phrase: "in the 422"

Phrase: "(aP2"

Phrase: ")"

Phrase: "promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(10"

Phrase: ") ."

Phrase: "All three C/EBP isoforms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0597298:Protein Isoforms [Amino Acid, Peptide, or Protein]
           Isoforms
   734   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(,"

Phrase: ","

Phrase: "and )"

Phrase: "bind at this site."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205145:Site [Spatial Concept]
   770   C1145667:Bind [Activity]
   770   C1167622:bind [Molecular Function]
   770   C1515974:Site [Body Location or Region]
   770   C2825164:Site [Spatial Concept]
Processing 00000000.tx.86: Although the gel shift banding patterns were complex (Fig.3, lanes 2 and 3), use of isoform-specific antibodies and changes in isoform level due to insulin treatment made it possible to identify DNA-protein complexes containing each of the C/EBP isoforms. 

Phrase: "Although"

Phrase: "the gel shift banding patterns"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1442158:band pattern [Clinical Attribute]
   812   C0449774:Patterns [Spatial Concept]

Phrase: "were"

Phrase: "complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "(Fig.3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "lanes 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "use of isoform-specific antibodies"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1524063:Use of [Functional Concept]
   760   C0042153:use [Functional Concept]
   760   C0457083:Use [Functional Concept]
   760   C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "changes in isoform level"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0392747:Change [Functional Concept]
   770   C0441889:Level [Qualitative Concept]
   770   C0443172:change [Quantitative Concept]
   770   C0456079:Level [Classification]
   770   C0597298:Isoform [Amino Acid, Peptide, or Protein]
   770   C1547707:Level [Geographic Area]
   770   C1705241:Change [Quantitative Concept]
   770   C2946261:Level [Pharmacologic Substance]

Phrase: "due to insulin treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "it possible to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332149:Possible [Qualitative Concept]
   861   C1705910:Possible [Qualitative Concept]
   861   C2362652:Possible [Qualitative Concept]

Phrase: "identify"

Phrase: "DNA-protein complexes"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   983   C2246376:DNA-protein complex [Cell Component]
   867   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   867   C1523872:protein complex [Cell Component]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1704241:Complexes [Chemical Viewed Structurally]
   793 E C0439855:Complex [Qualitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "each of the C/EBP isoforms."
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   833   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   800   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0597298:Protein Isoforms [Amino Acid, Peptide, or Protein]
           Isoforms
   770   C2752241:enhancer binding [Genetic Function]
   767 E C0033618:Protein Binding [Molecular Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C1457900:Each [Quantitative Concept]
Processing 00000000.tx.87: While addition of preimmune sera stabilized the binding of C/EBP isoforms to this probe, the relative intensities of the bands were similar, and no ``new'' bands were observed (Fig.3, lanes 4 and 5). 

Phrase: "While"

Phrase: "addition of preimmune sera"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1883712:Addition [Functional Concept]

Phrase: "stabilized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0184512:Stabilized [Qualitative Concept]

Phrase: "the binding of C/EBP isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "to this probe,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0182400:Probe [Medical Device]
  1000   C1704681:Probe [Gene or Genome]
  1000   C2347609:Probe [Chemical Viewed Functionally]
  1000   C3536729:Probe [Manufactured Object]

Phrase: "the relative intensities of the bands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0522510:intensities [Qualitative Concept]

Phrase: "were"

Phrase: "similar,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348205:Similar [Qualitative Concept]

Phrase: "and"

Phrase: "no ``new'' bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0175723:Bands [Medical Device]
   793 E C0439645:Band [Spatial Concept]
   793 E C1521913:band [Cell Component]

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(Fig.3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "lanes 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.88: Supershift experiments with antisera against C/EBP and C/EBP gave rise to DNA-protein complexes with low mobility. 

Phrase: "Supershift experiments with antisera"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0681814:Experiments [Research Activity]
   737 E C1706386:Experiment [Conceptual Entity]

Phrase: "against C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "rise to DNA-protein complexes"

Phrase: "with low mobility."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0425245:Mobility [Finding]
   861   C0449580:Mobility [Qualitative Concept]
   789 E C0231435:Mobile [Functional Concept]
   789 E C1552449:Mobile [Health Care Related Organization,Manufactured Object]
Processing 00000000.tx.89: This facilitated detection of DNA-protein complexes containing C/EBP and revealed that 6 h of insulin treatment suppressed the relative amount of C/EBP available for binding to the C/EBP-binding site (Fig.3, compare lanes 6 and 7). 

Phrase: "This facilitated detection of DNA-protein complexes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that 6 h of insulin treatment"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0444953:H 6 [Intellectual Product]
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]

Phrase: "suppressed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:Suppressed [Functional Concept]

Phrase: "the relative amount of C/EBP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1265611:Amount [Quantitative Concept]

Phrase: "available for binding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0470187:Available [Functional Concept]

Phrase: "to the C/EBP-binding site"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   858   C0005456:Binding Site [Receptor]
   858   C0682969:Binding Site [Amino Acid Sequence]
   827   C0033618:Protein Binding [Molecular Function]
   799   C0205145:Site [Spatial Concept]
   799   C1515974:Site [Body Location or Region]
   799   C2825164:Site [Spatial Concept]
   734   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig.3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "lanes 6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "7"

Phrase: ")."
Processing 00000000.tx.90: In a similar fashion, supershifting C/EBP and C/EBP revealed that insulin increased the relative amount of C/EBP-containing DNA-protein complexes (Fig.3, compare lanes 8 and 9), and supershifting C/EBP and C/EBP revealed that insulin increased the relative amount of C/EBP-containing DNA-protein complex (Fig.3, compare lanes 10 and 11). 

Phrase: "In a similar fashion,"

Phrase: "supershifting"

Phrase: "C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the relative amount"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1265611:Amount [Quantitative Concept]

Phrase: "of C/EBP-containing DNA-protein complexes"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   844   C1523872:protein-protein complex [Cell Component]
           protein complex
   841   C2246376:protein-DNA complex [Cell Component]
   834   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C1704241:Complexes [Chemical Viewed Structurally]
   760 E C0439855:Complex [Qualitative Concept]

Phrase: "(Fig.3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "lanes 8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "9"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "supershifting C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   937   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C2752241:enhancer binding [Genetic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0243122:binding [Functional Concept]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the relative amount"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1265611:Amount [Quantitative Concept]

Phrase: "of C/EBP-containing DNA-protein complex"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   855   C1523872:protein-protein complex [Cell Component]
           protein complex
   852   C2246376:protein-DNA complex [Cell Component]
   850   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0439855:Complex [Qualitative Concept]
   793   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "(Fig.3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "lanes 10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "11"

Phrase: ")."
Processing 00000000.tx.91: Supershifting with antiserum specific to the N-terminal region of C/EBP (recognizes only LAP) revealed that the band of highest mobility contains LIP/LIP homodimers, ()and it is presumed that the intermediate C/EBP-containing band is composed of LAP/LIP heterodimers. 

Phrase: "Supershifting with antiserum"

Phrase: "specific to the N-terminal region of C/EBP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0205369:Specific [Qualitative Concept]
   738   C1552740:specific [Intellectual Product]

Phrase: "("

Phrase: "recognizes"

Phrase: "only LAP)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540509:LAP [Gene or Genome]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "the band of highest mobility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0175723:Band [Medical Device]
   760   C0439645:Band [Spatial Concept]
   760   C1521913:band [Cell Component]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "LIP/LIP homodimers,"

Phrase: "("

Phrase: ")"

Phrase: "and"

Phrase: "it"

Phrase: "is"

Phrase: "presumed"

Phrase: "that"

Phrase: "the intermediate C/EBP-containing band"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   795   C0175723:Band [Medical Device]
   795   C0439645:Band [Spatial Concept]
   795   C1521913:band [Cell Component]
   710   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "composed of LAP/LIP heterodimers."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0023759:Lip [Body Part, Organ, or Organ Component]
   760   C1278911:Lip [Body Part, Organ, or Organ Component]
   760   C3540509:LAP [Gene or Genome]
Processing 00000000.tx.92: Therefore, LIP appears to predominate over LAP (and C/EBP) in both the basal and insulin-stimulated states (see ``Discussion''). 

Phrase: "Therefore,"

Phrase: "LIP"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0023759:Lip [Body Part, Organ, or Organ Component]
  1000   C1278911:Lip [Body Part, Organ, or Organ Component]
   907 E C0227759:Labia [Body Part, Organ, or Organ Component]
   907 E C1070701:Labia [Eukaryote]
   907 E C2626732:Labium [Eukaryote]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "predominate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332251:Predominate [Qualitative Concept]

Phrase: "over LAP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205136:Over [Spatial Concept]
   861   C3540509:LAP [Gene or Genome]

Phrase: "("

Phrase: "and"

Phrase: "C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: ")"

Phrase: "in both"

Phrase: "the basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "and"

Phrase: "insulin-stimulated states"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1301808:states [Geographic Area]
   793 E C1442792:State [Functional Concept]
   793 E C3148680:State [Geographic Area]

Phrase: "(see ``Discussion''"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557061:Discussion [Therapeutic or Preventive Procedure]
   861   C2584313:Discussion [Social Behavior]

Phrase: ")."
Processing 00000000.tx.93: At 24 h, suppression of C/EBP and induction of C/EBP could still be observed, however, binding of C/EBP was the same as in control adipocyte extracts (data not shown). 

Phrase: "At 24 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "suppression of C/EBP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0221103:Suppression [Pathologic Function]
   753   C0301625:Suppression [Organism Function]
   753   C0439181:% suppression [Quantitative Concept]
   753   C0728721:suppression [Mental Process]
   716   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "induction of C/EBP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205263:Induction [Functional Concept]
   753   C0857127:induction [Therapeutic or Preventive Procedure]
   716   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "could"

Phrase: "still"

Phrase: "be"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: ","

Phrase: "however,"

Phrase: "binding of C/EBP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   882   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   814   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C0033618:Protein Binding [Molecular Function]
   783   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C2752241:enhancer binding [Genetic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "the same"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0445247:Same [Qualitative Concept]

Phrase: "as in control adipocyte extracts"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0206131:Adipocyte [Cell]
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
   726   C2828366:Extract [Substance]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.94: It should be noted that all of the oligonucleotide-protein complexes detected by gel shift analysis with nuclear extracts from control and insulin-treated adipocytes were supershifted by a combination of antibodies to all three C/EBP isoforms (Fig.3, lanes 12 and 13). 

Phrase: "It"

Phrase: "should"

Phrase: "be"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "all of the oligonucleotide-protein complexes"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   767   C1180347:complex protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756 E C1523872:protein complex [Cell Component]
   753   C0028953:Oligonucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0444868:All [Quantitative Concept]
   753   C1704241:Complexes [Chemical Viewed Structurally]
   753   C3539085:All [Idea or Concept]
   719 E C0439855:Complex [Qualitative Concept]

Phrase: "detected by gel shift analysis"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   862   C0598490:Gel Shift Analysis [Laboratory Procedure]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0017243:Gel [Biomedical or Dental Material]
   760   C0333051:Shift [Functional Concept]
   760   C0442726:Detected [Finding]
   760   C0936012:Analysis [Research Activity]
   760   C1382104:Gel [Substance]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C1524024:analysis [Functional Concept]
   760   C2347509:Shift [Phenomenon or Process]

Phrase: "with nuclear extracts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1518434:Nuclear Extract [Biomedical or Dental Material]
   861   C0521447:Nuclear [Spatial Concept]
   827   C2828366:Extract [Substance]

Phrase: "from control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "insulin-treated adipocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206131:Adipocytes [Cell]

Phrase: "were"

Phrase: "supershifted by a combination of antibodies"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0205195:Combination [Qualitative Concept]
   753   C1947911:Combination [Physical Object]
   719 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "to all three C/EBP isoforms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0597298:Protein Isoforms [Amino Acid, Peptide, or Protein]
           Isoforms
   734   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig.3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "lanes 12"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "13"

Phrase: ")."
Processing 00000000.tx.95: Identical gel shift patterns were observed with the C/EBP-binding site from the C/EBP promoter (data not shown). 

Phrase: "Identical gel shift patterns"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0449774:Patterns [Spatial Concept]

Phrase: "were"

Phrase: "observed with the C/EBP-binding site"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   818   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0033618:Protein Binding [Molecular Function]
   764   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C2752241:enhancer binding [Genetic Function]
   762   C0005456:Binding Site [Receptor]
   762   C0682969:Binding Site [Amino Acid Sequence]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0205145:Site [Spatial Concept]
   742   C0243122:binding [Functional Concept]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]
   742   C1441672:Observed [Functional Concept]
   742   C1515974:Site [Body Location or Region]
   742   C2825164:Site [Spatial Concept]

Phrase: "from the C/EBP promoter"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   771   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.96: Taken together, these findings are consistent with the results of Western blot analysis, and show that insulin induces changes in the relative cellular levels of C/EBP transcription factors. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "are"

Phrase: "consistent with the results of Western blot analysis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "and"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "changes in the relative cellular levels"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "of C/EBP transcription factors."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   896   C0526260:Transcription Factor, CCAAT-Binding [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           CCAAT-Binding Factor
   827   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0040649:Transcription [Genetic Function]
   766   C1521761:Factor [Functional Concept]
   766   C2827422:Factor [Conceptual Entity]
   734   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.97: Figure 3: Gel shift analysis of C/EBP isoforms from untreated 3T3-L1 adipocytes (ADIP) and those treated with insulin. 

Phrase: "Figure 3"

Phrase: ":"

Phrase: "Gel shift analysis of C/EBP isoforms"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0598490:Gel Shift Analysis [Laboratory Procedure]
   762   C1514534:Protein Analysis [Molecular Biology Research Technique]
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]

Phrase: "from untreated 3T3-L1 adipocytes (ADIP)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0206131:Adipocytes [Cell]

Phrase: "and"

Phrase: "those"

Phrase: "treated with insulin."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   756 E C1292734:TREAT [Functional Concept]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.98: Nuclei were isolated and nuclear extracts were prepared from untreated control adipocytes 11 days after initiating differentiation or adipocytes treated with 167 nM insulin for 6 h (INS). 

Phrase: "Nuclei"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0007610:Nucleus [Cell Component]

Phrase: "were"

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "nuclear extracts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1518434:Nuclear Extract [Biomedical or Dental Material]
   861   C0521447:Nuclear [Spatial Concept]
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "prepared from untreated control adipocytes 11 days"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   748   C0206131:Adipocytes [Cell]
   748   C0243148:control [Qualitative Concept]
   748   C0332155:untreated [Finding]
   748   C0439228:days [Temporal Concept]
   748   C1550141:Control [Substance]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]
   714 E C0332173:/day [Temporal Concept]
   714 E C0439505:/day [Temporal Concept]
   714   C1521827:Prepare [Functional Concept]

Phrase: "after initiating differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0007589:Differentiation [Cell Function]
   861   C1511938:Differentiation [Clinical Attribute]
   861   C2945687:Differentiation [Functional Concept]
   789 E C0205615:Differentiated [Qualitative Concept]

Phrase: "or"

Phrase: "adipocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206131:Adipocytes [Cell]

Phrase: "treated with 167 nM insulin"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0312860:NM [Cell Function]
   760   C1522326:Treated [Functional Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   726 E C1292734:TREAT [Functional Concept]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "for 6 h (INS"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.99: Gel shift analysis was performed using 3.0 10 dpm of a P-labeled oligonucleotide corresponding to the C/EBP-binding site from the 422/aP2 gene promoter, and 8 g of nuclear protein. 

Phrase: "Gel shift analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0598490:Gel Shift Analysis [Laboratory Procedure]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "3.0 10 dpm of a P-labeled oligonucleotide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1512024:DPM [Intellectual Product]
   742   C1634619:dpm [Quantitative Concept]

Phrase: "corresponding to the C/EBP-binding site"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   818   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0033618:Protein Binding [Molecular Function]
   764   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C2752241:enhancer binding [Genetic Function]
   762   C0005456:Binding Site [Receptor]
   762   C0682969:Binding Site [Amino Acid Sequence]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0205145:Site [Spatial Concept]
   742   C0243122:binding [Functional Concept]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]
   742   C1515974:Site [Body Location or Region]
   742   C2825164:Site [Spatial Concept]

Phrase: "from the 422/aP2 gene promoter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "8 g of nuclear protein."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0060916:protein g [Amino Acid, Peptide, or Protein]
   797   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.100: Oligonucleotide-protein complexes were separated on a 6% polyacrylamide gel at 9 V/cm for 4 h. 

Phrase: "Oligonucleotide-protein complexes"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   867   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   867   C1523872:protein complex [Cell Component]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1704241:Complexes [Chemical Viewed Structurally]
   793 E C0439855:Complex [Qualitative Concept]

Phrase: "were"

Phrase: "separated on a 6% polyacrylamide gel"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   753   C0086972:Separated [Finding]
   753   C0443299:separated [Spatial Concept]
   753   C0687118:Separated [Functional Concept]
   753   C1382104:Gel [Substance]

Phrase: "at 9 V/cm"

Phrase: "for 4 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.101: Free-labeled oligonucleotide was run off the gel. 

Phrase: "Free-labeled oligonucleotide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0028953:Oligonucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "run off"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0035953:run [Daily or Recreational Activity]
   861   C0600140:run [Finding]
   861   C1704688:Run [Functional Concept]
   861   C2346414:Run [Finding]

Phrase: "the gel."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017243:Gel [Biomedical or Dental Material]
  1000   C1382104:Gel [Substance]
Processing 00000000.tx.102: Autoradiography was performed at -80 C for 16 h. 

Phrase: "Autoradiography"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004400:Autoradiography [Laboratory Procedure]
   900 E C2986957:Autoradiograph [Manufactured Object]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "at -80 C for 16 h."
Processing 00000000.tx.103: Supershifting was performed using the indicated combinations of antiserum (2 l each) with preimmune (PI) serum added to bring the total sera volume to 6 l. refers to antiserum to C/EBP; 

Phrase: "Supershifting"

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the indicated combinations of antiserum"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0453882:Combinations [Manufactured Object]
   726 E C0205195:Combination [Qualitative Concept]
   726 E C1947911:Combination [Physical Object]

Phrase: "(2 l"

Phrase: "each"

Phrase: ")"

Phrase: "with preimmune (PI) serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0229671:Serum [Body Substance]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "bring"

Phrase: "the total sera volume to 6 l."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0449468:Total Volume [Quantitative Concept]
           *Volume
   748   C1690016:% volume [Qualitative Concept]
   748   C1705102:Volume [Intellectual Product]
   748   C2700258:Volume [Laboratory Procedure]

Phrase: "refers to antiserum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   790   C0205543:refer [Functional Concept]

Phrase: "to C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: ";"
Processing 00000000.tx.104: to antiserum to C/EBP; 

Phrase: "to antiserum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "to C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: ";"
Processing 00000000.tx.105: and to antiserum to C/EBP. 

Phrase: "and to antiserum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   790   C1515981:And [Idea or Concept]

Phrase: "to C/EBP."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
Processing 00000000.tx.106: Concentration Dependence and Specificity of the Insulin ResponseTo ascertain whether the insulin-induced changes in cellular levels of C/EBP, C/EBP, and C/EBP are mediated by the insulin receptor or by the insulin-like growth factor-1 (IGF-1) receptor, the dependence of these changes on concentration of insulin or IGF-1 was assessed. 

Phrase: "Concentration Dependence"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0011546:Dependence [Mental Process]
   861   C0439857:Dependence [Mental or Behavioral Dysfunction]
   861   C2698668:DEPENDENCE [Regulation or Law]
   789 E C0851827:Dependent [Qualitative Concept]
   789 E C1701901:Dependent [Qualitative Concept]
   789 E C3244310:dependent [Functional Concept]
   761 E C1546937:Dependency [Idea or Concept]

Phrase: "and"

Phrase: "Specificity of the Insulin ResponseTo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037791:Specificity [Quantitative Concept]
   760   C1511884:Specificity [Quantitative Concept]

Phrase: "ascertain"

Phrase: "whether"

Phrase: "the insulin-induced changes in cellular levels"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   757   C0025320:The change [Physiologic Function]
   748   C0392747:changes [Functional Concept]
   748   C0443172:changes [Quantitative Concept]
   714 E C1705241:Change [Quantitative Concept]

Phrase: "of C/EBP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "C/EBP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "are"

Phrase: "mediated by the insulin receptor"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   806   C1334133:INSULIN RECEPTOR [Gene or Genome]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "or by the insulin-like growth factor-1 (IGF-1) receptor,"
Meta Candidates (Total=21; Excluded=0; Pruned=0; Remaining=21)
   882   C0140080:Insulin-Like Growth Factor 1 Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   882   C1334088:insulin-like growth factor 1 receptor [Gene or Genome]
   849   C0021665:Insulin-like growth factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   849   C0202220:Insulin-like Growth Factor-1 [Laboratory Procedure]
   838   C0140079:Insulin-Like Growth Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   818   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   818   C1753359:insulin-like growth factor [Molecular Function]
   784   C0206454:Growth Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   764   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   762   C1334133:INSULIN RECEPTOR [Gene or Genome]
   742   C0018270:'growth' NOS [Organism Function]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0220844:growth [Physiologic Function]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   742   C1521761:Factor [Functional Concept]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]
   742   C1621966:Growth [Organ or Tissue Function]
   742   C2827422:Factor [Conceptual Entity]
   742   C2911660:Growth [Activity]

Phrase: "the dependence of these changes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0011546:Dependence [Mental Process]
   760   C0439857:Dependence [Mental or Behavioral Dysfunction]
   760   C2698668:DEPENDENCE [Regulation or Law]

Phrase: "on concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "or"

Phrase: "IGF-1"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
  1000   C0021665:Insulin-like growth factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0202220:Insulin-like Growth Factor-1 [Laboratory Procedure]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "assessed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]
Processing 00000000.tx.107: As illustrated in Fig.4, the concentration of insulin for half-maximal effects on the expression of C/EBP, C/EBP, and C/EBP occurred around 3-10 nM insulin. 

Phrase: "As"

Phrase: "illustrated in Fig.4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0349966:Fig [Food]
   770   C1337208:FIG [Food]

Phrase: "the concentration of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0086045:Concentration [Mental Process]
   770   C1446561:Concentration [Quantitative Concept]

Phrase: "for half-maximal effects"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   827   C0205289:Maximal [Qualitative Concept]
   827   C0806909:Maximal [Quantitative Concept]
   827   C1280500:effects [Qualitative Concept]
   827   C2825407:Half [Quantitative Concept]
   793 E C2348382:Effect [Qualitative Concept]
   755 E C1552615:maximum [Quantitative Concept]
   755 E C2826546:MAXIMUM [Quantitative Concept]

Phrase: "on the expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of C/EBP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "C/EBP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "occurred around 3-10 nM insulin."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   783   C1328200:NM-3 [Pharmacologic Substance]
   783   C1883310:10^3 [Quantitative Concept]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0312860:NM [Cell Function]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1709305:Occurred [Activity]
   719 E C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.108: This is in good agreement with the reported K for insulin with the insulin receptor of intact 3T3-L1 adipocytes(39) . While IGF-1 did not influence the expression of C/EBP or C/EBP in these cells, IGF-1 induced expression of C/EBP with a concentration dependence consistent with an effect mediated by the IGF-1 receptor. 

Phrase: "This"

Phrase: "is in good agreement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205170:Good [Qualitative Concept]
   770   C0680240:Agreement [Social Behavior]

Phrase: "with the reported K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "for insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "with the insulin receptor"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C1334133:INSULIN RECEPTOR [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "of intact 3T3-L1 adipocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0206131:Adipocytes [Cell]

Phrase: "(39"

Phrase: ") ."

Phrase: "While"

Phrase: "IGF-1"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
  1000   C0021665:Insulin-like growth factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0202220:Insulin-like Growth Factor-1 [Laboratory Procedure]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "influence"

Phrase: "the expression of C/EBP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1171362:expression protein [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "C/EBP in these cells,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   853   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   814   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C2752241:enhancer binding [Genetic Function]
   774 E C0033618:Protein Binding [Molecular Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]

Phrase: "IGF-1 induced expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   795   C0185117:Expression [Therapeutic or Preventive Procedure]
   747   C0021665:Insulin-like growth factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   747   C0202220:Insulin-like Growth Factor-1 [Laboratory Procedure]
   710   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   710   C1753359:insulin-like growth factor [Molecular Function]

Phrase: "of C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "with a concentration dependence"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0011546:Dependence [Mental Process]
   861   C0439857:Dependence [Mental or Behavioral Dysfunction]
   861   C2698668:DEPENDENCE [Regulation or Law]
   789 E C0851827:Dependent [Qualitative Concept]
   789 E C1701901:Dependent [Qualitative Concept]
   789 E C3244310:dependent [Functional Concept]
   761 E C1546937:Dependency [Idea or Concept]

Phrase: "consistent with an effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "mediated by the IGF-1 receptor."
Meta Candidates (Total=23; Excluded=0; Pruned=0; Remaining=23)
   882   C0140080:Insulin-Like Growth Factor 1 Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   882   C1334088:insulin-like growth factor 1 receptor [Gene or Genome]
   849   C0021665:Insulin-like growth factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   849   C0202220:Insulin-like Growth Factor-1 [Laboratory Procedure]
   838   C0140079:Insulin-Like Growth Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   818   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   818   C1753359:insulin-like growth factor [Molecular Function]
   784   C0206454:Growth Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   764   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   762   C1334133:INSULIN RECEPTOR [Gene or Genome]
   742   C0018270:'growth' NOS [Organism Function]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0086597:mediated [Social Behavior]
   742   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   742   C0220844:growth [Physiologic Function]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   742   C1521761:Factor [Functional Concept]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]
   742   C1621966:Growth [Organ or Tissue Function]
   742   C2827422:Factor [Conceptual Entity]
   742   C2911660:Growth [Activity]
Processing 00000000.tx.109: These findings support the view that insulin regulates expression of these C/EBP family members through the insulin receptor, and that IGF-1 also induces C/EBP through the IGF-1 receptor. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the view"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "regulates"

Phrase: "expression of these C/EBP family members"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C1171362:expression protein [Genetic Function]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "through the insulin receptor,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C1334133:INSULIN RECEPTOR [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "that IGF-1 also"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   947   C0021665:Insulin-like growth factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C0202220:Insulin-like Growth Factor-1 [Laboratory Procedure]
   901   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1753359:insulin-like growth factor [Molecular Function]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0220844:growth [Physiologic Function]
   799   C1521761:Factor [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "through the IGF-1 receptor."
Meta Candidates (Total=23; Excluded=2; Pruned=0; Remaining=21)
  1000   C0140080:Insulin-Like Growth Factor 1 Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C1334088:insulin-like growth factor 1 receptor [Gene or Genome]
   947   C0021665:Insulin-like growth factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C0202220:Insulin-like Growth Factor-1 [Laboratory Procedure]
   941   C0140079:Insulin-Like Growth Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1753359:insulin-like growth factor [Molecular Function]
   895   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   895   C1334133:INSULIN RECEPTOR [Gene or Genome]
   867   C0206454:Growth Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0220844:growth [Physiologic Function]
   799   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   799   C1521761:Factor [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.110: Figure 4: Effect of insulin or IGF-1 concentration on expression of C/EBP (A), C/EBP (B), and C/EBP (C). 

Phrase: "Figure 4"

Phrase: ":"

Phrase: "Effect of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "or"

Phrase: "IGF-1 concentration on expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0086045:Concentration [Mental Process]
   744   C1446561:Concentration [Quantitative Concept]
   703   C0021665:Insulin-like growth factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   703   C0202220:Insulin-like Growth Factor-1 [Laboratory Procedure]

Phrase: "of C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "(A"

Phrase: ")"

Phrase: ","

Phrase: "C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "(C)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.111: The indicated concentrations of insulin or IGF-1 were added to 3T3-L1 adipocytes for 24 h (C/EBP) or 2 h (C/EBP and C/EBP) on day 11 after initiating differentiation. 

Phrase: "The indicated concentrations of insulin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0086045:Concentrations [Mental Process]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "or"

Phrase: "IGF-1"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
  1000   C0021665:Insulin-like growth factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0202220:Insulin-like Growth Factor-1 [Laboratory Procedure]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "were"

Phrase: "added to 3T3-L1 adipocytes"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0206131:Adipocytes [Cell]
   760   C0441918:L1 [Finding]
   760   C1179698:L1 [Body Location or Region]
   760   C1416177:L1 [Gene or Genome]
   760   C1524062:Added [Functional Concept]
   726 E C1883712:Add [Functional Concept]

Phrase: "for 24 h (C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   901   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C2752241:enhancer binding [Genetic Function]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0243122:binding [Functional Concept]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]

Phrase: ")"

Phrase: "or"

Phrase: "2 h (C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   901   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C2752241:enhancer binding [Genetic Function]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0243122:binding [Functional Concept]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: ")"

Phrase: "on day 11"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "after initiating differentiation."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0007589:Differentiation [Cell Function]
   861   C1511938:Differentiation [Clinical Attribute]
   861   C2945687:Differentiation [Functional Concept]
   789 E C0205615:Differentiated [Qualitative Concept]
Processing 00000000.tx.112: After lysis and Western analysis, results were quantified by laser densitometry and are presented relative to the maximal level of expression for each C/EBP. 

Phrase: "After lysis"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0024348:Lysis [Pathologic Function]
  1000   C1536403:lysis [Cell Function]
   928 E C0439680:Lytic [Qualitative Concept]

Phrase: "and"

Phrase: "Western analysis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "were"

Phrase: "quantified by laser densitometry"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0011321:Densitometry [Laboratory Procedure]
   770   C0023089:Laser [Manufactured Object]
   770   C0458142:Laser [Phenomenon or Process]
   770   C1023865:Laser [Plant]
   770   C1706315:Laser [Medical Device]
   737   C1709793:Quantify [Quantitative Concept]

Phrase: "and"

Phrase: "are"

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "relative to the maximal level of expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0080103:Relative [Family Group]
   748   C0205345:Relative [Qualitative Concept]
   748   C1547039:*Relative [Quantitative Concept]

Phrase: "for each C/EBP."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
Processing 00000000.tx.113: Results from the insulin concentration dependence are representative of three independent experiments while the IGF-1 experiment was performed once. 

Phrase: "Results from the insulin concentration dependence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "are"

Phrase: "representative of three independent experiments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882932:Representative [Activity]

Phrase: "while"

Phrase: "the IGF-1 experiment"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   799   C0681814:Experiment [Research Activity]
   799   C1706386:Experiment [Conceptual Entity]
   780   C0021665:Insulin-like growth factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   780   C0202220:Insulin-like Growth Factor-1 [Laboratory Procedure]
   734   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   734   C1753359:insulin-like growth factor [Molecular Function]
   727 E C1517586:Experimental [Qualitative Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "once."
Processing 00000000.tx.114: The half-maximal insulin effect on the expression of C/EBP, C/EBP, and C/EBP was observed at 3-10 nM insulin. 

Phrase: "The half-maximal insulin effect on the expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "of C/EBP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "C/EBP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "observed at 3-10 nM insulin."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   783   C1328200:NM-3 [Pharmacologic Substance]
   783   C1883310:10^3 [Quantitative Concept]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0312860:NM [Cell Function]
   753   C1441672:Observed [Functional Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
Processing 00000000.tx.115: While IGF-1 induced expression of C/EBP with a half-maximal effect at 10 nM, IGF-1 did not influence the expression of either C/EBP or C/EBP. 

Phrase: "While"

Phrase: "IGF-1 induced expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   795   C0185117:Expression [Therapeutic or Preventive Procedure]
   747   C0021665:Insulin-like growth factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   747   C0202220:Insulin-like Growth Factor-1 [Laboratory Procedure]
   710   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   710   C1753359:insulin-like growth factor [Molecular Function]

Phrase: "of C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "with a half-maximal effect"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0205289:Maximal [Qualitative Concept]
   827   C0806909:Maximal [Quantitative Concept]
   827   C1280500:Effect [Qualitative Concept]
   827   C2348382:Effect [Qualitative Concept]
   827   C2825407:Half [Quantitative Concept]
   755 E C1552615:maximum [Quantitative Concept]
   755 E C2826546:MAXIMUM [Quantitative Concept]

Phrase: "at 10 nM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "IGF-1"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
  1000   C0021665:Insulin-like growth factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0202220:Insulin-like Growth Factor-1 [Laboratory Procedure]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "influence"

Phrase: "the expression of either C/EBP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1171362:expression protein [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "C/EBP."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
Processing 00000000.tx.116: Effect of Insulin on mRNA Levels of C/EBP, , and To determine whether changes in the expression of the C/EBP proteins were due to changes in steady-state levels of mRNA, Northern analysis was performed on total RNA isolated from fully-differentiated 3T3-L1 adipocytes treated with insulin for different periods of time. 

Phrase: "Effect of Insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on mRNA Levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "of C/EBP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: ","

Phrase: "and"

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "changes in the expression of the C/EBP proteins"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   738   C0392747:changes [Functional Concept]
   738   C0443172:changes [Quantitative Concept]
   704 E C1705241:Change [Quantitative Concept]

Phrase: "were due to changes"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0678226:Due to [Functional Concept]
           due
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   770   C3146286:Due [Idea or Concept]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "in steady-state levels"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   901   C0678587:steady state [Natural Phenomenon or Process]
   884   C0683927:state level [Spatial Concept]
   827   C0205361:Steady [Qualitative Concept]
   827   C0441889:Levels [Qualitative Concept]
   827   C1301808:State [Geographic Area]
   827   C1442792:State [Functional Concept]
   827   C3148680:State [Geographic Area]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "of mRNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "Northern analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "performed on total RNA"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0439175:% total [Quantitative Concept]
   770   C0439810:Total [Qualitative Concept]
   770   C0884358:Performed [Functional Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "isolated from fully-differentiated 3T3-L1 adipocytes"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   748   C0007589:Differentiated [Cell Function]
   748   C0205409:Isolated [Functional Concept]
   748   C0205615:Differentiated [Qualitative Concept]
   748   C0206131:Adipocytes [Cell]
   748   C0441918:L1 [Finding]
   748   C1179698:L1 [Body Location or Region]
   748   C1416177:L1 [Gene or Genome]
   748   C1548221:Isolated [Idea or Concept]
   721   C1159884:adipocyte differentiation [Cell Function]
   714 E C0370215:Isolate [Substance]
   714 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "treated with insulin"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   756 E C1292734:TREAT [Functional Concept]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "for different periods"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0439531:/period [Temporal Concept]
   827   C1948053:Period [Temporal Concept]
   777 E C0332182:Periodic [Temporal Concept]
   777 E C1706381:PERIODIC [Intellectual Product]
   755 E C0031084:Periodicities [Temporal Concept]

Phrase: "of time."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.117: Analysis of C/EBP, C/EBP, and C/EBP mRNA levels revealed that the effects of insulin on these C/EBP isoforms could be accounted for by changes in the cellular levels of their respective mRNAs (Fig.5, A and B). 

Phrase: "Analysis of C/EBP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C1514534:Protein Analysis [Molecular Biology Research Technique]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
   716   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "C/EBP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "C/EBP mRNA levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   822   C0428479:Protein level [Laboratory or Test Result]
   799   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0441889:Levels [Qualitative Concept]
   766 E C0456079:Level [Classification]
   766 E C1547707:Level [Geographic Area]
   766 E C2946261:Level [Pharmacologic Substance]
   734   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "the effects of insulin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "on these C/EBP isoforms"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0597298:Protein Isoforms [Amino Acid, Peptide, or Protein]
           Isoforms
   771   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "could"

Phrase: "be"

Phrase: "accounted for"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1551359:account [Idea or Concept]
   799   C2741673:Account # [Clinical Attribute]
   799   C2981730:Account [Classification]

Phrase: "by changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "in the cellular levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "of their respective mRNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(Fig.5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.118: Insulin caused a decrease in the expression of C/EBP mRNA, the greatest decrease occurring between 1 and 2 h of treatment, with low levels of expression persisting until at least 24 h. 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a decrease in the expression of C/EBP mRNA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0392756:Decrease [Qualitative Concept]
   738   C0547047:Decrease [Quantitative Concept]

Phrase: "the greatest decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0392756:Decrease [Qualitative Concept]
   861   C0547047:Decrease [Quantitative Concept]

Phrase: "occurring between 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C1709305:Occur [Activity]
   756   C2745955:OCCUR [Temporal Concept]

Phrase: "and"

Phrase: "2 h of treatment,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0011744:2 H [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "with low levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "of expression persisting"

Phrase: "until at least 24 h."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0033727:H+ [Element, Ion, or Isotope]
   760   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441932:H+ [Classification]
   760   C0564385:/h [Quantitative Concept]
   760   C1720302:Until [Intellectual Product]
Processing 00000000.tx.119: In contrast, insulin transiently induced the level of C/EBP and C/EBP mRNAs, which reached a maximum at 2 and 1 h, respectively (Fig.5B). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "insulin transiently"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "the level of C/EBP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0428479:Protein level [Laboratory or Test Result]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "C/EBP mRNAs,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   771   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   771   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "which"

Phrase: "reached"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2584321:Reach [Organism Function]

Phrase: "a maximum at 2"

Phrase: "and"

Phrase: "1 h,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "respectively"

Phrase: "(Fig.5B"

Phrase: ")."
Processing 00000000.tx.120: It is evident, therefore, that insulin regulates expression of C/EBP, C/EBP, and C/EBP primarily by regulating the steady-state levels of their respective mRNAs. 

Phrase: "It"

Phrase: "is"

Phrase: "evident, therefore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0332120:Evidence [Functional Concept]

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "regulates"

Phrase: "expression of C/EBP,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1171362:expression protein [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   716   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "C/EBP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "C/EBP primarily by"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   882   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C2752241:enhancer binding [Genetic Function]
   783 E C0033618:Protein Binding [Molecular Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "regulating"

Phrase: "the steady-state levels of their respective mRNAs."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   770   C0678587:steady state [Natural Phenomenon or Process]
   754   C0683927:state level [Spatial Concept]
   744   C0205361:Steady [Qualitative Concept]
   744   C0441889:Levels [Qualitative Concept]
   744   C1301808:State [Geographic Area]
   744   C1442792:State [Functional Concept]
   744   C3148680:State [Geographic Area]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.121: Figure 5: Comparison of the effect of insulin on the kinetics of expression of C/EBP, C/EBP, and C/EBP mRNAs. 

Phrase: "Figure 5"

Phrase: ":"

Phrase: "Comparison of the effect of insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1707455:Comparison [Activity]

Phrase: "on the kinetics"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022702:Kinetics [Natural Phenomenon or Process]
  1000   C0220865:kinetics [Functional Concept]
  1000   C2825046:Kinetics [Occupation or Discipline]

Phrase: "of expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of C/EBP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "C/EBP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "C/EBP mRNAs."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   771   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   771   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.122: A, insulin (167 nM) was added to 3T3-L1 adipocytes on day 12 after initiation of differentiation, and total RNA was prepared from two independent cell monolayers after 0, 1, 2, 4, 6, 10, or 24 h. 

Phrase: "A,"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(167 nM)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "was"

Phrase: "added to 3T3-L1 adipocytes"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0206131:Adipocytes [Cell]
   760   C0441918:L1 [Finding]
   760   C1179698:L1 [Body Location or Region]
   760   C1416177:L1 [Gene or Genome]
   760   C1524062:Added [Functional Concept]
   726 E C1883712:Add [Functional Concept]

Phrase: "on day 12"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "after initiation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0589507:Initiation [Mental Process]
  1000   C1158830:Initiation [Genetic Function]
  1000   C1704686:Initiation [Functional Concept]

Phrase: "of differentiation,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "and"

Phrase: "total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "prepared from two independent cell monolayers"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0007634:Cell [Cell]
   753   C0085862:Independent [Idea or Concept]
   753   C0205448:Two [Quantitative Concept]
   753   C0872351:monolayers [Clinical Drug]
   753   C1269647:Cell [Cell]
   753   C1299583:Independent [Finding]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   719   C1521827:Prepare [Functional Concept]

Phrase: "after 0,"

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "4,"

Phrase: "6,"

Phrase: "10,"

Phrase: "or"

Phrase: "24 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.123: Equal amounts of RNA (20 g) were electrophoresed, and analyzed by Northern blotting using DNA fragments complementary to C/EBP, C/EBP, or C/EBP mRNAs. 

Phrase: "Equal amounts of RNA (20 g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:amounts [Quantitative Concept]

Phrase: "were"

Phrase: "electrophoresed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0013855:electrophorese [Laboratory Procedure]

Phrase: ","

Phrase: "and"

Phrase: "analyzed by Northern blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005861:Northern Blotting [Molecular Biology Research Technique]
   816 E C1621557:Northern Blot [Research Device]
   770   C0936012:Analyzed [Research Activity]
   770   C1709269:Northern [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "fragments"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332255:fragment [Functional Concept]
  1000   C0486805:Fragments [Body Substance]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "complementary to C/EBP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   716   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "C/EBP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "or"

Phrase: "C/EBP mRNAs."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   771   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   771   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.124: Results are representative of three independent experiments. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "representative of three independent experiments."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882932:Representative [Activity]
Processing 00000000.tx.125: Autoradiography was for 48 h at -80 C for C/EBP and C/EBP; 

Phrase: "Autoradiography"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004400:Autoradiography [Laboratory Procedure]
   900 E C2986957:Autoradiograph [Manufactured Object]

Phrase: "was for 48 h at -80 C"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0033727:H+ [Element, Ion, or Isotope]
   748   C0043194:WAS [Disease or Syndrome]
   748   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441932:H+ [Classification]
   748   C0564385:/h [Quantitative Concept]
   748   C1421478:WAS [Gene or Genome]

Phrase: "for C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: ";"
Processing 00000000.tx.126: 24 h for C/EBP. 

Phrase: "24 h for C/EBP."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0033727:H+ [Element, Ion, or Isotope]
   748   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441932:H+ [Classification]
   748   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.127: B, results in A were quantified by laser densitometry and the mean result  range are shown graphically relative to the maximal level of expression. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "results in A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1274040:Result [Functional Concept]
   790   C1546471:Result [Idea or Concept]
   790   C2825142:Result [Finding]

Phrase: "were"

Phrase: "quantified by laser densitometry"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0011321:Densitometry [Laboratory Procedure]
   770   C0023089:Laser [Manufactured Object]
   770   C0458142:Laser [Phenomenon or Process]
   770   C1023865:Laser [Plant]
   770   C1706315:Laser [Medical Device]
   737   C1709793:Quantify [Quantitative Concept]

Phrase: "and"

Phrase: "the mean result  range"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1514721:Range [Quantitative Concept]
   827   C2348147:Range [Quantitative Concept]
   827   C3542016:Range [Intellectual Product]

Phrase: "are"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "graphically relative to the maximal level of expression."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0080103:Relative [Family Group]
   744   C0205345:Relative [Qualitative Concept]
   744   C1547039:*Relative [Quantitative Concept]
Processing 00000000.tx.128: Effect of Insulin on Transcription of the C/EBP, C/EBP, and C/EBP GenesTo ascertain whether the rapid changes in the mRNA levels for C/EBP, C/EBP, and C/EBP were due to changes in gene transcription, the effect of insulin on nuclear run-on transcription was evaluated. 

Phrase: "Effect of Insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on Transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040649:Transcription [Genetic Function]

Phrase: "of the C/EBP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "C/EBP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "C/EBP GenesTo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "ascertain"

Phrase: "whether"

Phrase: "the rapid changes in the mRNA levels"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   757   C0025320:The change [Physiologic Function]
   748   C0392747:changes [Functional Concept]
   748   C0443172:changes [Quantitative Concept]
   714 E C1705241:Change [Quantitative Concept]

Phrase: "for C/EBP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "C/EBP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "were due to changes"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0678226:Due to [Functional Concept]
           due
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   770   C3146286:Due [Idea or Concept]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "in gene transcription,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040649:Gene Transcription [Genetic Function]
           Transcription

Phrase: "the effect of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on nuclear run-on transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0040649:Transcription [Genetic Function]

Phrase: "was"

Phrase: "evaluated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]
Processing 00000000.tx.129: As shown in Fig.6, insulin markedly (65%) repressed C/EBP gene transcription within 1 h and this suppressed rate of transcription was maintained for at least 4 h. 

Phrase: "As"

Phrase: "shown in Fig.6,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0349966:Fig [Food]
   770   C1337208:FIG [Food]
   737   C1547282:Show [Intellectual Product]

Phrase: "insulin markedly"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(65%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: ")"

Phrase: "repressed C/EBP gene transcription within 1 h"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0040649:Gene Transcription [Genetic Function]
           Transcription
   722   C0920533:Transcription Repression [Genetic Function]

Phrase: "and"

Phrase: "this suppressed rate of transcription"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "was"

Phrase: "maintained for"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C1314677:Maintained [Functional Concept]
   799 E C0024501:Maintain [Activity]

Phrase: "at least 4 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.130: In contrast, insulin induced (3-fold) transcription of both the C/EBP and C/EBP genes by 1 h (Fig.6). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "(3-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: "transcription of both"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0040649:Transcription [Genetic Function]

Phrase: "the C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "C/EBP genes by 1 h (Fig.6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   743   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0017337:Genes [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.131: Other experiments showed induction levels of up to 8-fold. 

Phrase: "Other experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "induction levels of"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0441889:Levels [Qualitative Concept]
   756 E C0456079:Level [Classification]
   756 E C1547707:Level [Geographic Area]
   756 E C2946261:Level [Pharmacologic Substance]

Phrase: "up to 8-fold."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]
Processing 00000000.tx.132: These changes in transcription precede and are comparable in magnitude to effects of insulin on the cellular levels of C/EBP, C/EBP, and C/EBP mRNAs (see Fig.5). 

Phrase: "These changes in transcription"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "precede"

Phrase: "and"

Phrase: "are"

Phrase: "comparable in magnitude"

Phrase: "to effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "of insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "on the cellular levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "of C/EBP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "C/EBP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "C/EBP mRNAs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   771   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   771   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig.5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.133: Therefore, insulin rapidly regulates the expression of C/EBP, C/EBP, and C/EBP mRNAs, in large part, by altering rates of transcription. 

Phrase: "Therefore,"

Phrase: "insulin rapidly"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "regulates"

Phrase: "the expression of C/EBP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1171362:expression protein [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "C/EBP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "C/EBP mRNAs,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   771   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   771   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in large part,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0449719:Part [Spatial Concept]
   861   C1709471:Part [Quantitative Concept]

Phrase: "by altering rates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]

Phrase: "of transcription."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040649:Transcription [Genetic Function]
Processing 00000000.tx.134: Figure 6: A) Effect of insulin on nuclear run-on transcription of the C/EBP, C/EBP, and C/EBP genes. 

Phrase: "Figure 6"

Phrase: ":"

Phrase: "A) Effect of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on nuclear run-on transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0040649:Transcription [Genetic Function]

Phrase: "of the C/EBP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "C/EBP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "C/EBP genes."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   823   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0017337:Genes [Gene or Genome]
   771   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.135: Nuclei were prepared from fully-differentiated 3T3-L1 adipocytes that were untreated, or treated with 167 nM insulin for 1 or 4 h. 

Phrase: "Nuclei"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0007610:Nucleus [Cell Component]

Phrase: "were"

Phrase: "prepared from fully-differentiated 3T3-L1 adipocytes"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0007589:Differentiated [Cell Function]
   748   C0205615:Differentiated [Qualitative Concept]
   748   C0206131:Adipocytes [Cell]
   748   C0441918:L1 [Finding]
   748   C1179698:L1 [Body Location or Region]
   748   C1416177:L1 [Gene or Genome]
   721   C1159884:adipocyte differentiation [Cell Function]
   714   C1521827:Prepare [Functional Concept]

Phrase: "that"

Phrase: "were"

Phrase: "untreated,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332155:untreated [Finding]

Phrase: "or"

Phrase: "treated with 167 nM insulin"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0312860:NM [Cell Function]
   760   C1522326:Treated [Functional Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   726 E C1292734:TREAT [Functional Concept]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "for 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "or"

Phrase: "4 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.136: After incubation of nuclei with [P]UTP and isolation of RNA, 18 10 dpm of P-labeled RNA were used for hybridization of blots containing 1 mg of DNA complementary for C/EBP, C/EBP, C/EBP, pBluescript, or genomic DNA. 

Phrase: "After incubation"

Phrase: "of nuclei"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0007610:Nucleus [Cell Component]

Phrase: "with"

Phrase: "[P]UTP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0042010:UTP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "isolation of RNA,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0204727:Isolation [Therapeutic or Preventive Procedure]
   790   C0205409:Isolation [Functional Concept]
   790   C0220862:isolation [Laboratory Procedure]
   718 E C1548221:Isolated [Idea or Concept]

Phrase: "18 10 dpm of P-labeled RNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1512024:DPM [Intellectual Product]
   748   C1634619:dpm [Quantitative Concept]

Phrase: "were"

Phrase: "used for hybridization of blots"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   781   C1524063:Use of [Functional Concept]
   760   C0020202:Hybridisation [Genetic Function]
   760   C1273517:used [Finding]
   760   C1300517:Hybridization [Laboratory Procedure]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1 mg of DNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439269:mg% [Quantitative Concept]
   770   C1960952:mg % [Quantitative Concept]
   770   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "complementary for C/EBP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   716   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "C/EBP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "C/EBP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "pBluescript,"

Phrase: "or"

Phrase: "genomic DNA."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0017428:Genomic [Gene or Genome]
   861   C0887950:genomic [Biomedical Occupation or Discipline]
Processing 00000000.tx.137: Filters were washed to high stringency, and exposed to film for 7 days at -80 C. 

Phrase: "Filters"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0180860:Filters [Manufactured Object]
   966 E C0581406:Filter [Medical Device]
   966 E C1522664:Filter [Intellectual Product]
   966 E C1704449:Filter [Conceptual Entity]
   966 E C1704684:Filter [Medical Device]
   966 E C1875155:FILTER [Medical Device]

Phrase: "were"

Phrase: "washed to high stringency,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0205250:High [Qualitative Concept]
   770   C1299351:High [Qualitative Concept]
   770   C1548982:Washed [Idea or Concept]
   770   C2700149:HIGH [Intellectual Product]
   737 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "exposed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332157:Exposed [Clinical Attribute]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "film for 7 days at -80 C."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   748   C0086296:Film [Manufactured Object]
   748   C0439228:days [Temporal Concept]
   748   C1561571:film [Biomedical or Dental Material]
   748   C1561572:film [Substance]
   714 E C0332173:/day [Temporal Concept]
   714 E C0439505:/day [Temporal Concept]
Processing 00000000.tx.138: Results are representative of two independent experiments. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "representative of two independent experiments."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882932:Representative [Activity]
Processing 00000000.tx.139: B, results in A were quantified by laser densitometry, normalized to the genomic signal, and the results for each C/EBP homologue expressed in arbitrary units. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "results in A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1274040:Result [Functional Concept]
   790   C1546471:Result [Idea or Concept]
   790   C2825142:Result [Finding]

Phrase: "were"

Phrase: "quantified by laser densitometry,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0011321:Densitometry [Laboratory Procedure]
   770   C0023089:Laser [Manufactured Object]
   770   C0458142:Laser [Phenomenon or Process]
   770   C1023865:Laser [Plant]
   770   C1706315:Laser [Medical Device]
   737   C1709793:Quantify [Quantitative Concept]

Phrase: "normalized to the genomic signal,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0017428:Genomic [Gene or Genome]
   760   C0887950:genomic [Biomedical Occupation or Discipline]
   760   C1710082:Signal [Phenomenon or Process]
   760   C1882115:Normalized [Research Activity]

Phrase: "and"

Phrase: "the results for each C/EBP homologue"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   708   C1274040:Result [Functional Concept]
   708   C1546471:Result [Idea or Concept]
   708   C2825142:Result [Finding]

Phrase: "expressed in arbitrary units."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   799   C0439183:Arbitrary unit [Quantitative Concept]
   770   C0439148:Units [Quantitative Concept]
   770   C1264693:*Arbitrary [Quantitative Concept]
   770   C1519795:Units [Quantitative Concept]
   737 E C1704753:Unit [Manufactured Object]
   737 E C1880519:Unit [Quantitative Concept]
Processing 00000000.tx.140: Effect of Insulin on the Phosphorylation State of C/EBPAs shown above (Fig.2) insulin rapidly (within 15 min) alters the mobility of p30 and p42 by SDS-PAGE. 

Phrase: "Effect of Insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on the Phosphorylation State"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]
   861   C1301808:State [Geographic Area]
   861   C1442792:State [Functional Concept]
   861   C3148680:State [Geographic Area]

Phrase: "of C/EBPAs"

Phrase: "shown above"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1547282:Show [Intellectual Product]

Phrase: "(Fig.2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "insulin rapidly"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "("

Phrase: "within 15 min)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the mobility of p30"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0425245:Mobility [Finding]
   770   C0449580:Mobility [Qualitative Concept]

Phrase: "and"

Phrase: "p42 by SDS-PAGE."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   716   C0600209:Sodium Dodecyl Sulfate-PAGE [Laboratory Procedure,Research Activity]
Processing 00000000.tx.141: Following exposure to insulin the initial double-band pattern of each isoform reverts to a single, higher-mobility band, i.e. corresponding to 41 and 29 kDa, reaching 50 and 100% completion within 15 and 30 min, respectively. 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "exposure to insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0332157:Exposure to [Clinical Attribute]
           Exposure
   790   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "the initial double-band pattern of each isoform"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1442158:band pattern [Clinical Attribute]
   744   C0449774:Pattern [Spatial Concept]

Phrase: "reverts to a single, higher-mobility band,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   748   C0037179:Single [Population Group]
   748   C0087136:single [Finding]
   748   C0175723:Band [Medical Device]
   748   C0205171:Single [Quantitative Concept]
   748   C0425245:Mobility [Finding]
   748   C0439645:Band [Spatial Concept]
   748   C0449580:Mobility [Qualitative Concept]
   748   C1521913:band [Cell Component]
   714   C0205250:High [Qualitative Concept]
   714   C1299351:High [Qualitative Concept]
   714   C2700149:HIGH [Intellectual Product]

Phrase: "i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "corresponding to 41"

Phrase: "and"

Phrase: "29 kDa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "reaching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2584321:Reaching [Organism Function]

Phrase: "50"

Phrase: "and"

Phrase: "100% completion within 15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205197:Completion [Qualitative Concept]
   770   C1554962:completion [Qualitative Concept]

Phrase: "and"

Phrase: "30 min,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "respectively."
Processing 00000000.tx.142: The rapidity of the response to insulin and the fact that blocking protein synthesis with cycloheximide did not prevent the response (results not shown) suggested that the changes in mobility of the C/EBP isoforms were the result of post-translational modification, such as phosphorylation. 

Phrase: "The rapidity of the response"

Phrase: "to insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "the fact"

Phrase: "that blocking protein synthesis with cycloheximide"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0597295:Protein Synthesis [Molecular Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0220781:synthesis [Biologic Function]
   753   C1883254:Synthesis [Activity]
   748 E C0597552:synthetic protein [Amino Acid, Peptide, or Protein]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "the response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "(results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the changes in mobility of the C/EBP isoforms"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   739   C0025320:The change [Physiologic Function]
   738   C0392747:changes [Functional Concept]
   738   C0443172:changes [Quantitative Concept]
   704 E C1705241:Change [Quantitative Concept]

Phrase: "were"

Phrase: "the result of post-translational modification,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1274040:Result [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C2825142:Result [Finding]

Phrase: "such as phosphorylation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.143: To ascertain whether the mobility differences were due to phosphorylation of the C/EBP isoforms, the effect of okadaic acid, a potent inhibitor of serine/threonine protein phosphatases 1 and 2A(40, 41) , was tested in the absence and presence of insulin. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "ascertain"

Phrase: "whether"

Phrase: "the mobility differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]

Phrase: "were due to phosphorylation of the C/EBP isoforms,"
Meta Candidates (Total=18; Excluded=1; Pruned=0; Remaining=17)
   797   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   775   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0597298:Protein Isoforms [Amino Acid, Peptide, or Protein]
           Isoforms
   756   C0678226:Due to [Functional Concept]
           due
   756   C2752241:enhancer binding [Genetic Function]
   754 E C0033618:Protein Binding [Molecular Function]
   754   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   738   C0031715:Phosphorylation [Molecular Function]
   738   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0243122:binding [Functional Concept]
   738   C1145667:Binding [Activity]
   738   C1167622:Binding [Molecular Function]
   738   C3146286:Due [Idea or Concept]

Phrase: "the effect of okadaic acid,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "a potent inhibitor of serine/threonine protein phosphatases 1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   793   C0072388:protein phosphatase inhibitor-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           phosphatase inhibitor 1
   767   C1514560:Protein Phosphatase Inhibitor [Pharmacologic Substance]
   762   C1418824:INHIBITOR 1 [Gene or Genome]
   745   C0597217:phosphatase inhibitor [Pharmacologic Substance]
   742   C1999216:Inhibitor [Qualitative Concept]

Phrase: "and"

Phrase: "2A"

Phrase: "(40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "41"

Phrase: ")"

Phrase: ","

Phrase: "was"

Phrase: "tested in the absence"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0332197:absence [Quantitative Concept]
   770   C0392366:tested [Intellectual Product]
   770   C1689985:Absence [Anatomical Abnormality]
   737 E C0022885:Test [Laboratory Procedure]
   737 E C0039593:Test [Functional Concept]

Phrase: "and"

Phrase: "presence of insulin."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0392148:Presence [Therapeutic or Preventive Procedure]
   718 E C0150312:Present [Quantitative Concept]
   718 E C0449450:Present [Idea or Concept]
Processing 00000000.tx.144: Insulin treatment generated the higher mobility forms of the two C/EBPs (most evident with p30), whereas treatment with 1.5 M okadaic acid for 45 min, either in the absence or presence of insulin, gave rise to the lower mobility forms (Fig.7A). 

Phrase: "Insulin treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "the higher mobility"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0425245:Mobility [Finding]
   861   C0449580:Mobility [Qualitative Concept]
   789 E C0231435:Mobile [Functional Concept]
   789 E C1552449:Mobile [Health Care Related Organization,Manufactured Object]

Phrase: "forms of the two C/EBPs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205448:Two [Quantitative Concept]
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]

Phrase: "("

Phrase: "most evident with p30"

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "treatment with 1.5 M okadaic acid"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0039798:treatment [Functional Concept]
   748   C0087111:Treatment [Therapeutic or Preventive Procedure]
   748   C1522326:Treatment [Functional Concept]
   748   C1533734:Treatment [Therapeutic or Preventive Procedure]
   748   C1705169:Treatment [Conceptual Entity]
   748   C3538994:TREATMENT [Research Activity]

Phrase: "for 45 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "either in the absence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "or"

Phrase: "presence of insulin,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0392148:Presence [Therapeutic or Preventive Procedure]
   718 E C0150312:Present [Quantitative Concept]
   718 E C0449450:Present [Idea or Concept]

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "rise to the lower mobility forms"

Phrase: "(Fig.7A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.145: Figure 7: Effect of insulin and okadaic acid on the post-translational modification of C/EBP. 

Phrase: "Figure 7"

Phrase: ":"

Phrase: "Effect of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "okadaic acid on the post-translational modification"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0069389:Ocadaic Acid [Hazardous or Poisonous Substance,Organic Chemical]
   748   C0001128:Acid [Chemical]
   748   C0202406:Acid [Laboratory Procedure]

Phrase: "of C/EBP."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
Processing 00000000.tx.146: A, 3T3-L1 adipocytes were treated for 45 min with MeSO (vehicle for okadaic acid; CONT), 167 nM insulin (INS), 1.5 M okadaic acid (OA), insulin after a 5-min pretreatment with okadaic acid (O+A), or okadaic acid after a 5-min pretreatment with insulin (I+O). 

Phrase: "A,"

Phrase: "3T3-L1 adipocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206131:Adipocytes [Cell]

Phrase: "were"

Phrase: "treated for 45 min"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0332293:treated [Therapeutic or Preventive Procedure]
   770   C0702093:/min [Temporal Concept]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "with MeSO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3641135:MESO [Conceptual Entity]

Phrase: "(vehicle for okadaic acid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0042444:Vehicle [Biomedical or Dental Material]
   770   C0348005:Vehicle [Manufactured Object]

Phrase: "; CONT),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2826258:CONT [Event]

Phrase: "167 nM insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(INS"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "1.5 M okadaic acid (OA),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0069389:Ocadaic Acid [Hazardous or Poisonous Substance,Organic Chemical]
   804   C0001128:Acid [Chemical]
   804   C0202406:Acid [Laboratory Procedure]

Phrase: "insulin after a 5-min pretreatment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "with okadaic acid (O+A),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0069389:Ocadaic Acid [Hazardous or Poisonous Substance,Organic Chemical]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "or"

Phrase: "okadaic acid after a 5-min pretreatment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0069389:Ocadaic Acid [Hazardous or Poisonous Substance,Organic Chemical]
   748   C0001128:Acid [Chemical]
   748   C0202406:Acid [Laboratory Procedure]

Phrase: "with insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(I+O"

Phrase: ")."
Processing 00000000.tx.147: Whole cell lysates containing equal cell equivalents (200 g of protein) were subjected to SDS-PAGE, and immunoblotted using antisera generated against C/EBP. 

Phrase: "Whole cell lysates"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   884   C1881488:Cell Lysate [Physical Object]
           Lysate
   827   C0007634:Cell [Cell]
   827   C0444667:Whole [Quantitative Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "equal cell equivalents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439185:Equivalents [Quantitative Concept]
   793 E C0205163:Equivalent [Qualitative Concept]

Phrase: "(200 g of protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0060916:protein g [Amino Acid, Peptide, or Protein]
   819   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "subjected to SDS-PAGE,"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   882   C0600209:Sodium Dodecyl Sulfate-PAGE [Laboratory Procedure,Research Activity]
   833   C0037506:Sodium Dodecyl Sulfate [Biomedical or Dental Material,Lipid,Pharmacologic Substance]
   790   C0058632:dodecyl sulfate [Lipid,Pharmacologic Substance]
   783   C0074769:Sodium sulphate [Inorganic Chemical,Pharmacologic Substance]
   753   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   753   C0038720:Sulfate [Inorganic Chemical]
   753   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   753   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C1704732:Page [Intellectual Product]
   753   C3536965:SULFATE [Element, Ion, or Isotope]
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "immunoblotted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antisera"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020960:Antisera [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "generated against C/EBP."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   882   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C2752241:enhancer binding [Genetic Function]
   783 E C0033618:Protein Binding [Molecular Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C3146294:Generated [Activity]
Processing 00000000.tx.148: B, 3T3-L1 adipocytes were incubated under serum-free conditions overnight. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "3T3-L1 adipocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206131:Adipocytes [Cell]

Phrase: "were"

Phrase: "incubated under serum-free conditions overnight."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   753   C0229671:Serum [Body Substance]
   753   C0332296:free [Functional Concept]
   753   C0439583:Overnight [Temporal Concept]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   753   C1880497:Free [Qualitative Concept]
   753   C1996904:Free [Qualitative Concept]
   719   C0012634:condition [Disease or Syndrome]
   719   C0348080:Condition [Qualitative Concept]
   719   C1705253:Condition [Conceptual Entity]
Processing 00000000.tx.149: After a wash in phosphate-free, serum-free media, adipocytes were incubated with [P]orthophosphate for 2 h, then insulin or not for another hour. 

Phrase: "After a wash in phosphate-free, serum-free media,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   845   C0085414:Serum-Free Media [Indicator, Reagent, or Diagnostic Aid]
   829   C0036820:phosphate serum [Laboratory Procedure]
   795   C0009458:Media [Intellectual Product]
   795   C0162867:Media [Tissue]
   795   C0229671:Serum [Body Substance]
   795   C1254021:Media [Tissue]
   795   C1546774:Serum [Intellectual Product]
   795   C1550100:Serum [Body Substance]
   762 E C0439536:Medium [Quantitative Concept]
   762 E C1705217:Medium [Substance]
   762 E C3244283:medium [Intellectual Product]

Phrase: "adipocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206131:Adipocytes [Cell]

Phrase: "were"

Phrase: "incubated with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1439852:Incubated [Laboratory Procedure]

Phrase: "[P]orthophosphate for 2 h,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0029356:Orthophosphate [Inorganic Chemical]

Phrase: "then insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "or"

Phrase: "not for another hour."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439227:Hour [Temporal Concept]
   770   C0564385:/hour [Quantitative Concept]
   770   C1518422:Not [Functional Concept]
Processing 00000000.tx.150: C/EBP was immunoprecipitated with antiserum against C/EBP using protein A-Sepharose, separated by SDS-PAGE, and visualized with autoradiography at -80 C. 

Phrase: "C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "immunoprecipitated with antiserum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   756   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "against C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "protein A-Sepharose,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0075172:protein A-sepharose [Carbohydrate]
   827   C0036681:Sepharose [Carbohydrate]
   734   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]

Phrase: "separated by SDS-PAGE,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   882   C0600209:Sodium Dodecyl Sulfate-PAGE [Laboratory Procedure,Research Activity]
   833   C0037506:Sodium Dodecyl Sulfate [Biomedical or Dental Material,Lipid,Pharmacologic Substance]
   790   C0058632:dodecyl sulfate [Lipid,Pharmacologic Substance]
   783   C0074769:Sodium sulphate [Inorganic Chemical,Pharmacologic Substance]
   753   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   753   C0038720:Sulfate [Inorganic Chemical]
   753   C0086972:Separated [Finding]
   753   C0443299:separated [Spatial Concept]
   753   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   753   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0687118:Separated [Functional Concept]
   753   C1704732:Page [Intellectual Product]
   753   C3536965:SULFATE [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "visualized with autoradiography at -80 C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0004400:Autoradiography [Laboratory Procedure]
   753   C0234621:Visualized [Functional Concept]
Processing 00000000.tx.151: C, nuclear extracts were prepared from adipocytes treated with 1.5 M okadaic acid for 45 min. 

Phrase: "C,"

Phrase: "nuclear extracts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1518434:Nuclear Extract [Biomedical or Dental Material]
   861   C0521447:Nuclear [Spatial Concept]
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "prepared from adipocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0206131:Adipocytes [Cell]
   756   C1521827:Prepare [Functional Concept]

Phrase: "treated with 1.5 M okadaic acid"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   778   C0069389:Ocadaic Acid [Hazardous or Poisonous Substance,Organic Chemical]
   778   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   774   C1440942:M-5 [Immunologic Factor]
   748   C0001128:Acid [Chemical]
   748   C0202406:Acid [Laboratory Procedure]
   748   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441923:M+ [Intellectual Product]
   748   C1522326:Treated [Functional Concept]
   714 E C1292734:TREAT [Functional Concept]

Phrase: "for 45 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.152: After precipitation with 12.5% trichloroacetic acid, the pellet was rinsed with cold acetone, and dissolved in 50 mM NaCl, 10 mM Tris-HCl, 10 mM MgCl, 1 mM dithiothreitol, and 0.1% SDS at 37 C for 8 h. 

Phrase: "After precipitation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0032931:Precipitation [Natural Phenomenon or Process]
  1000   C0032932:Precipitation [Molecular Function]
  1000   C1642401:% precipitation [Quantitative Concept]
  1000   C2584299:Precipitation [Natural Phenomenon or Process]

Phrase: "with 12.5% trichloroacetic acid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]

Phrase: "the pellet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441436:Pellet [Manufactured Object]
  1000   C0993610:Pellet [Biomedical or Dental Material]
  1000   C1998480:Pellet [Quantitative Concept]

Phrase: "was"

Phrase: "rinsed with cold acetone,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0001002:Acetone [Organic Chemical,Pharmacologic Substance]
   770   C0009264:Cold [Natural Phenomenon or Process]
   770   C0009443:Cold [Disease or Syndrome]
   770   C0234192:Cold [Physiologic Function]
   737   C1701810:Rinse [Functional Concept]
   737   C1882955:Rinse [Activity]

Phrase: "and"

Phrase: "dissolved in 50 mM NaCl,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   760   C1959973:% NaCl [Quantitative Concept]
   726   C1549535:Dissolve [Functional Concept]

Phrase: "10 mM Tris-HCl,"

Phrase: "10 mM MgCl,"

Phrase: "1 mM dithiothreitol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "0.1% SDS at 37 C"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   800   C0037506:Sodium Dodecyl Sulfate [Biomedical or Dental Material,Lipid,Pharmacologic Substance]
   770   C0058632:dodecyl sulfate [Lipid,Pharmacologic Substance]
   767   C0074769:Sodium sulphate [Inorganic Chemical,Pharmacologic Substance]
   767   C0597484:Sodium 1+ [Element, Ion, or Isotope,Pharmacologic Substance]
           Sodium+
   744   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   744   C0038720:Sulfate [Inorganic Chemical]
   744   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   744   C3536965:SULFATE [Element, Ion, or Isotope]

Phrase: "for 8 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.153: After addition of Triton X-100 to 1%, 50 units of calf intestinal phosphatase were added to half the sample prior to an overnight incubation at 37 C. 

Phrase: "After addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of Triton X-100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   901   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   827   C0242759:Triton [Geographic Area]

Phrase: "to 1%,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "50 units of calf intestinal phosphatase"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0439148:Units [Quantitative Concept]
   753   C1519795:Units [Quantitative Concept]
   719 E C1704753:Unit [Manufactured Object]
   719 E C1880519:Unit [Quantitative Concept]

Phrase: "were"

Phrase: "added to half"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1524062:Added [Functional Concept]
   790   C2825407:Half [Quantitative Concept]
   756 E C1883712:Add [Functional Concept]

Phrase: "the sample prior to an overnight incubation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0370003:Sample [Substance]
   748   C2347026:Sample [Conceptual Entity]

Phrase: "at 37 C."
Processing 00000000.tx.154: C/EBP was analyzed following SDS-PAGE by Western blot analysis. 

Phrase: "C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "SDS-PAGE by Western blot analysis."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0600209:Sodium Dodecyl Sulfate-PAGE [Laboratory Procedure,Research Activity]
   800   C0037506:Sodium Dodecyl Sulfate [Biomedical or Dental Material,Lipid,Pharmacologic Substance]
   770   C0058632:dodecyl sulfate [Lipid,Pharmacologic Substance]
   767   C0074769:Sodium sulphate [Inorganic Chemical,Pharmacologic Substance]
   744   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   744   C0038720:Sulfate [Inorganic Chemical]
   744   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   744   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   744   C1704732:Page [Intellectual Product]
   744   C3536965:SULFATE [Element, Ion, or Isotope]
Processing 00000000.tx.155: All results above are representative of at least two independent experiments. 

Phrase: "All"

Phrase: "results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "above"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]

Phrase: "are"

Phrase: "representative of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1882932:Representative [Activity]

Phrase: "at least two independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.156: Since inhibition of a phosphatase (by okadaic acid) might be expected to have the opposite effect of insulin, it follows that insulin may function to activate a type 1 or 2A protein phosphatase. 

Phrase: "Since"

Phrase: "inhibition of a phosphatase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "("

Phrase: "by okadaic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0069389:Ocadaic Acid [Hazardous or Poisonous Substance,Organic Chemical]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: "might"

Phrase: "be"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "the opposite effect of insulin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "it"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "may"

Phrase: "function"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "a type 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441729:Type 1 [Classification]
   861   C0332307:Type [Qualitative Concept]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "2A protein phosphatase."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1149880:phosphatase [Molecular Function]
Processing 00000000.tx.157: Activation of protein phosphatase type 1 by insulin is well documented in several cell types(42, 43) , including 3T3-L1 adipocytes(44) . Moreover, protein phosphatase type 1 has been shown to be regulated during the cell cycle(45) , and this is correlated with the predominance of the higher mobility band in elutriation experiments. 

Phrase: "Activation of protein phosphatase type 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0599177:protein activation [Genetic Function]
   753   C1879547:Activation [Activity]

Phrase: "by insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "well documented in several cell types"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   753   C0205170:Well [Qualitative Concept]
   753   C1301725:Documented [Health Care Activity]
   753   C1609436:documented [Idea or Concept]
   753   C3146287:Well [Manufactured Object]
   750   C1547673:Document type [Intellectual Product]
       E   Document
   750   C3484371:Document type [Clinical Attribute]
   719 E C1301746:document [Intellectual Product]

Phrase: "(42,"

Phrase: "43"

Phrase: ")"

Phrase: ","

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "3T3-L1 adipocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206131:Adipocytes [Cell]

Phrase: "(44"

Phrase: ") . Moreover,"

Phrase: "protein phosphatase type 1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   923   C1956003:Protein Phosphatase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0441729:Type 1 [Classification]
   812   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0332307:Type [Qualitative Concept]
   812   C1149880:phosphatase [Molecular Function]
   812   C1547052:*Type [Quantitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "regulated during the cell cycle"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0007586:Cell Cycle [Cell Function]
   806   C1155839:Cell Cycle [Cell Function]
   760   C0007634:Cell [Cell]
   760   C0851285:Regulated [Governmental or Regulatory Activity]
   760   C1269647:Cell [Cell]
   760   C1511572:Cycle [Temporal Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "(45"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "this"

Phrase: "is"

Phrase: "correlated with the predominance of the higher mobility band"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   742   C0175723:Band [Medical Device]
   742   C0425245:Mobility [Finding]
   742   C0439645:Band [Spatial Concept]
   742   C0449580:Mobility [Qualitative Concept]
   742   C1521913:band [Cell Component]
   742   C1707520:Correlated [Qualitative Concept]
   708   C0205250:High [Qualitative Concept]
   708   C1299351:High [Qualitative Concept]
   708   C2700149:HIGH [Intellectual Product]

Phrase: "in elutriation experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.158: ()Whether this phosphatase acts to directly dephosphorylate C/EBP or acts through a second messenger pathway which leads to dephosphorylation remains unclear. 

Phrase: "("

Phrase: ")"

Phrase: "Whether"

Phrase: "this phosphatase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1149880:phosphatase [Molecular Function]

Phrase: "acts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "to directly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1883351:To [Qualitative Concept]
   861   C1947931:Directly [Qualitative Concept]

Phrase: "dephosphorylate"

Phrase: "C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "or"

Phrase: "acts through a second messenger pathway"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   790   C0036522:second messenger [Molecular Function]
   790   C1508748:second messenger [Biologically Active Substance]
   783   C0682673:second pathway [Body Part, Organ, or Organ Component]
   753   C0079613:ACT [Therapeutic or Preventive Procedure]
   753   C0169911:messenger [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   753   C0205436:Second [Quantitative Concept]
   753   C0335218:Messenger [Professional or Occupational Group]
   753   C0457385:Second [Temporal Concept]
   753   C0565930:/second [Quantitative Concept]
   753   C1561503:second [Idea or Concept]
   753   C1704259:Pathway [Molecular Function]
   753   C1705190:Second [Qualitative Concept]
   753   C1705987:Pathway [Conceptual Entity]

Phrase: "which"

Phrase: "leads to dephosphorylation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   790   C0181586:leads [Medical Device]
   790   C1158884:Dephosphorylation [Molecular Function]
   790   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   790   C1522538:Lead [Functional Concept]
   790   C2348269:Lead [Element, Ion, or Isotope]
   790   C3160734:Dephosphorylation [Molecular Function]
   790   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "remains"

Phrase: "unclear."
Processing 00000000.tx.159: Ex vivo labeling of 3T3-L1 adipocytes with [P]orthophosphate followed by immunoprecipitation and SDS-PAGE revealed that both the 42- and 30-kDa forms of C/EBP are highly phosphorylated. 

Phrase: "Ex vivo labeling of 3T3-L1 adipocytes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1167624:Labeling [Mental Process]
   748   C1947902:Labeling [Manufactured Object]
   748   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "with"

Phrase: "[P]orthophosphate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029356:Orthophosphate [Inorganic Chemical]

Phrase: "followed by immunoprecipitation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0021069:Immunoprecipitation [Laboratory Procedure]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "and"

Phrase: "SDS-PAGE"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0600209:Sodium Dodecyl Sulfate-PAGE [Laboratory Procedure,Research Activity]
   923   C0037506:Sodium Dodecyl Sulfate [Biomedical or Dental Material,Lipid,Pharmacologic Substance]
   875   C0074769:Sodium sulphate [Inorganic Chemical,Pharmacologic Substance]
   861   C0058632:dodecyl sulfate [Lipid,Pharmacologic Substance]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0038720:Sulfate [Inorganic Chemical]
   812   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C1704732:Page [Intellectual Product]
   812   C3536965:SULFATE [Element, Ion, or Isotope]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "both the 42-"

Phrase: "and"

Phrase: "30-kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "forms of C/EBP"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   882   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C2752241:enhancer binding [Genetic Function]
   783 E C0033618:Protein Binding [Molecular Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0243122:binding [Functional Concept]
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1522492:Form [Functional Concept]

Phrase: "are"

Phrase: "highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "phosphorylated."
Processing 00000000.tx.160: Nevertheless, the gross level of phosphorylation of both isoforms did not appear to be affected by insulin treatment (Fig.7B). 

Phrase: "Nevertheless,"

Phrase: "the gross level of phosphorylation of both isoforms"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0441889:Level [Qualitative Concept]
   744   C0456079:Level [Classification]
   744   C1547707:Level [Geographic Area]
   744   C2946261:Level [Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "affected by insulin treatment"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   833   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C0392760:Affected [Functional Concept]
   770   C1314939:Affected [Functional Concept]
   770   C1522326:Treatment [Functional Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]
   737 E C0001721:Affect [Mental Process]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(Fig.7B"

Phrase: ")."
Processing 00000000.tx.161: It is possible that an insulin (and okadaic acid-)-sensitive phosphatase targets only one of multiple phosphorylation sites on C/EBP and would, therefore, only lead to small fractional changes which would make the dephosphorylation event difficult to detect. 

Phrase: "It"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "an insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "("

Phrase: "and"

Phrase: "okadaic acid-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0069389:Ocadaic Acid [Hazardous or Poisonous Substance,Organic Chemical]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: ")-"

Phrase: "sensitive phosphatase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1149880:phosphatase [Molecular Function]

Phrase: "targets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521840:Target [Functional Concept]
  1000   C2986546:TARGET [Diagnostic Procedure]

Phrase: "only one of multiple phosphorylation sites"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205447:One [Quantitative Concept]

Phrase: "on C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "would"

Phrase: ","

Phrase: "therefore,"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "lead to small fractional changes"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   760   C0700321:Small [Quantitative Concept]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]
   726 E C1705241:Change [Quantitative Concept]

Phrase: "which"

Phrase: "would"

Phrase: "make"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "the dephosphorylation event difficult to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0441471:Event [Event]

Phrase: "detect."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]
Processing 00000000.tx.162: Phosphoamino acid analysis of p30 from 293 cells transiently transfected with a p30 expression vector showed that this isoform is phosphorylated on serine and threonine (in an 1:1 ratio), but not on tyrosine. 

Phrase: "Phosphoamino acid analysis of p30"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0001128:Acid [Chemical]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0202406:Acid [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "from 293 cells transiently"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with a p30 expression vector"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0069919:P30 [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   753   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0442335:Vector [Spatial Concept]
   753   C1538722:p30 [Gene or Genome]
   753   C1705099:Vector [Idea or Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "this isoform"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597298:Isoform [Amino Acid, Peptide, or Protein]

Phrase: "is"

Phrase: "phosphorylated on serine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "threonine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040005:Threonine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "("

Phrase: "in an 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1 ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "not on tyrosine."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   790   C1518422:Not [Functional Concept]
Processing 00000000.tx.163: As expected, inhibition of tyrosine kinase activity with genestein (Calbiochem) inhibited the rapid effects of insulin on C/EBP post-translational modification (results not shown). 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "inhibition of tyrosine kinase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   891   C2247121:inhibition of kinase activity [Molecular Function]
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "with genestein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0061202:Genestein [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "(Calbiochem"

Phrase: ")"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "the rapid effects of insulin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on C/EBP post-translational modification"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   845   C0033666:Post-Translational Modification [Molecular Function]
           Protein Modification
   845   C2263112:protein modification [Molecular Function]
   795   C0392747:Modification [Functional Concept]
   795   C0687676:Post [Temporal Concept]
   795   C1519614:Translational [Genetic Function]
   795   C1554963:modification [Qualitative Concept]
   795   C1704687:Post [Manufactured Object]
   794   C0597295:Protein Translation [Molecular Function]
       E   translation
   724 E C0040712:Translation [Intellectual Product]
   724 E C1514253:Postal [Functional Concept]
   710   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.164: Further evidence that post-translational modification of C/EBP is due to phosphorylation is provided in Fig.7C. 

Phrase: "Further evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that post-translational modification of C/EBP"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   804   C0033666:Protein Modification, Post-Translational [Molecular Function]
           Post-Translational Modification
           Protein Modification
   781   C1449566:Protein Modification, Translational [Molecular Function]
   762   C2263112:protein modification [Molecular Function]
   742   C0392747:Modification [Functional Concept]
   742   C0687676:Post [Temporal Concept]
   742   C1519614:Translational [Genetic Function]
   742   C1554963:modification [Qualitative Concept]
   742   C1704687:Post [Manufactured Object]
   726   C0597295:Protein Translation [Molecular Function]

Phrase: "is due to phosphorylation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0678226:Due to [Functional Concept]
           due
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]
   770   C3146286:Due [Idea or Concept]

Phrase: "is"

Phrase: "provided in Fig.7C."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0349966:Fig [Food]
   770   C1337208:FIG [Food]
   770   C1999230:Provided [Activity]
Processing 00000000.tx.165: Nuclear extracts from 3T3-L1 adipocytes treated with okadaic acid, and prepared in the presence of phosphatase inhibitors (30 mM -glycerol phosphate and 1 mM orthovanadate) gave rise to the low mobility band of both C/EBP isoforms. 

Phrase: "Nuclear extracts from 3T3-L1 adipocytes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1518434:Nuclear Extract [Biomedical or Dental Material]
   753   C0521447:Nuclear [Spatial Concept]
   719   C2828366:Extract [Substance]

Phrase: "treated with okadaic acid,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0069389:Ocadaic Acid [Hazardous or Poisonous Substance,Organic Chemical]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0001128:Acid [Chemical]
   770   C0202406:Acid [Laboratory Procedure]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "and"

Phrase: "prepared in the presence of phosphatase inhibitors"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   762   C0597217:phosphatase inhibitor [Pharmacologic Substance]
   748   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0243077:inhibitors [Chemical Viewed Functionally]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C1149880:phosphatase [Molecular Function]
   714   C1521827:Prepare [Functional Concept]
   714 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "(30 mM -glycerol phosphate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   812   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031701:phosphate [Organophosphorus Compound]
   812   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "1 mM orthovanadate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0029366:Orthovanadate [Inorganic Chemical]

Phrase: ")"

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "rise to the low mobility band"

Phrase: "of both C/EBP isoforms."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0597298:Protein Isoforms [Amino Acid, Peptide, or Protein]
           Isoforms
   771   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.166: When the extracts were treated with calf intestinal phosphatase, the low mobility band was lost and the high mobility band was observed (Fig.7C). 

Phrase: "When"

Phrase: "the extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "treated with calf intestinal phosphatase,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0021853:Intestinal [Body Part, Organ, or Organ Component]
   760   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0230445:Calf [Body Location or Region]
   760   C1149880:phosphatase [Molecular Function]
   760   C1305418:Calf [Body Part, Organ, or Organ Component]
   760   C1522326:Treated [Functional Concept]
   726 E C1292734:TREAT [Functional Concept]
   704 E C0626053:sural [Pharmacologic Substance]

Phrase: "the low mobility band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0175723:Band [Medical Device]
   827   C0439645:Band [Spatial Concept]
   827   C1521913:band [Cell Component]

Phrase: "was"

Phrase: "lost"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0745777:Lost [Functional Concept]

Phrase: "and"

Phrase: "the high mobility band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0175723:Band [Medical Device]
   827   C0439645:Band [Spatial Concept]
   827   C1521913:band [Cell Component]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(Fig.7C"

Phrase: ")."
Processing 00000000.tx.167: These experiments strongly suggest that insulin, in addition to suppressing the expression of C/EBP within several hours, also acutely stimulates dephosphorylation of both C/EBP isoforms. 

Phrase: "These experiments strongly"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in addition to suppressing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1260953:suppressing [Functional Concept]
  1000   C2003921:Suppressing [Phenomenon or Process]

Phrase: "the expression of C/EBP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1171362:expression protein [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "within several hours,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "also acutely"

Phrase: "stimulates"

Phrase: "dephosphorylation of both C/EBP isoforms."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1158884:Protein dephosphorylation [Molecular Function]
           Dephosphorylation
   744   C3160734:Dephosphorylation [Molecular Function]
Processing 00000000.tx.168: Temporal Relationship of Down-regulation of C/EBP and GLUT4 mRNA Caused by InsulinIn view of the findings that both C/EBP (Fig.5) and GLUT4 mRNA(46) ; Fig.8) are down-regulated by insulin in terminally differentiated 3T3-L1 adipocytes, it was of interest to ascertain whether the kinetics of these processes were compatible with a causal relationship. 

Phrase: "Temporal Relationship of Down-regulation of C/EBP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0449235:Temporal relationship [Temporal Concept]
   739   C0439849:Relationship [Qualitative Concept]
   739   C1705630:Relationship [Idea or Concept]
   739   C1706279:Relationship [Idea or Concept]
   739   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "GLUT4 mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "Caused by InsulinIn view of the findings"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   778   C1333617:Finding by Cause [Finding]
   748   C0449911:View [Spatial Concept]
   748   C2607943:findings [Functional Concept]
   748   C2926606:Findings [Clinical Attribute]
   748   C3539655:Findings [Intellectual Product]
   714   C0015127:cause [Functional Concept]
   714 E C0037088:Finding [Sign or Symptom]
   714 E C0243095:Finding [Finding]
   714   C1524003:Cause [Conceptual Entity]
   714 E C2825141:Finding [Finding]

Phrase: "that both C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "(Fig.5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "and"

Phrase: "GLUT4 mRNA(46"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0166441:GLUT-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1420175:GLUT4 [Gene or Genome]
   827   C2982484:GLUT4 [Gene or Genome]

Phrase: ")"

Phrase: "; Fig.8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "are"

Phrase: "down-regulated by insulin"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0851285:Regulated [Governmental or Regulatory Activity]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   715   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   715   C2626739:Lanugo [Eukaryote]

Phrase: "in terminally differentiated 3T3-L1 adipocytes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0206131:Adipocytes [Cell]

Phrase: "it"

Phrase: "was of interest to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0043194:WAS [Disease or Syndrome]
   770   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0543488:Interest [Mental Process]
   770   C1421478:WAS [Gene or Genome]

Phrase: "ascertain"

Phrase: "whether"

Phrase: "the kinetics of these processes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0022702:Kinetics [Natural Phenomenon or Process]
   760   C0220865:kinetics [Functional Concept]
   760   C2825046:Kinetics [Occupation or Discipline]

Phrase: "were"

Phrase: "compatible with a causal relationship."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332290:compatible [Idea or Concept]
   760   C1524057:Compatible [Qualitative Concept]
Processing 00000000.tx.169: It should be noted that during differentiation of 3T3-L1 preadipocytes, C/EBP serves as a transactivator of the GLUT4 gene whose promoter possesses a C/EBP-binding site(13, 17) . As shown in Fig.8, following the insulin-induced drop in the C/EBP message, the decline of C/EBP protein is virtually coincident with the decline of GLUT4 message in 3T3-L1 adipocytes. 

Phrase: "It"

Phrase: "should"

Phrase: "be"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "that during differentiation of 3T3-L1 preadipocytes,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0007589:Differentiation [Cell Function]
   748   C0441918:L1 [Finding]
   748   C1179698:L1 [Body Location or Region]
   748   C1416177:L1 [Gene or Genome]
   748   C1511938:Differentiation [Clinical Attribute]
   748   C2945687:Differentiation [Functional Concept]

Phrase: "C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "serves as a transactivator of the GLUT4 gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0017337:Gene [Gene or Genome]
   744   C0040627:Trans-Activator [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0166441:GLUT-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1420175:GLUT4 [Gene or Genome]
   744   C2982484:GLUT4 [Gene or Genome]

Phrase: "whose promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "possesses"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0850310:possess [Mental or Behavioral Dysfunction]
  1000   C3154893:Possess [Idea or Concept]

Phrase: "a C/EBP-binding site"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   858   C0005456:Binding Site [Receptor]
   858   C0682969:Binding Site [Amino Acid Sequence]
   827   C0033618:Protein Binding [Molecular Function]
   799   C0205145:Site [Spatial Concept]
   799   C1515974:Site [Body Location or Region]
   799   C2825164:Site [Spatial Concept]
   734   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(13,"

Phrase: "17"

Phrase: ") ."

Phrase: "As"

Phrase: "shown in Fig.8,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0349966:Fig [Food]
   770   C1337208:FIG [Food]
   737   C1547282:Show [Intellectual Product]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the insulin-induced drop in the C/EBP message,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   738   C1321095:Drop [Quantitative Concept]
   738   C1705648:Drop [Activity]
   738   C2347093:Drop [Quantitative Concept]
   738   C2348338:Drop [Quantitative Concept]

Phrase: "the decline of C/EBP protein"

Phrase: "is"

Phrase: "virtually coincident with the decline of GLUT4 message"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205420:Coincident [Temporal Concept]

Phrase: "in 3T3-L1 adipocytes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206131:Adipocytes [Cell]
Processing 00000000.tx.170: Although this result is consistent with trans-activation of the GLUT4 gene by C/EBP in the adipocyte, the possibility that dephosphorylation of C/EBP is involved cannot be ruled out (see ``Discussion''). 

Phrase: "Although"

Phrase: "this result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "is"

Phrase: "consistent with trans-activation of the GLUT4 gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "by C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "in the adipocyte,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206131:Adipocyte [Cell]

Phrase: "the possibility"

Phrase: "that dephosphorylation of C/EBP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C1158884:Protein dephosphorylation [Molecular Function]
           Dephosphorylation
   748   C3160734:Dephosphorylation [Molecular Function]

Phrase: "is"

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "cannot"

Phrase: "be"

Phrase: "ruled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1446409:ruled [Qualitative Concept]
   966 E C0805874:Rule [Idea or Concept]
   966 E C0870077:Rule [Intellectual Product]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "(see ``Discussion''"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557061:Discussion [Therapeutic or Preventive Procedure]
   861   C2584313:Discussion [Social Behavior]

Phrase: ")."
Processing 00000000.tx.171: Figure 8: Kinetic analysis of the effects of insulin on expression of C/EBP mRNA and protein, and GLUT4 mRNAs. 

Phrase: "Figure 8"

Phrase: ":"

Phrase: "Kinetic analysis of the effects of insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "on expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of C/EBP mRNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   771   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "GLUT4 mRNAs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.172: 3T3-L1 adipocytes were treated with 167 nM insulin for various times prior to preparation of whole cell lysates or total RNA. 

Phrase: "3T3-L1 adipocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206131:Adipocytes [Cell]

Phrase: "were"

Phrase: "treated with 167 nM insulin"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0312860:NM [Cell Function]
   760   C1522326:Treated [Functional Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   726 E C1292734:TREAT [Functional Concept]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "for various times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: "prior to preparation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0455052:Preparation [Health Care Activity]
  1000   C1521827:Preparation [Functional Concept]

Phrase: "of whole cell lysates"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   884   C1881488:Cell Lysate [Physical Object]
           Lysate
   827   C0007634:Cell [Cell]
   827   C0444667:Whole [Quantitative Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "total RNA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.173: The amount of C/EBP protein and C/EBP or GLUT4 mRNAs were analyzed by immunoblot and Northern analyses, respectively. 

Phrase: "The amount of C/EBP protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1265611:Amount [Quantitative Concept]

Phrase: "and"

Phrase: "C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "or"

Phrase: "GLUT4 mRNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "analyzed by immunoblot"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020985:Immunoblot [Laboratory Procedure]
   790   C0936012:Analyzed [Research Activity]

Phrase: "and"

Phrase: "Northern analyses,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "respectively."
Processing 00000000.tx.174: Protein and mRNA levels were quantified using laser densitometry and are represented graphically relative to their maximal levels of expression. 

Phrase: "Protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "mRNA levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "quantified"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "laser densitometry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0011321:Densitometry [Laboratory Procedure]

Phrase: "and"

Phrase: "are"

Phrase: "represented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "graphically relative to their maximal levels of expression."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0080103:Relative [Family Group]
   744   C0205345:Relative [Qualitative Concept]
   744   C1547039:*Relative [Quantitative Concept]
Processing 00000000.tx.175: To ascertain whether long-term exposure of 3T3-L1 adipocytes to insulin affects expression of the C/EBP isoforms and the adipocyte-marker GLUT4, preadipocytes were subjected to the standard differentiation protocol, which includes insulin, after which the differentiated adipocytes were maintained for 4 days in medium with or without insulin. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "ascertain"

Phrase: "whether"

Phrase: "long-term exposure of 3T3-L1 adipocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0274281:Exposure, NOS [Injury or Poisoning]
   748   C0332157:Exposure [Clinical Attribute]

Phrase: "to insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "expression of the C/EBP isoforms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1171362:expression protein [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "the adipocyte-marker GLUT4,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0166441:GLUT-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1420175:GLUT4 [Gene or Genome]
   827   C2982484:GLUT4 [Gene or Genome]

Phrase: "preadipocytes"

Phrase: "were"

Phrase: "subjected to the standard differentiation protocol,"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   753   C0007589:Differentiation [Cell Function]
   753   C0442711:Protocol [Intellectual Product]
   753   C1442989:Standard [Qualitative Concept]
   753   C1507394:Protocol [Intellectual Product]
   753   C1511938:Differentiation [Clinical Attribute]
   753   C1522729:Protocol [Intellectual Product]
   753   C2348563:Protocol [Intellectual Product]
   753   C2828392:Standard [Intellectual Product]
   753   C2945687:Differentiation [Functional Concept]
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]

Phrase: "which"

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "after"

Phrase: "which the differentiated adipocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0206131:Adipocytes [Cell]

Phrase: "were"

Phrase: "maintained for 4 days"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0439228:days [Temporal Concept]
   770   C1314677:Maintained [Functional Concept]
   737 E C0024501:Maintain [Activity]
   737 E C0332173:/day [Temporal Concept]
   737 E C0439505:/day [Temporal Concept]

Phrase: "in medium with"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0009458:Medium [Intellectual Product]
   790   C0150312:In [Quantitative Concept]
   790   C0332285:In [Spatial Concept]
   790   C0439536:Medium [Quantitative Concept]
   790   C1705217:Medium [Substance]
   790   C3244283:medium [Intellectual Product]

Phrase: "or without insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.176: Northern analysis revealed that insulin treatment beyond day 4 of adipocyte differentiation markedly suppressed the expression of C/EBP and GLUT4 mRNAs (Fig.9A) without affecting the expression of C/EBP or C/EBP (Fig.9B). 

Phrase: "Northern analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that insulin treatment beyond day 4 of adipocyte differentiation markedly"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   739   C0039798:treatment [Functional Concept]
   739   C0087111:Treatment [Therapeutic or Preventive Procedure]
   739   C1522326:Treatment [Functional Concept]
   739   C1533734:Treatment [Therapeutic or Preventive Procedure]
   739   C1705169:Treatment [Conceptual Entity]
   739   C3538994:TREATMENT [Research Activity]

Phrase: "suppressed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:Suppressed [Functional Concept]

Phrase: "the expression of C/EBP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1171362:expression protein [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "GLUT4 mRNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(Fig.9A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553641:9a [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: "without affecting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affecting [Functional Concept]
  1000   C1314939:Affecting [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "the expression of C/EBP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1171362:expression protein [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "(Fig.9B"

Phrase: ")."
Processing 00000000.tx.177: Some cells were treated with or without insulin for an additional 4 days, i.e. to day 12, at which time cell monolayers were stained for triacylglycerol with oil red-O. 

Phrase: "Some cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   833   C1522326:Treated [Functional Concept]
   799 E C1292734:TREAT [Functional Concept]

Phrase: "or without insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "for an additional 4 days,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0439228:days [Temporal Concept]
   793 E C0332173:/day [Temporal Concept]
   793 E C0439505:/day [Temporal Concept]

Phrase: "i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "to day 12,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "at which time cell monolayers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0872351:monolayers [Clinical Drug]

Phrase: "were"

Phrase: "stained for triacylglycerol"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0041004:Triacylglycerol [Biologically Active Substance,Lipid]
   790   C2986582:Stained [Qualitative Concept]
   756 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "with oil red-O."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0069388:oil red O [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0028908:Oil [Lipid]
   827   C0332575:Red [Finding]
   827   C1260956:Red [Qualitative Concept]
   827   C1517288:Oil [Food,Lipid]
   771 E C0996956:Olea [Plant]
   755 E C0234925:OILY [Finding]
Processing 00000000.tx.178: Cell monolayers chronically treated with insulin had fewer adipocytes with large unilocular triacylglycerol vacuoles, and had a higher proportion of adipocytes with a multilocular adipocyte phenotype. 

Phrase: "Cell monolayers chronically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0872351:monolayers [Clinical Drug]

Phrase: "treated with insulin"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   756 E C1292734:TREAT [Functional Concept]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "had"

Phrase: "fewer adipocytes with large unilocular triacylglycerol vacuoles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0206131:Adipocytes [Cell]

Phrase: "and"

Phrase: "had"

Phrase: "a higher proportion of adipocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709707:Proportion [Quantitative Concept]

Phrase: "with a multilocular adipocyte phenotype."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031437:Phenotype [Organism Attribute]
   827   C1285572:Phenotype [Laboratory Procedure]
Processing 00000000.tx.179: These findings are consistent with a causal relationship between insulin-induced suppression of C/EBP, and the reduced levels of GLUT4 mRNA and other mRNAs (e.g. SCD1 mRNA; results not shown), which give rise to the adipocyte phenotype. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "are"

Phrase: "consistent with a causal relationship"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "between insulin-induced suppression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0221103:Suppression [Pathologic Function]
   827   C0301625:Suppression [Organism Function]
   827   C0439181:% suppression [Quantitative Concept]
   827   C0728721:suppression [Mental Process]

Phrase: "of C/EBP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "the reduced levels of GLUT4 mRNA"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "other mRNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "("

Phrase: "e.g. SCD1 mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ";"

Phrase: "results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "give"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "rise to the adipocyte phenotype."
Processing 00000000.tx.180: Figure 9: Effect of chronic exposure to insulin on the expression of C/EBP, C/EBP, C/EBP, and GLUT4. 

Phrase: "Figure 9"

Phrase: ":"

Phrase: "Effect of chronic exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "to insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "on the expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of C/EBP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "C/EBP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "C/EBP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "GLUT4."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0166441:GLUT-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420175:GLUT4 [Gene or Genome]
  1000   C2982484:GLUT4 [Gene or Genome]
Processing 00000000.tx.181: 3T3-L1 preadipocytes were differentiated by the standard protocol until day 4. 

Phrase: "3T3-L1 preadipocytes"

Phrase: "were"

Phrase: "differentiated by the standard protocol"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0007589:Differentiated [Cell Function]
   760   C0205615:Differentiated [Qualitative Concept]
   760   C0442711:Protocol [Intellectual Product]
   760   C1442989:Standard [Qualitative Concept]
   760   C1507394:Protocol [Intellectual Product]
   760   C1522729:Protocol [Intellectual Product]
   760   C2348563:Protocol [Intellectual Product]
   760   C2828392:Standard [Intellectual Product]

Phrase: "until day 4."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]
Processing 00000000.tx.182: At this time, half of the cells continued to receive insulin every 2 days with feeding. 

Phrase: "At this time,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "half of the cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2825407:Half [Quantitative Concept]

Phrase: "continued"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549178:Continued [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "receive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Receive [Qualitative Concept]

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "every 2 days with feeding."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   781   C0332173:Every day [Temporal Concept]
       E   /day
   760   C0439228:days [Temporal Concept]
   726 E C0439505:/day [Temporal Concept]
Processing 00000000.tx.183: Total RNA was harvested on day 0, and then daily starting at day 2. 

Phrase: "Total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "harvested on day 0,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0332173:/day [Temporal Concept]
   770   C0439228:day [Temporal Concept]
   770   C0439505:/day [Temporal Concept]
   737   C1512335:Harvest [Health Care Activity]

Phrase: "and"

Phrase: "then daily starting at day 2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0439659:Start [Temporal Concept]
Processing 00000000.tx.184: Northern analysis was used to evaluate the expression of: A, C/EBP and GLUT4 mRNA levels, as well as, B, C/EBP and C/EBP. 

Phrase: "Northern analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "the expression of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: ":"

Phrase: "A,"

Phrase: "C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "GLUT4 mRNA levels,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "as well as"

Phrase: ","

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "C/EBP."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
Processing 00000000.tx.185: Data were quantified using laser densitometry and are represented graphically in arbitrary units. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "quantified"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "laser densitometry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0011321:Densitometry [Laboratory Procedure]

Phrase: "and"

Phrase: "are"

Phrase: "represented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "graphically in arbitrary units."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   799   C0439183:Arbitrary unit [Quantitative Concept]
   770   C0439148:Units [Quantitative Concept]
   770   C1264693:*Arbitrary [Quantitative Concept]
   770   C1519795:Units [Quantitative Concept]
   737 E C1704753:Unit [Manufactured Object]
   737 E C1880519:Unit [Quantitative Concept]
Processing 00000000.tx.186: DISCUSSION This study shows that insulin reciprocally regulates the gene encoding C/EBP, and those encoding C/EBP and C/EBP in fully-differentiated 3T3-L1 adipocytes. 

Phrase: "DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that insulin reciprocally"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "regulates"

Phrase: "the gene encoding C/EBP,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   901   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   895   C0751455:gene protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C2752241:enhancer binding [Genetic Function]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0243122:binding [Functional Concept]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "those encoding C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   937   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C2752241:enhancer binding [Genetic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0243122:binding [Functional Concept]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "C/EBP in fully-differentiated 3T3-L1 adipocytes."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   806   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   782   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C2752241:enhancer binding [Genetic Function]
   757 E C0033618:Protein Binding [Molecular Function]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0243122:binding [Functional Concept]
   739   C1145667:Binding [Activity]
   739   C1167622:Binding [Molecular Function]
Processing 00000000.tx.187: While insulin represses the expression of C/EBP for at least 24 h, insulin rapidly and transiently induces the expression of C/EBP and C/EBP (Fig.1). 

Phrase: "While"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "represses"

Phrase: "the expression of C/EBP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1171362:expression protein [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "for"

Phrase: "at least 24 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "insulin rapidly"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "transiently"

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "the expression of C/EBP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1171362:expression protein [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "(Fig.1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.188: These changes are due largely to changes in steady-state levels of their respective mRNAs (Fig.5), which are correlated with changes in the rates of transcription of the corresponding C/EBP genes (Fig.6). 

Phrase: "These changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "are"

Phrase: "due largely to changes"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   819   C0678226:Due to [Functional Concept]
           due
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   770   C3146286:Due [Idea or Concept]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "in steady-state levels"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   901   C0678587:steady state [Natural Phenomenon or Process]
   884   C0683927:state level [Spatial Concept]
   827   C0205361:Steady [Qualitative Concept]
   827   C0441889:Levels [Qualitative Concept]
   827   C1301808:State [Geographic Area]
   827   C1442792:State [Functional Concept]
   827   C3148680:State [Geographic Area]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "of their respective mRNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(Fig.5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "are"

Phrase: "correlated with changes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0392747:changes [Functional Concept]
   790   C0443172:changes [Quantitative Concept]
   790   C1707520:Correlated [Qualitative Concept]
   756 E C1705241:Change [Quantitative Concept]

Phrase: "in the rates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0871208:Rate [Activity]
   966   C1521828:Rate [Quantitative Concept]

Phrase: "of transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040649:Transcription [Genetic Function]

Phrase: "of the corresponding C/EBP genes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   810   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0017337:Genes [Gene or Genome]
   734   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig.6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.189: In addition to regulating C/EBP by repressing its expression, insulin may also regulate the activity of C/EBP itself by controlling its state of phosphorylation. 

Phrase: "In addition to"

Phrase: "regulating"

Phrase: "C/EBP by repressing"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   882   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C2752241:enhancer binding [Genetic Function]
   783 E C0033618:Protein Binding [Molecular Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "its expression,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "may"

Phrase: "also"

Phrase: "regulate"

Phrase: "the activity of C/EBP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C1537044:protein activity [Molecular Function]
   774   C2266866:Binding Activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "itself by controlling"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0332298:controlling [Functional Concept]
   790   C2587213:Controlling [Functional Concept]
   756 E C0243148:control [Qualitative Concept]
   756 E C1550141:Control [Substance]
   756 E C1882979:Control [Conceptual Entity]
   756 E C3274648:Control [Qualitative Concept]

Phrase: "its state of phosphorylation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1301808:State [Geographic Area]
   770   C1442792:State [Functional Concept]
   770   C3148680:State [Geographic Area]
Processing 00000000.tx.190: Indeed, it has been reported (47) that C/EBP can be phosphorylated in vitro on serine 299 by protein kinase C, and that phosphorylation attenuated its binding to DNA. 

Phrase: "Indeed,"

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "(47"

Phrase: ")"

Phrase: "that C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "can"

Phrase: "be"

Phrase: "phosphorylated"

Phrase: "in vitro on serine 299"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0021135:In Vitro [Intellectual Product]
   806   C1533691:in vitro [Qualitative Concept]
           vitro
   806   C2827718:In Vitro [Functional Concept]

Phrase: "by protein kinase C,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "that phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "attenuated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332161:Attenuated [Qualitative Concept]
  1000   C0599946:Attenuated [Activity]

Phrase: "its binding to DNA."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C1148673:DNA Binding [Genetic Function]
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]
Processing 00000000.tx.191: Evidence presented in this paper indicates that C/EBP exists in a phosphorylated state in 3T3-L1 adipocytes (Fig.7B), and that insulin promotes its apparent dephosphorylation by an okadaic acid-sensitive phosphatase (Fig.7A), presumably protein phosphatase 1 or 2A. 

Phrase: "Evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "presented in this paper"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0030351:Paper [Manufactured Object]
   770   C0449450:Presented [Idea or Concept]
   770   C1547566:Paper [Idea or Concept]
   737 E C0150312:Present [Quantitative Concept]

Phrase: "indicates"

Phrase: "that C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "exists in a phosphorylated state"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1301808:State [Geographic Area]
   760   C1442792:State [Functional Concept]
   760   C2987476:Exist [Conceptual Entity]
   760   C3148680:State [Geographic Area]

Phrase: "in 3T3-L1 adipocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206131:Adipocytes [Cell]

Phrase: "(Fig.7B"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "that insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "its apparent dephosphorylation by an okadaic acid-sensitive phosphatase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1158884:Dephosphorylation [Molecular Function]
   742   C3160734:Dephosphorylation [Molecular Function]

Phrase: "(Fig.7A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: ","

Phrase: "presumably protein phosphatase 1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C1956003:Protein Phosphatase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1149880:phosphatase [Molecular Function]

Phrase: "or"

Phrase: "2A."
Processing 00000000.tx.192: Although insulin-activated dephosphorylation of C/EBP has the potential to regulate transcription of adipocyte genes (e.g. GLUT4), the findings presented in this paper do not specifically address this issue. 

Phrase: "Although"

Phrase: "insulin-activated dephosphorylation of C/EBP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1158884:Protein dephosphorylation [Molecular Function]
           Dephosphorylation
   744   C3160734:Dephosphorylation [Molecular Function]

Phrase: "has"

Phrase: "the potential to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3245505:Potential [Qualitative Concept]

Phrase: "regulate"

Phrase: "transcription of adipocyte genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0040649:genes transcription [Genetic Function]
           Transcription

Phrase: "("

Phrase: "e.g. GLUT4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0166441:GLUT-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420175:GLUT4 [Gene or Genome]
  1000   C2982484:GLUT4 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "the findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "presented in this paper"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0030351:Paper [Manufactured Object]
   770   C0449450:Presented [Idea or Concept]
   770   C1547566:Paper [Idea or Concept]
   737 E C0150312:Present [Quantitative Concept]

Phrase: "do"

Phrase: "not specifically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "this issue."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033213:Issue [Finding]
  1000   C1706387:Issue [Intellectual Product]
Processing 00000000.tx.193: It should be noted, however, that the time frame within which apparent dephosphorylation of C/EBP occurs is consistent with the rate at which GLUT 4 transcription and mRNA fall(46) . Thus, apparent dephosphorylation of C/EBP is complete within 30 min (Fig.2) and the rate of GLUT4 gene transcription reaches a minimum in less than 2 h (46) . In this connection, it has been reported that insulin transiently activates type 1 protein phosphatase in several cell types including 3T3-L1 adipocytes(42, 43, 44) . Insulin has also recently been shown to promote dephosphorylation and suppression of CREB (cAMP response element-binding protein) activity by a type 1 protein phosphatase(45) . Further work will be necessary to determine whether insulin-promoted dephosphorylation of C/EBP, repressed transcription of the C/EBP gene, or other factors are responsible for the physiological effects of insulin on the expression of GLUT4 and other adipocyte genes. 

Phrase: "It"

Phrase: "should"

Phrase: "be"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: ","

Phrase: "however,"

Phrase: "that"

Phrase: "the time frame within which apparent dephosphorylation of C/EBP"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0332168:Time frame [Temporal Concept]
   753   C0872291:Time Frame [Temporal Concept]
   736   C0040223:Time [Temporal Concept]
   736   C0080089:Frame [Nucleotide Sequence]
   736   C0180979:Frame [Medical Device]
   736   C1705858:Frame [Manufactured Object]
   736   C3541383:Time [Temporal Concept]

Phrase: "occurs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "is"

Phrase: "consistent with the rate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "at which GLUT 4 transcription"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0040649:Transcription [Genetic Function]
   734   C0166441:GLUT-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1420175:GLUT4 [Gene or Genome]
   734   C2982484:GLUT4 [Gene or Genome]

Phrase: "and"

Phrase: "mRNA fall"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085639:Fall [Finding]
   861   C0238715:Fall [Temporal Concept]

Phrase: "(46"

Phrase: ") . Thus,"

Phrase: "apparent dephosphorylation of C/EBP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C1158884:Protein dephosphorylation [Molecular Function]
           Dephosphorylation
   748   C3160734:Dephosphorylation [Molecular Function]

Phrase: "is"

Phrase: "complete within 30 min (Fig.2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205197:Complete [Qualitative Concept]
   753   C0725685:COMPLEAT [Food]

Phrase: ")"

Phrase: "and"

Phrase: "the rate of GLUT4 gene transcription"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0871208:Rate [Activity]
   753   C1521828:Rate [Quantitative Concept]

Phrase: "reaches"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0596012:Reaches [Finding]
  1000   C2584321:Reach [Organism Function]

Phrase: "a minimum in less"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1524031:Minimum [Qualitative Concept]
   770   C1552614:minimum [Idea or Concept]
   770   C2826545:MINIMUM [Quantitative Concept]

Phrase: "than 2 h (46"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0011744:2 H [Element, Ion, or Isotope]
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]
   827   C0740116:+2 [Quantitative Concept]
   827   C2827735:2+ [Quantitative Concept]
   827   C2981700:2+ [Classification]

Phrase: ") ."

Phrase: "In this connection,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449379:Connection [Intellectual Product]

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that insulin transiently"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "type 1 protein phosphatase in several cell types"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   793   C1956003:Protein Phosphatase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0031686:Protein phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0441729:Type 1 [Classification]
   767   C0449475:type cell [Intellectual Product]
   744   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0332307:Type [Qualitative Concept]
   744   C1149880:phosphatase [Molecular Function]
   744   C1547052:*Type [Quantitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "3T3-L1 adipocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206131:Adipocytes [Cell]

Phrase: "(42,"

Phrase: "43,"

Phrase: "44"

Phrase: ") . Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "has"

Phrase: "also recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332185:Recently [Temporal Concept]

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "dephosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1158884:Dephosphorylation [Molecular Function]
  1000   C3160734:Dephosphorylation [Molecular Function]

Phrase: "and"

Phrase: "suppression of CREB"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0221103:Suppression [Pathologic Function]
   790   C0301625:Suppression [Organism Function]
   790   C0439181:% suppression [Quantitative Concept]
   790   C0728721:suppression [Mental Process]

Phrase: "(cAMP response element-binding protein"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
  1000   C0056695:cAMP Response Element-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C3158668:cAMP response element binding [Genetic Function]
   884   C1511573:cAMP Response Element [Gene or Genome]
   875   C1148918:cAMP binding [Molecular Function]
   840   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0013879:Element [Element, Ion, or Isotope]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   804   C0243122:binding [Functional Concept]
   804   C0871261:Response [Organism Attribute]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   804   C1704632:Response [Finding]
   804   C1705248:Element [Conceptual Entity]
   804   C1706817:Response [Intellectual Product]
   804   C2911692:Response [Mental Process]

Phrase: ")"

Phrase: "activity by a type 1 protein phosphatase"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   879   C1323656:type 1 protein phosphatase activity [Molecular Function]
   831   C2261644:protein phosphatase-1 activity [Molecular Function]
   804   C1149927:protein phosphatase activity [Molecular Function]
   774   C1149880:phosphatase activity [Molecular Function]
   774   C1537044:protein activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "(45"

Phrase: ") . Further work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043227:Work [Occupational Activity]

Phrase: "will"

Phrase: "be"

Phrase: "necessary to"

Phrase: "determine"

Phrase: "whether"

Phrase: "insulin-promoted dephosphorylation of C/EBP,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1158884:Protein dephosphorylation [Molecular Function]
           Dephosphorylation
   744   C3160734:Dephosphorylation [Molecular Function]

Phrase: "repressed transcription of the C/EBP gene,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   781   C0086222:Enhancer of transcription [Nucleic Acid, Nucleoside, or Nucleotide]
   762   C0040649:Gene Transcription [Genetic Function]
           Transcription
   726   C0920533:Transcription Repression [Genetic Function]

Phrase: "or"

Phrase: "other factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521761:Factor [Functional Concept]
   966   C2827422:Factor [Conceptual Entity]

Phrase: "are"

Phrase: "responsible for the physiological effects of insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1273518:Responsible [Finding]

Phrase: "on the expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of GLUT4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0166441:GLUT-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420175:GLUT4 [Gene or Genome]
  1000   C2982484:GLUT4 [Gene or Genome]

Phrase: "and"

Phrase: "other adipocyte genes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]
Processing 00000000.tx.194: In addition to regulating the post-translational modification and transcription of C/EBP, insulin transiently induces the expression of C/EBP, as well as both forms of C/EBP (LAP and LIP). 

Phrase: "In addition to"

Phrase: "regulating"

Phrase: "the post-translational modification"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0033666:Post-Translational Modification [Molecular Function]
   827   C0392747:Modification [Functional Concept]
   827   C0687676:Post [Temporal Concept]
   827   C1519614:Translational [Genetic Function]
   827   C1554963:modification [Qualitative Concept]
   827   C1704687:Post [Manufactured Object]
   755 E C0040712:Translation [Intellectual Product]
   755 E C0597295:translation [Molecular Function]
   755 E C1514253:Postal [Functional Concept]

Phrase: "and"

Phrase: "transcription of C/EBP,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   814   C0086222:Enhancer of transcription [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0040649:Transcription [Genetic Function]
   716   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "insulin transiently"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "the expression of C/EBP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1171362:expression protein [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "as well as"

Phrase: "both"

Phrase: "forms of C/EBP"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   882   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C2752241:enhancer binding [Genetic Function]
   783 E C0033618:Protein Binding [Molecular Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0243122:binding [Functional Concept]
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1522492:Form [Functional Concept]

Phrase: "(LAP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540509:LAP [Gene or Genome]

Phrase: "and"

Phrase: "LIP"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0023759:Lip [Body Part, Organ, or Organ Component]
  1000   C1278911:Lip [Body Part, Organ, or Organ Component]
   907 E C0227759:Labia [Body Part, Organ, or Organ Component]
   907 E C1070701:Labia [Eukaryote]
   907 E C2626732:Labium [Eukaryote]

Phrase: ")."
Processing 00000000.tx.195: Western and gel-shift analyses suggest that the level of LIP predominates over that of LAP or C/EBP in both the basal and insulin-stimulated states ( Fig.1and Fig.3). 

Phrase: "Western"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705493:Western [Spatial Concept]

Phrase: "and"

Phrase: "gel-shift analyses"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0598490:Gel Shift Analyses [Laboratory Procedure]
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the level of LIP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1547707:Level [Geographic Area]
   770   C2946261:Level [Pharmacologic Substance]

Phrase: "predominates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332251:Predominate [Qualitative Concept]

Phrase: "over"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205136:Over [Spatial Concept]

Phrase: "that of LAP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C3540509:LAP [Gene or Genome]

Phrase: "or"

Phrase: "C/EBP in both"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   882   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C2752241:enhancer binding [Genetic Function]
   783 E C0033618:Protein Binding [Molecular Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "the basal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205112:Basal [Spatial Concept]

Phrase: "and"

Phrase: "insulin-stimulated states"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1301808:states [Geographic Area]
   793 E C1442792:State [Functional Concept]
   793 E C3148680:State [Geographic Area]

Phrase: "( Fig.1and Fig.3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0349966:Fig [Food]
   812   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.196: Since LIP can act as a dominant negative inhibitor of C/EBP-regulated gene transcription by forming inactive heterodimers (37) , the induction of LIP by insulin would most likely offset (or at least dampen) the increases in LAP or C/EBP, and would further accentuate the loss of C/EBP. 

Phrase: "Since"

Phrase: "LIP"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0023759:Lip [Body Part, Organ, or Organ Component]
  1000   C1278911:Lip [Body Part, Organ, or Organ Component]
   907 E C0227759:Labia [Body Part, Organ, or Organ Component]
   907 E C1070701:Labia [Eukaryote]
   907 E C2626732:Labium [Eukaryote]

Phrase: "can"

Phrase: "act as a dominant negative inhibitor"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   753   C0079613:ACT [Therapeutic or Preventive Procedure]
   753   C0205160:Negative [Qualitative Concept]
   753   C1513916:Negative [Finding]
   753   C1527180:Dominant [Functional Concept]
   753   C1999216:Inhibitor [Qualitative Concept]
   753   C2825415:Negative [Conceptual Entity]
   753   C2825491:Negative [Qualitative Concept]

Phrase: "of C/EBP-regulated gene transcription"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   818   C0040649:Gene Transcription [Genetic Function]
           Transcription
   710   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "by forming inactive heterodimers"

Phrase: "(37"

Phrase: ")"

Phrase: ","

Phrase: "the induction of LIP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205263:Induction [Functional Concept]
   770   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "by insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "would"

Phrase: "most likely offset"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1711330:Offset [Quantitative Concept]
   734   C0750501:most likely [Idea or Concept]

Phrase: "("

Phrase: "or at least"

Phrase: "dampen"

Phrase: ")"

Phrase: "the increases in LAP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0442805:increases [Functional Concept]

Phrase: "or"

Phrase: "C/EBP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "would"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "accentuate"

Phrase: "the loss of C/EBP."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1517945:Loss [Quantitative Concept]
Processing 00000000.tx.197: Reciprocal regulation of the C/EBP transcription factors is a recurring theme. 

Phrase: "Reciprocal regulation of the C/EBP transcription factors"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   795   C1655411:regulation of protein binding [Molecular Function]
   777   C1523122:regulation of binding [Molecular Function]
   757   C1158770:Transcription Regulation [Genetic Function]
   739   C0851285:Regulation [Governmental or Regulatory Activity]
   739   C1327622:Regulation [Biologic Function]

Phrase: "is"

Phrase: "a recurring theme."
Processing 00000000.tx.198: For example, during the acute-phase response of liver or hepatocytes, cytokines suppress the expression of C/EBP while markedly increasing the expression of C/EBP and C/EBP(48) . This results in the induction of a number of acute-phase response proteins such as serum amyloid A(49, 50) , -acid glycoprotein (51, 52, 53) , and complement component C3(54) , whose gene promoters contain critical C/EBP-binding sites. 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "during the acute-phase response"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0001349:Response, Acute-Phase [Pathologic Function]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]
   734   C0439557:Acute phase [Temporal Concept]

Phrase: "of liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "or"

Phrase: "hepatocytes,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0227525:Hepatocytes [Cell]
   966 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "cytokines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "suppress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "the expression of C/EBP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1171362:expression protein [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "while"

Phrase: "markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:Markedly [Qualitative Concept]

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the expression of C/EBP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1171362:expression protein [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "(48"

Phrase: ") ."

Phrase: "This results in the induction of a number of acute-phase response proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   702   C1274040:Result [Functional Concept]
   702   C1546471:Result [Idea or Concept]
   702   C2825142:Result [Finding]

Phrase: "such as serum amyloid A"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0002723:Serum Amyloid A [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Amyloid A
           serum amyloid
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0229671:Serum [Body Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: "(49,"

Phrase: "50"

Phrase: ")"

Phrase: ", -"

Phrase: "acid glycoprotein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0001128:Acid [Chemical]
   861   C0017968:Glycoprotein [Amino Acid, Peptide, or Protein,Carbohydrate]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "(51,"

Phrase: "52,"

Phrase: "53"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "complement component C3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0009506:Complement component C3 [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Complement C3
   901   C0312743:Complement component [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0009498:Complement [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0449432:Component [Manufactured Object]
   827   C1705248:Component [Conceptual Entity]

Phrase: "(54"

Phrase: ")"

Phrase: ","

Phrase: "whose gene promoters"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0314621:gene promoters [Gene or Genome]
   861   C0086860:promoters [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "critical C/EBP-binding sites."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   845   C0005456:Binding Sites [Receptor]
   829 E C0682969:Binding Site [Amino Acid Sequence]
   818   C0033618:Protein Binding [Molecular Function]
   795   C0205145:Sites [Spatial Concept]
   762 E C1515974:Site [Body Location or Region]
   762 E C2825164:Site [Spatial Concept]
   710   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.199: The C/EBP transcription factors are also reciprocally regulated in fully-differentiated adipocytes. 

Phrase: "The C/EBP transcription factors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   896   C0526260:Transcription Factor, CCAAT-Binding [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           CCAAT-Binding Factor
   827   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0040649:Transcription [Genetic Function]
   766   C1521761:Factor [Functional Concept]
   766   C2827422:Factor [Conceptual Entity]
   734   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "also reciprocally"

Phrase: "regulated in fully-differentiated adipocytes."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0007589:Differentiated [Cell Function]
   760   C0205615:Differentiated [Qualitative Concept]
   760   C0206131:Adipocytes [Cell]
   760   C0851285:Regulated [Governmental or Regulatory Activity]
   745   C1159884:adipocyte differentiation [Cell Function]
Processing 00000000.tx.200: For example, treatment of 3T3-L1 adipocytes with monocyte-conditioned medium (containing tumor necrosis factor ) causes an induction of C/EBP while suppressing the expression of C/EBP(55, 56, 57) . A variation of this reciprocity is observed with 3T3-L1 adipocytes treated with glucocorticoids(22) . While expression of C/EBP is transiently decreased and C/EBP is transiently increased, no change is observed in the expression of C/EBP. 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "treatment of 3T3-L1 adipocytes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "with monocyte-conditioned medium"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0162518:Conditioned Medium [Indicator, Reagent, or Diagnostic Aid]
   827   C0009458:Medium [Intellectual Product]
   827   C0439536:Medium [Quantitative Concept]
   827   C1705217:Medium [Substance]
   827   C3244283:medium [Intellectual Product]

Phrase: "(containing tumor necrosis factor"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   923   C0041368:tumor necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   923   C1323304:tumor necrosis factor [Molecular Function]
   923   C1456820:Tumour necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0333516:Tumor necrosis [Neoplastic Process]
   812   C0027540:Necrosis [Organ or Tissue Function]
   812   C0027651:Tumor [Neoplastic Process]
   812   C1334928:Necrosis [Finding]
   812   C1521761:Factor [Functional Concept]
   812   C1578706:Tumor [Intellectual Product]
   812   C2827422:Factor [Conceptual Entity]
   812   C3273930:Tumor [Finding]

Phrase: ")"

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "an induction of C/EBP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205263:Induction [Functional Concept]
   748   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "while"

Phrase: "suppressing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1260953:suppressing [Functional Concept]
  1000   C2003921:Suppressing [Phenomenon or Process]

Phrase: "the expression of C/EBP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1171362:expression protein [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "56,"

Phrase: "57"

Phrase: ") ."

Phrase: "A variation of this reciprocity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205419:Variation [Qualitative Concept]

Phrase: "is"

Phrase: "observed with 3T3-L1 adipocytes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0206131:Adipocytes [Cell]
   760   C0441918:L1 [Finding]
   760   C1179698:L1 [Body Location or Region]
   760   C1416177:L1 [Gene or Genome]
   760   C1441672:Observed [Functional Concept]

Phrase: "treated with glucocorticoids"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0017710:Glucocorticoids [Hormone,Steroid]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "(22"

Phrase: ") ."

Phrase: "While"

Phrase: "expression of C/EBP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1171362:expression protein [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   716   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "transiently"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "and"

Phrase: "C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "is"

Phrase: "transiently"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: ","

Phrase: "no change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "is"

Phrase: "observed in the expression of C/EBP."
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   818   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C2752241:enhancer binding [Genetic Function]
   762 E C0033618:Protein Binding [Molecular Function]
   762   C1171362:expression protein [Genetic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]
   742   C0243122:binding [Functional Concept]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]
   742   C1441672:Observed [Functional Concept]
Processing 00000000.tx.201: The current report demonstrates that in mature adipocytes, insulin also reciprocally regulates the C/EBPs. 

Phrase: "The current report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0684224:Report [Intellectual Product]
   861   C0700287:Report [Health Care Activity]
   861   C3273238:Report [Intellectual Product]

Phrase: "demonstrates"

Phrase: "that in mature adipocytes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205286:Mature [Temporal Concept]
   770   C0206131:Adipocytes [Cell]

Phrase: "insulin also reciprocally"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "regulates"

Phrase: "the C/EBPs."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0108685:C/EBP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.202: In this case, C/EBP is persistently suppressed, and both C/EBP and C/EBP are transiently induced. 

Phrase: "In this case,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "is"

Phrase: "persistently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750508:persistently [Idea or Concept]

Phrase: "suppressed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:Suppressed [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "both C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "are"

Phrase: "transiently"

Phrase: "induced."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]
Processing 00000000.tx.203: The fact that different hormones/cytokines give rise to similar (i.e. reciprocal) patterns of expression of the C/EBP isoforms both during (12) and after terminal cell differentiation (see above) suggests that the C/EBPs play a central role in controlling gene transcription in a variety of metabolic situations. 

Phrase: "The fact"

Phrase: "that different hormones/cytokines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "give"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "rise to similar"

Phrase: "(i.e. reciprocal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1882911:Reciprocal [Qualitative Concept]
   734   C0683454:I-E [Diagnostic Procedure,Intellectual Product]

Phrase: ")"

Phrase: "patterns of expression of the C/EBP isoforms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   741   C1317658:Protein pattern [Clinical Attribute]
   741   C1523331:pattern binding [Molecular Function]
   739   C0449774:Patterns [Spatial Concept]

Phrase: "both during"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0238767:Both [Spatial Concept]
   833   C1706086:Both [Qualitative Concept]

Phrase: "(12"

Phrase: ")"

Phrase: "and after terminal cell differentiation"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   806   C0007589:Cell Differentiation [Cell Function]
           Differentiation
   797   C2752630:terminal differentiation [Cell Function]
   760   C0007634:Cell [Cell]
   760   C0205088:Terminal [Temporal Concept]
   760   C1269647:Cell [Cell]
   760   C1511938:Differentiation [Clinical Attribute]
   760   C1515981:And [Idea or Concept]
   760   C1704653:Cell [Medical Device]
   760   C1705314:Terminal [Manufactured Object]
   760   C1705315:Terminal [Spatial Concept]
   760   C1948049:Cell [Spatial Concept]
   760   C2945687:Differentiation [Functional Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "above"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]

Phrase: ")"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the C/EBPs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0108685:C/EBP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1553033:[c] [Quantitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a central role in controlling gene transcription"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "in a variety"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1883525:Variety [Conceptual Entity]
  1000   C2346866:Variety [Conceptual Entity]

Phrase: "of metabolic situations."
Processing 00000000.tx.204: Presumably, the unique, but overlapping, sets of genes that are transcriptionally activated or repressed in each metabolic state would depend on the specific combination of active trans-acting factors (e.g. the glucocorticoid receptor), the complement of C/EBP homo- and heterodimers, and the cis-elements in each of the gene promoters affected. 

Phrase: "Presumably,"

Phrase: "the unique,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710548:Unique [Qualitative Concept]

Phrase: "but"

Phrase: "overlapping,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0185027:Overlapping [Therapeutic or Preventive Procedure]
  1000   C1948020:Overlapping [Conceptual Entity]

Phrase: "sets of genes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   841   C1366517:SET gene [Gene or Genome]
   790   C0017337:Genes [Gene or Genome]
   790   C0036849:Set [Mental Process]
   790   C1442518:Set [Functional Concept]
   790   C1705195:Set [Conceptual Entity]

Phrase: "that"

Phrase: "are"

Phrase: "transcriptionally"

Phrase: "activated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:Activated [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "or"

Phrase: "repressed in each metabolic state"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0311400:Metabolic [Functional Concept]
   760   C1301808:State [Geographic Area]
   760   C1442792:State [Functional Concept]
   760   C1524026:Metabolic [Cell Function]
   760   C2707259:Metabolic [Clinical Attribute]
   760   C3148680:State [Geographic Area]

Phrase: "would"

Phrase: "depend on the specific combination of active trans-acting factors"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   782   C0040627:Trans-Acting Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0205177:Active [Functional Concept]
   739   C0205195:Combination [Qualitative Concept]
   739   C0205369:Specific [Qualitative Concept]
   739   C0725813:depend [Medical Device]
   739   C1552740:specific [Intellectual Product]
   739   C1947911:Combination [Physical Object]
   739   C2826298:TRANS [Idea or Concept]
   706   C0079613:ACT [Therapeutic or Preventive Procedure]
   706   C1521761:Factor [Functional Concept]
   706   C2827422:Factor [Conceptual Entity]

Phrase: "("

Phrase: "e.g."

Phrase: "the glucocorticoid receptor"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0034809:Glucocorticoid Receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1334899:GLUCOCORTICOID RECEPTOR [Gene or Genome]
  1000   C1370369:Glucocorticoid Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0017710:Glucocorticoid [Hormone,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ")"

Phrase: ","

Phrase: "the complement of C/EBP homo-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0009498:Complement Protein [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Complement
   767   C1523308:complement binding [Molecular Function]

Phrase: "and"

Phrase: "heterodimers,"

Phrase: "and"

Phrase: "the cis-elements in each of the gene promoters"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0013879:Elements [Element, Ion, or Isotope]
   708 E C1705248:Element [Conceptual Entity]

Phrase: "affected."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]
Processing 00000000.tx.205: This concept extends the hypothesis (58) that C/EBP serves as a central regulator of energy metabolism. 

Phrase: "This concept"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0178566:concept [Idea or Concept]

Phrase: "extends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231448:Extend [Functional Concept]
  1000   C0439792:extend [Spatial Concept]

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "(58"

Phrase: ")"

Phrase: "that C/EBP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "serves as a central regulator of energy metabolism."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C0014272:Energy Metabolism [Physiologic Function]
   744   C0025519:Metabolism [Organism Function]
   744   C0025520:metabolism [Functional Concept]
   744   C0182953:REGULATOR [Medical Device]
   744   C0205099:Central [Spatial Concept]
   744   C0424589:Energy [Finding]
   744   C0542479:Energy [Natural Phenomenon or Process]
   744   C1442080:Energy [Quantitative Concept]
   744   C1704734:Regulator [Medical Device]
   744   C1704735:Regulator [Conceptual Entity]
   744   C1879652:Central - [Laboratory Procedure]
Processing 00000000.tx.206: FOOTNOTES * This work was supported in part by a research grant from National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health. 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported in part"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0449719:Part [Spatial Concept]
   790   C1521721:Supported [Conceptual Entity]
   790   C1709471:Part [Quantitative Concept]
   756 E C0183683:Support [Medical Device]

Phrase: "by a research grant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0260206:research grant [Research Activity]
   861   C0018173:Grant [Quantitative Concept]
   861   C1548284:Grant [Idea or Concept]

Phrase: "from National Institute"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021622:institute [Organization]
   861   C1272753:Institute [Idea or Concept]

Phrase: "of Diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "Digestive"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0012238:Digestive [Organism Function]
  1000   C0012240:Digestive [Body System]

Phrase: "and"

Phrase: "Kidney Diseases,"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
  1000   C0022658:Kidney Diseases [Disease or Syndrome]
   861   C0012634:Diseases [Disease or Syndrome]
   861   C0022646:Kidney [Body Part, Organ, or Organ Component]
   861   C0227665:kidney [Body Part, Organ, or Organ Component]
   861   C1278978:Kidney [Body Part, Organ, or Organ Component]
   861   C1514845:KIDNEY [Tissue]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]
   768 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "National Institutes of Health."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health
   812   C0018684:Health [Idea or Concept]
   812   C0021622:Institutes [Organization]
   812   C3245503:national [Intellectual Product]
   779 E C1272753:Institute [Idea or Concept]
   712 E C0031206:healthiness [Finding]
Processing 00000000.tx.207: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.208: This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. 

Phrase: "This article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore by hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: "``advertisement''"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18 U.S.C."
Processing 00000000.tx.209: Section 1734 solely to indicate this fact.  

Phrase: "Section 1734 solely to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205155:Section [Spatial Concept]
   812   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   812   C1522472:Section [Substance]
   812   C1552923:Section [Quantitative Concept]
   812   C1705191:Section [Physical Object]

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.210: Supported by a National Research Service award from the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health.  

Phrase: "Supported by a National Research Service award"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   774   C0035176:research supported [Quantitative Concept]
   748   C0004446:Award [Manufactured Object]
   748   C0035168:research [Research Activity]
   748   C0242481:Research [Research Activity]
   748   C0557854:Service [Occupational Activity]
   748   C1521721:Supported [Conceptual Entity]
   748   C2825316:Service [Manufactured Object]
   748   C3245478:service [Idea or Concept]
   748   C3245503:national [Intellectual Product]
   714 E C0183683:Support [Medical Device]

Phrase: "from the National Institute"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021622:institute [Organization]
   861   C1272753:Institute [Idea or Concept]

Phrase: "of Diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "Digestive"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0012238:Digestive [Organism Function]
  1000   C0012240:Digestive [Body System]

Phrase: "and"

Phrase: "Kidney Diseases,"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
  1000   C0022658:Kidney Diseases [Disease or Syndrome]
   861   C0012634:Diseases [Disease or Syndrome]
   861   C0022646:Kidney [Body Part, Organ, or Organ Component]
   861   C0227665:kidney [Body Part, Organ, or Organ Component]
   861   C1278978:Kidney [Body Part, Organ, or Organ Component]
   861   C1514845:KIDNEY [Tissue]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]
   768 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "National Institutes of Health."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health
   812   C0018684:Health [Idea or Concept]
   812   C0021622:Institutes [Organization]
   812   C3245503:national [Intellectual Product]
   779 E C1272753:Institute [Idea or Concept]
   712 E C0031206:healthiness [Finding]
Processing 00000000.tx.211: Supported by a National Research Service award from the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health. 

Phrase: "Supported by a National Research Service award"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   774   C0035176:research supported [Quantitative Concept]
   748   C0004446:Award [Manufactured Object]
   748   C0035168:research [Research Activity]
   748   C0242481:Research [Research Activity]
   748   C0557854:Service [Occupational Activity]
   748   C1521721:Supported [Conceptual Entity]
   748   C2825316:Service [Manufactured Object]
   748   C3245478:service [Idea or Concept]
   748   C3245503:national [Intellectual Product]
   714 E C0183683:Support [Medical Device]

Phrase: "from the National Institute"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021622:institute [Organization]
   861   C1272753:Institute [Idea or Concept]

Phrase: "of Diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "Digestive"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0012238:Digestive [Organism Function]
  1000   C0012240:Digestive [Body System]

Phrase: "and"

Phrase: "Kidney Diseases,"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
  1000   C0022658:Kidney Diseases [Disease or Syndrome]
   861   C0012634:Diseases [Disease or Syndrome]
   861   C0022646:Kidney [Body Part, Organ, or Organ Component]
   861   C0227665:kidney [Body Part, Organ, or Organ Component]
   861   C1278978:Kidney [Body Part, Organ, or Organ Component]
   861   C1514845:KIDNEY [Tissue]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]
   768 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "National Institutes of Health."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health
   812   C0018684:Health [Idea or Concept]
   812   C0021622:Institutes [Organization]
   812   C3245503:national [Intellectual Product]
   779 E C1272753:Institute [Idea or Concept]
   712 E C0031206:healthiness [Finding]
Processing 00000000.tx.212: Present address: The Procter & Gamble Co., Miami Valley Laboratories, 11810 E. 

Phrase: "Present address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0376649:Address [Intellectual Product]
   861   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "The Procter & Gamble Co.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0331890:Procter & Gamble [Health Care Related Organization]

Phrase: "Miami Valley Laboratories,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0022877:Laboratories [Manufactured Object,Organization]
   827   C1619828:Laboratories [Intellectual Product]
   793 E C3244292:laboratory [Functional Concept]

Phrase: "11810 E."
Processing 00000000.tx.213: Miami River Rd., Ross, OH 45061. 

Phrase: "Miami River Rd.,"

Phrase: "Ross,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0331968:Ross [Health Care Related Organization]
  1000   C2699100:Ross [Bird]

Phrase: "OH 45061."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0220853:OH- [Element, Ion, or Isotope]
Processing 00000000.tx.214: ** Supported by a summer student grant from the Juvenile Diabetes Foundation.  

Phrase: "*"

Phrase: "*"

Phrase: "Supported by a summer student grant"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   753   C0018173:Grant [Quantitative Concept]
   753   C0038492:student [Professional or Occupational Group]
   753   C0241301:Summer [Temporal Concept]
   753   C1521721:Supported [Conceptual Entity]
   753   C1548284:Grant [Idea or Concept]
   753   C1551041:student [Idea or Concept]
   753   C1552573:student [Intellectual Product]
   719 E C0183683:Support [Medical Device]

Phrase: "from the Juvenile Diabetes Foundation."
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   827   C0016617:Foundation [Organization]
   743 E C0002055:base [Inorganic Chemical]
   743 E C0178499:Base [Chemical Viewed Functionally]
   743 E C1626935:Bases [Quantitative Concept]
   743 E C1880279:Base [Biomedical or Dental Material]
   734   C0011854:Juvenile Diabetes [Disease or Syndrome]
   721 E C0205112:Basal [Spatial Concept]
Processing 00000000.tx.215: To whom all correspondence should be addressed: Dept. of Biological Chemistry, The Johns Hopkins University, School of Medicine, 725 N. 

Phrase: "To whom"

Phrase: "all correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Dept."

Phrase: "of Biological Chemistry,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0005477:Chemistry, Biological [Occupation or Discipline]
   861   C0005532:Biological [Biomedical Occupation or Discipline]
   861   C0007996:Chemistry [Occupation or Discipline]
   861   C0079107:chemistry [Classification]
   861   C0201682:Chemistry [Laboratory Procedure]
   861   C0205460:biological [Qualitative Concept]

Phrase: "The Johns Hopkins University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0036375:School [Manufactured Object,Organization]

Phrase: "725 N."
Processing 00000000.tx.216: Wolfe St., Baltimore, MD 21205. 

Phrase: "Wolfe St., Baltimore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0004716:Baltimore [Geographic Area]

Phrase: "MD 21205."
Processing 00000000.tx.217: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.218: 410-955-3554; 

Phrase: "410-955-3554"

Phrase: ";"
Processing 00000000.tx.219: Fax: 410-955-0903. 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "410-955-0903."
Processing 00000000.tx.220: () The abbreviations used are: C/EBP, CCAAT/enhancer-binding protein; 

Phrase: "("

Phrase: ")"

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "C/EBP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "CCAAT/enhancer-binding protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0108685:CCAAT-Enhancer-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0597716:Enhancer Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2752241:enhancer binding [Genetic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: ";"
Processing 00000000.tx.221: GLUT4, insulin-responsive glucose transporter; 

Phrase: "GLUT4,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0166441:GLUT-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420175:GLUT4 [Gene or Genome]
  1000   C2982484:GLUT4 [Gene or Genome]

Phrase: "insulin-responsive glucose transporter"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0166441:Insulin-Responsive Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420175:GLUCOSE TRANSPORTER, INSULIN-RESPONSIVE [Gene or Genome]
   861   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.222: IGF-1, insulin-like growth factor-1; 

Phrase: "IGF-1,"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
  1000   C0021665:Insulin-like growth factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0202220:Insulin-like Growth Factor-1 [Laboratory Procedure]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "insulin-like growth factor-1"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
  1000   C0021665:Insulin-like growth factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0202220:Insulin-like Growth Factor-1 [Laboratory Procedure]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.223: PAGE, polyacrylamide gel electrophoresis; 

Phrase: "PAGE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704732:Page [Intellectual Product]

Phrase: "polyacrylamide gel electrophoresis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   901   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   901   C0596607:Gel Electrophoresis [Laboratory Procedure]
   827   C0013855:Electrophoresis [Laboratory Procedure]
   827   C0017243:Gel [Biomedical or Dental Material]
   827   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   827   C1382104:Gel [Substance]

Phrase: ";"
Processing 00000000.tx.224: LIP, liver inhibitory protein; 

Phrase: "LIP,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0023759:Lip [Body Part, Organ, or Organ Component]
  1000   C1278911:Lip [Body Part, Organ, or Organ Component]
   907 E C0227759:Labia [Body Part, Organ, or Organ Component]
   907 E C1070701:Labia [Eukaryote]
   907 E C2626732:Labium [Eukaryote]

Phrase: "liver inhibitory protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   885   C1840635:HEPATIC PROTEIN [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.225: LAP, liver activator protein. 

Phrase: "LAP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540509:LAP [Gene or Genome]

Phrase: "liver activator protein."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0209548:Liver Activator Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413323:LIVER ACTIVATOR PROTEIN [Gene or Genome]
   885   C1840635:HEPATIC PROTEIN [Gene or Genome]
   827   C0023884:Liver [Body Part, Organ, or Organ Component]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0736268:LIVER [Body Part, Organ, or Organ Component]
   827   C1278929:Liver [Body Part, Organ, or Organ Component]
   827   C2346688:LIVER [Food]
   771 E C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.226: () P. 

Phrase: "("

Phrase: ")"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.227: Cornelius and M. 

Phrase: "Cornelius"

Phrase: "and"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.228: D. 

Phrase: "D."
Processing 00000000.tx.229: Lane, unpublished data. 

Phrase: "Lane,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708639:Lane [Spatial Concept]

Phrase: "unpublished data."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]
Processing 00000000.tx.230: () F.-T. 

Phrase: "("

Phrase: ")"

Phrase: "F.-T."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.231: Lin and M. 

Phrase: "Lin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "and"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.232: D. 

Phrase: "D."
Processing 00000000.tx.233: Lane, unpublished results. 

Phrase: "Lane,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708639:Lane [Spatial Concept]

Phrase: "unpublished results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]
Processing 00000000.tx.234: REFERENCES Cornelius, P., MacDougald, O. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Cornelius,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "MacDougald,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.235: A., and Lane, M. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Lane,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708639:Lane [Spatial Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.236: D. 

Phrase: "D."
Processing 00000000.tx.237: (1994) Annu. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Annu."
Processing 00000000.tx.238: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.239: Nutr. 

Phrase: "Nutr."
Processing 00000000.tx.240: 14, 99-129 [CrossRef][Medline] [OrderarticleviaInfotrieve] Green, H., and Kehinde, O. 

Phrase: "14,"

Phrase: "99-129"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Green,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Kehinde,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.241: (1974) Cell 1, 113-116 Green, H., and Meuth, M. 

Phrase: "(1974"

Phrase: ")"

Phrase: "Cell 1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "113-116 Green,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0332583:Green [Qualitative Concept]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Meuth,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.242: (1974) Cell 3, 127-133 [Medline] [OrderarticleviaInfotrieve] Green, H., and Kehinde, O. 

Phrase: "(1974"

Phrase: ")"

Phrase: "Cell 3,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "127-133"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Green,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Kehinde,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.243: (1975) Cell 5, 19-27 [Medline] [OrderarticleviaInfotrieve] Coleman, R. 

Phrase: "(1975"

Phrase: ")"

Phrase: "Cell 5,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "19-27"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Coleman,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.244: A., Reed, B. 

Phrase: "A.,"

Phrase: "Reed,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.245: C., Mackall, J. 

Phrase: "C., Mackall,"

Phrase: "J."
Processing 00000000.tx.246: C., Student, A. 

Phrase: "C., Student,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0038492:student [Professional or Occupational Group]
   861   C1551041:student [Idea or Concept]
   861   C1552573:student [Intellectual Product]

Phrase: "A."
Processing 00000000.tx.247: K., Lane, M. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Lane,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708639:Lane [Spatial Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.248: D., and Bell, R. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Bell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706917:Bell [Manufactured Object]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.249: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.250: (1978) J. 

Phrase: "(1978"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.251: Biol. 

Phrase: "Biol."
Processing 00000000.tx.252: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.253: 253, 7256-7261 [Medline] [OrderarticleviaInfotrieve] Mackall, J. 

Phrase: "253,"

Phrase: "7256-7261"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Mackall,"

Phrase: "J."
Processing 00000000.tx.254: C., Student, A. 

Phrase: "C., Student,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0038492:student [Professional or Occupational Group]
   861   C1551041:student [Idea or Concept]
   861   C1552573:student [Intellectual Product]

Phrase: "A."
Processing 00000000.tx.255: K., Polakis, S. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Polakis,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.256: E., and Lane, M. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Lane,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708639:Lane [Spatial Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.257: D. 

Phrase: "D."
Processing 00000000.tx.258: (1976) J. 

Phrase: "(1976"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.259: Biol. 

Phrase: "Biol."
Processing 00000000.tx.260: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.261: 251, 6462-6464 [Abstract] Mackall, J. 

Phrase: "251,"

Phrase: "6462-6464"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Mackall,"

Phrase: "J."
Processing 00000000.tx.262: C., and Lane, M. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Lane,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708639:Lane [Spatial Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.263: D. 

Phrase: "D."
Processing 00000000.tx.264: (1977) Biochem. 

Phrase: "(1977"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.265: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.266: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.267: Commun. 

Phrase: "Commun."
Processing 00000000.tx.268: 79, 720-725 [Medline] [OrderarticleviaInfotrieve] Bernlohr, D. 

Phrase: "79,"

Phrase: "720-725"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Bernlohr,"

Phrase: "D."
Processing 00000000.tx.269: A., Bolanowski, M. 

Phrase: "A.,"

Phrase: "Bolanowski,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.270: A., Kelly, T. 

Phrase: "A.,"

Phrase: "Kelly,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.271: J., and Lane, M. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Lane,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708639:Lane [Spatial Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.272: D. 

Phrase: "D."
Processing 00000000.tx.273: (1985) J. 

Phrase: "(1985"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.274: Biol. 

Phrase: "Biol."
Processing 00000000.tx.275: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.276: 260, 5563-5567 [Abstract] Cook, K. 

Phrase: "260,"

Phrase: "5563-5567"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Cook,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0335326:Cook [Daily or Recreational Activity]
  1000   C1306756:Cook [Professional or Occupational Group]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.277: S., Hunt, C. 

Phrase: "S."

Phrase: ","

Phrase: "Hunt,"

Phrase: "C."
Processing 00000000.tx.278: R., and Spiegelman, B. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Spiegelman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.279: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.280: (1985) J. 

Phrase: "(1985"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.281: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.282: 100, 514-520 [Abstract] Christy, R. 

Phrase: "100,"

Phrase: "514-520"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Christy,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.283: J., Yang, V. 

Phrase: "J.,"

Phrase: "Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "V."
Processing 00000000.tx.284: W., Ntambi, J. 

Phrase: "W., Ntambi,"

Phrase: "J."
Processing 00000000.tx.285: M., Geiman, D. 

Phrase: "M."

Phrase: ","

Phrase: "Geiman,"

Phrase: "D."
Processing 00000000.tx.286: E., Landschulz, W. 

Phrase: "E.,"

Phrase: "Landschulz,"

Phrase: "W."
Processing 00000000.tx.287: H., Friedman, A. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Friedman,"

Phrase: "A."
Processing 00000000.tx.288: D., Nakabeppu, Y., Kelly, T. 

Phrase: "D."

Phrase: ","

Phrase: "Nakabeppu,"

Phrase: "Y.,"

Phrase: "Kelly,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.289: J., and Lane, M. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Lane,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708639:Lane [Spatial Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.290: D. 

Phrase: "D."
Processing 00000000.tx.291: (1989) Genes & Dev. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Genes & Dev."
Processing 00000000.tx.292: 3, 1323-1335 Christy, R. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "1323-1335 Christy,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.293: J., Kaestner, K. 

Phrase: "J.,"

Phrase: "Kaestner,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.294: H., Geiman, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Geiman,"

Phrase: "D."
Processing 00000000.tx.295: E., and Lane, M. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Lane,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708639:Lane [Spatial Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.296: D. 

Phrase: "D."
Processing 00000000.tx.297: (1991) Proc. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.298: Natl. 

Phrase: "Natl."
Processing 00000000.tx.299: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.300: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.301: U. 

Phrase: "U."
Processing 00000000.tx.302: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.303: A. 

Phrase: "A."
Processing 00000000.tx.304: 88, 2593-2597 [Abstract] Cao, Z., Umek, R. 

Phrase: "88,"

Phrase: "2593-2597"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Cao,"

Phrase: "Z.,"

Phrase: "Umek,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.305: M., and McKnight, S. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "McKnight,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.306: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.307: (1991) Genes & Dev. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Genes & Dev."
Processing 00000000.tx.308: 5, 1538-1552 Lin, F-T., and Lane, M. 

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "1538-1552 Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0861352:LIN [Neoplastic Process]

Phrase: "F-T.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Lane,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708639:Lane [Spatial Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.309: D. 

Phrase: "D."
Processing 00000000.tx.310: (1992) Genes & Dev. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Genes & Dev."
Processing 00000000.tx.311: 6, 533-544 Lin, F-T., and Lane, M. 

Phrase: "6,"

Phrase: "533-544 Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0861352:LIN [Neoplastic Process]

Phrase: "F-T.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Lane,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708639:Lane [Spatial Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.312: D. 

Phrase: "D."
Processing 00000000.tx.313: (1994) Proc. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.314: Natl. 

Phrase: "Natl."
Processing 00000000.tx.315: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.316: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.317: U. 

Phrase: "U."
Processing 00000000.tx.318: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.319: A. 

Phrase: "A."
Processing 00000000.tx.320: 91, 8757-8761 [Abstract] Freytag, S. 

Phrase: "91,"

Phrase: "8757-8761"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Freytag,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.321: O., Paielli, D. 

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Paielli,"

Phrase: "D."
Processing 00000000.tx.322: L., and Gilbert, J. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Gilbert,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551090:Gilbert [Quantitative Concept]

Phrase: "J."
Processing 00000000.tx.323: D. 

Phrase: "D."
Processing 00000000.tx.324: (1994) Genes & Dev. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Genes & Dev."
Processing 00000000.tx.325: 8, 1654-1663 Umek, R. 

Phrase: "8,"

Phrase: "1654-1663 Umek,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.326: M., Friedman, A. 

Phrase: "M."

Phrase: ","

Phrase: "Friedman,"

Phrase: "A."
Processing 00000000.tx.327: D., and McKnight, S. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "McKnight,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.328: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.329: (1991) Science 251, 288-292 [Medline] [OrderarticleviaInfotrieve] Kaestner, K. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Science 251,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "288-292"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kaestner,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.330: H., Christy, R. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Christy,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.331: J., and Lane, M. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Lane,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708639:Lane [Spatial Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.332: D. 

Phrase: "D."
Processing 00000000.tx.333: (1990) Proc. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.334: Natl. 

Phrase: "Natl."
Processing 00000000.tx.335: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.336: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.337: U. 

Phrase: "U."
Processing 00000000.tx.338: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.339: A. 

Phrase: "A."
Processing 00000000.tx.340: 87, 251-255 [Abstract] Lin, F-T., MacDougald, O. 

Phrase: "87,"

Phrase: "251-255"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "F-T.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "MacDougald,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.341: A., Diehl, A. 

Phrase: "A.,"

Phrase: "Diehl,"

Phrase: "A."
Processing 00000000.tx.342: M., and Lane, M. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Lane,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708639:Lane [Spatial Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.343: D. 

Phrase: "D."
Processing 00000000.tx.344: (1993) Proc. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.345: Natl. 

Phrase: "Natl."
Processing 00000000.tx.346: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.347: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.348: U. 

Phrase: "U."
Processing 00000000.tx.349: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.350: A. 

Phrase: "A."
Processing 00000000.tx.351: 90, 9606-9610 [Abstract] Samuelsson, L., Stromberg, K., Vikman, K., Bjursell, G., and Enerback, S. 

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "9606-9610"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Samuelsson,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Stromberg,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Vikman,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Bjursell,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Enerback,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.352: (1991) EMBO J. 

Phrase: "(1991"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.353: 10, 3787-3793 [Abstract] Ossipow, V., Descombes, P., and Schibler, U. 

Phrase: "10,"

Phrase: "3787-3793"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Ossipow,"

Phrase: "V.,"

Phrase: "Descombes,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Schibler,"

Phrase: "U."
Processing 00000000.tx.354: (1993) Proc. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.355: Natl. 

Phrase: "Natl."
Processing 00000000.tx.356: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.357: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.358: U. 

Phrase: "U."
Processing 00000000.tx.359: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.360: A. 

Phrase: "A."
Processing 00000000.tx.361: 90, 8219-8223 [Abstract/Free FullText] McKnight, S. 

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "8219-8223"

Phrase: "[Abstract/Free FullText"

Phrase: "] McKnight,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.362: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.363: (1992) in Transcriptional Regulation (McKnight, S. L., and Yamamoto, K. R., ed) pp. 

Phrase: "(1992"

Phrase: ")"

Phrase: "in Transcriptional Regulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1158770:Transcriptional Regulation [Genetic Function]
   861   C0851285:Regulation [Governmental or Regulatory Activity]
   861   C1327622:Regulation [Biologic Function]

Phrase: "(McKnight,"

Phrase: "S. L.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439394:s l [Quantitative Concept]

Phrase: "and"

Phrase: "Yamamoto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450955:Yamamoto [Body Location or Region]

Phrase: "K. R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "ed) pp."
Processing 00000000.tx.364: 771-796, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY MacDougald, O. 

Phrase: "771-796,"

Phrase: "Cold Spring Harbor Laboratory Press,"

Phrase: "Cold Spring Harbor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0475311:Harbor [Manufactured Object]

Phrase: "NY MacDougald,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.365: A., Cornelius, P., Lin, F-T., Chen, S. 

Phrase: "A.,"

Phrase: "Cornelius,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "F-T.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.366: S., and Lane, M. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Lane,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708639:Lane [Spatial Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.367: D. 

Phrase: "D."
Processing 00000000.tx.368: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.369: Biol. 

Phrase: "Biol."
Processing 00000000.tx.370: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.371: 269, 19041-19047 [Abstract/Free FullText] Rodbell, M. 

Phrase: "269,"

Phrase: "19041-19047"

Phrase: "[Abstract/Free FullText"

Phrase: "] Rodbell,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.372: (1964) J. 

Phrase: "(1964"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.373: Biol. 

Phrase: "Biol."
Processing 00000000.tx.374: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.375: 239, 375-380 [Free FullText] Rubin, C. 

Phrase: "239,"

Phrase: "375-380"

Phrase: "[Free FullText"

Phrase: "] Rubin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0252873:rubin's [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "C."
Processing 00000000.tx.376: S., Lai, E., and Rosen, O. 

Phrase: "S."

Phrase: ","

Phrase: "Lai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443021:Lai [Intellectual Product]

Phrase: "E.,"

Phrase: "and"

Phrase: "Rosen,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.377: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.378: (1977) J. 

Phrase: "(1977"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.379: Biol. 

Phrase: "Biol."
Processing 00000000.tx.380: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.381: 252, 3554-3557 [Abstract] Jeanrenaud, B., and Renold, A. 

Phrase: "252,"

Phrase: "3554-3557"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Jeanrenaud,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Renold,"

Phrase: "A."
Processing 00000000.tx.382: E. 

Phrase: "E."
Processing 00000000.tx.383: (1960) J. 

Phrase: "(1960"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.384: Biol. 

Phrase: "Biol."
Processing 00000000.tx.385: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.386: 235, 2217-2223 [Medline] [OrderarticleviaInfotrieve] Exton, J. 

Phrase: "235,"

Phrase: "2217-2223"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Exton,"

Phrase: "J."
Processing 00000000.tx.387: H., Friedmann, N., Wong, E. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Friedmann,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Wong,"

Phrase: "E."
Processing 00000000.tx.388: H-A., Brineaux, J. 

Phrase: "H-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "A.,"

Phrase: "Brineaux,"

Phrase: "J."
Processing 00000000.tx.389: P., Corbin, J. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Corbin,"

Phrase: "J."
Processing 00000000.tx.390: D., and Park, C. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Park,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562547:Park [Manufactured Object]
  1000   C3160718:PARK [Disease or Syndrome]

Phrase: "C."
Processing 00000000.tx.391: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.392: (1972) J. 

Phrase: "(1972"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.393: Biol. 

Phrase: "Biol."
Processing 00000000.tx.394: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.395: 247, 3579-3588 [Abstract/Free FullText] Student, A. 

Phrase: "247,"

Phrase: "3579-3588"

Phrase: "[Abstract/Free FullText"

Phrase: "] Student,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0038492:student [Professional or Occupational Group]
  1000   C1551041:student [Idea or Concept]
  1000   C1552573:student [Intellectual Product]

Phrase: "A."
Processing 00000000.tx.396: K., Hsu, R. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Hsu,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.397: Y., and Lane, M. 

Phrase: "Y.,"

Phrase: "and"

Phrase: "Lane,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708639:Lane [Spatial Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.398: D. 

Phrase: "D."
Processing 00000000.tx.399: (1980) J. 

Phrase: "(1980"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.400: Biol. 

Phrase: "Biol."
Processing 00000000.tx.401: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.402: 255, 4745-4750 [Abstract/Free FullText] Sambrook, J., Fritsch, E. 

Phrase: "255,"

Phrase: "4745-4750"

Phrase: "[Abstract/Free FullText"

Phrase: "] Sambrook,"

Phrase: "J.,"

Phrase: "Fritsch,"

Phrase: "E."
Processing 00000000.tx.403: F., and Maniatis, T. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Maniatis,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.404: (1989) Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY Potter, J. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Molecular Cloning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009017:Cloning, Molecular [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0009015:Cloning [Research Activity]

Phrase: ":"

Phrase: "A Laboratory Manual, Cold Spring Harbor Laboratory Press,"

Phrase: "Cold Spring Harbor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0475311:Harbor [Manufactured Object]

Phrase: "NY Potter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0336168:potter [Professional or Occupational Group]

Phrase: "J."
Processing 00000000.tx.405: J., Mezey, E., Cornelius, P., Crabb, D. 

Phrase: "J.,"

Phrase: "Mezey,"

Phrase: "E.,"

Phrase: "Cornelius,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Crabb,"

Phrase: "D."
Processing 00000000.tx.406: W., and Yang, V. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "V."
Processing 00000000.tx.407: W. 

Phrase: "W."
Processing 00000000.tx.408: (1992) Arch. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.409: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.410: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.411: 295, 360-368 [Medline] [OrderarticleviaInfotrieve] Feinberg, A. 

Phrase: "295,"

Phrase: "360-368"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Feinberg,"

Phrase: "A."
Processing 00000000.tx.412: P., and Vogelstein, B. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Vogelstein,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.413: (1983) Anal. 

Phrase: "(1983"

Phrase: ")"

Phrase: "Anal."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003461:Anal [Body Part, Organ, or Organ Component]
  1000   C2939124:Anal [Spatial Concept]
Processing 00000000.tx.414: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.415: 132, 6-13 [Medline] [OrderarticleviaInfotrieve] Swick, A. 

Phrase: "132,"

Phrase: "6-13"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Swick,"

Phrase: "A."
Processing 00000000.tx.416: G., Blake, M. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Blake,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.417: C., Kahn, J. 

Phrase: "C., Kahn,"

Phrase: "J."
Processing 00000000.tx.418: W., and Azizkhan, J. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Azizkhan,"

Phrase: "J."
Processing 00000000.tx.419: C. 

Phrase: "C."
Processing 00000000.tx.420: (1989) Nucleic Acids Res. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Nucleic Acids Res."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2347379:RES [Finding]
   734   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.421: 17, 9291-9304 [Abstract] Dignam, J. 

Phrase: "17,"

Phrase: "9291-9304"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Dignam,"

Phrase: "J."
Processing 00000000.tx.422: D., Lebovitz, R. 

Phrase: "D."

Phrase: ","

Phrase: "Lebovitz,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.423: M., and Roeder, R. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Roeder,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.424: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.425: (1983) Nucleic Acids Res. 

Phrase: "(1983"

Phrase: ")"

Phrase: "Nucleic Acids Res."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2347379:RES [Finding]
   734   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.426: 11, 1475-1489 [Abstract] Lavery, D. 

Phrase: "11,"

Phrase: "1475-1489"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Lavery,"

Phrase: "D."
Processing 00000000.tx.427: J., and Schibler, U. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Schibler,"

Phrase: "U."
Processing 00000000.tx.428: (1993) Genes & Dev. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Genes & Dev."
Processing 00000000.tx.429: 7, 1871-1884 Cornelius, P., Marlowe, M., Lee, M. 

Phrase: "7,"

Phrase: "1871-1884 Cornelius,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Marlowe,"

Phrase: "M."

Phrase: ","

Phrase: "Lee,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.430: D., and Pekala, P.H. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Pekala,"

Phrase: "P.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.431: (1990) J. 

Phrase: "(1990"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.432: Biol. 

Phrase: "Biol."
Processing 00000000.tx.433: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.434: 265, 20506-20516 [Abstract/Free FullText] Gorski, K., Carneiro, M., and Schibler, U. 

Phrase: "265,"

Phrase: "20506-20516"

Phrase: "[Abstract/Free FullText"

Phrase: "] Gorski,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Carneiro,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Schibler,"

Phrase: "U."
Processing 00000000.tx.435: (1986) Cell 47, 767-776 [Medline] [OrderarticleviaInfotrieve] Descombes, P., Chojkier, M., Lichtsteiner, S., Falvey, E., and Schibler, U. 

Phrase: "(1986"

Phrase: ")"

Phrase: "Cell 47,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "767-776"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Descombes,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Chojkier,"

Phrase: "M."

Phrase: ","

Phrase: "Lichtsteiner,"

Phrase: "S."

Phrase: ","

Phrase: "Falvey,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Schibler,"

Phrase: "U."
Processing 00000000.tx.436: (1990) Genes & Dev. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Genes & Dev."
Processing 00000000.tx.437: 4, 1541-1551 Descombes, P., and Schibler, U. 

Phrase: "4,"

Phrase: "1541-1551 Descombes,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Schibler,"

Phrase: "U."
Processing 00000000.tx.438: (1991) Cell 67, 569-579 [Medline] [OrderarticleviaInfotrieve] Decaux, J. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Cell 67,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "569-579"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Decaux,"

Phrase: "J."
Processing 00000000.tx.439: F., Marcillat, O., Pichard, A. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Marcillat,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Pichard,"

Phrase: "A."
Processing 00000000.tx.440: L., Henry, J., and Kahn, A. 

Phrase: "L., Henry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0582517:henry [Quantitative Concept]

Phrase: "J.,"

Phrase: "and"

Phrase: "Kahn,"

Phrase: "A."
Processing 00000000.tx.441: (1991) J. 

Phrase: "(1991"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.442: Biol. 

Phrase: "Biol."
Processing 00000000.tx.443: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.444: 266, 3432-3438 [Abstract/Free FullText] Rubin, C. 

Phrase: "266,"

Phrase: "3432-3438"

Phrase: "[Abstract/Free FullText"

Phrase: "] Rubin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0252873:rubin's [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "C."
Processing 00000000.tx.445: S., Hirsch, A., Fung, C., and Rosen, O. 

Phrase: "S."

Phrase: ","

Phrase: "Hirsch,"

Phrase: "A.,"

Phrase: "Fung,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Rosen,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.446: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.447: (1978) J. 

Phrase: "(1978"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.448: Biol. 

Phrase: "Biol."
Processing 00000000.tx.449: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.450: 253, 7570-7578 [Medline] [OrderarticleviaInfotrieve] Bialojan, C., and Takai, A. 

Phrase: "253,"

Phrase: "7570-7578"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Bialojan,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Takai,"

Phrase: "A."
Processing 00000000.tx.451: (1988) Biochem. 

Phrase: "(1988"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.452: J. 

Phrase: "J."
Processing 00000000.tx.453: 256, 283-290 [Medline] [OrderarticleviaInfotrieve] Cohen, P., Holmes, C. 

Phrase: "256,"

Phrase: "283-290"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Cohen,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Holmes,"

Phrase: "C."
Processing 00000000.tx.454: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.455: B., and Tsukitani, Y. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Tsukitani,"

Phrase: "Y."
Processing 00000000.tx.456: (1990) Trends Biochem. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Biochem."
Processing 00000000.tx.457: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.458: 15, 98-102 [CrossRef][Medline] [OrderarticleviaInfotrieve] Srinivasan, M., and Begum, N. 

Phrase: "15,"

Phrase: "98-102"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Srinivasan,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Begum,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.459: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.460: Biol. 

Phrase: "Biol."
Processing 00000000.tx.461: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.462: 269, 16662-16667 [Abstract/Free FullText] Chan, C. 

Phrase: "269,"

Phrase: "16662-16667"

Phrase: "[Abstract/Free FullText"

Phrase: "] Chan,"

Phrase: "C."
Processing 00000000.tx.463: P., McNall, S. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "McNall,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.464: J., Krebs, E. 

Phrase: "J.,"

Phrase: "Krebs,"

Phrase: "E."
Processing 00000000.tx.465: G., and Fischer, E. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Fischer,"

Phrase: "E."
Processing 00000000.tx.466: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.467: (1988) Proc. 

Phrase: "(1988"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.468: Natl. 

Phrase: "Natl."
Processing 00000000.tx.469: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.470: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.471: U. 

Phrase: "U."
Processing 00000000.tx.472: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.473: A. 

Phrase: "A."
Processing 00000000.tx.474: 85, 6257-6261 [Abstract] Villa-Moruzzi, E. 

Phrase: "85,"

Phrase: "6257-6261"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Villa-Moruzzi,"

Phrase: "E."
Processing 00000000.tx.475: (1989) FEBS Lett. 

Phrase: "(1989"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.476: 258, 208-210 [CrossRef][Medline] [OrderarticleviaInfotrieve] Dohadwala, M., Da Cruz E Silva, E. 

Phrase: "258,"

Phrase: "208-210"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Dohadwala,"

Phrase: "M."

Phrase: ","

Phrase: "Da Cruz E Silva,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   741   C0144237:Silvan [Organic Chemical]
   719 E C0043217:Wood [Substance]
   719 E C0442548:Woods [Geographic Area]

Phrase: "E."
Processing 00000000.tx.477: F., Hall, F. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Hall,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.478: L., Williams, R. 

Phrase: "L., Williams,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.479: T., Carbonaro-Hall, D. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Carbonaro-Hall,"

Phrase: "D."
Processing 00000000.tx.480: A., Nairn, A. 

Phrase: "A.,"

Phrase: "Nairn,"

Phrase: "A."
Processing 00000000.tx.481: C., Greengard, P., and Berndt, N. 

Phrase: "C., Greengard,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Berndt,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.482: (1994) Proc. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.483: Natl. 

Phrase: "Natl."
Processing 00000000.tx.484: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.485: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.486: U. 

Phrase: "U."
Processing 00000000.tx.487: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.488: A. 

Phrase: "A."
Processing 00000000.tx.489: 91, 6408-6412 [Abstract] Flores-Riveros, J. 

Phrase: "91,"

Phrase: "6408-6412"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Flores-Riveros,"

Phrase: "J."
Processing 00000000.tx.490: R., McLenithan, J. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "McLenithan,"

Phrase: "J."
Processing 00000000.tx.491: C., Ezaki, O., and Lane, M. 

Phrase: "C., Ezaki,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "and"

Phrase: "Lane,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708639:Lane [Spatial Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.492: D. 

Phrase: "D."
Processing 00000000.tx.493: (1993) Proc. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.494: Natl. 

Phrase: "Natl."
Processing 00000000.tx.495: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.496: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.497: U. 

Phrase: "U."
Processing 00000000.tx.498: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.499: A. 

Phrase: "A."
Processing 00000000.tx.500: 90, 512-516 [Abstract] Mahoney, C. 

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "512-516"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Mahoney,"

Phrase: "C."
Processing 00000000.tx.501: W., Shuman, J., McKnight, S. 

Phrase: "W., Shuman,"

Phrase: "J.,"

Phrase: "McKnight,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.502: L., Chen, H-C., and Huang, K. 

Phrase: "L., Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0999213:Chen [Bird]

Phrase: "H-C.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Huang,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.503: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.504: (1992) J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.505: Biol. 

Phrase: "Biol."
Processing 00000000.tx.506: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.507: 267, 19396-19403 [Abstract/Free FullText] Alam, T., An, M. 

Phrase: "267,"

Phrase: "19396-19403"

Phrase: "[Abstract/Free FullText"

Phrase: "] Alam,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "An,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.508: R., and Papaconstantinou, J. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Papaconstantinou,"

Phrase: "J."
Processing 00000000.tx.509: (1992) J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.510: Biol. 

Phrase: "Biol."
Processing 00000000.tx.511: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.512: 267, 5021-5024 [Abstract/Free FullText] Huang, J. 

Phrase: "267,"

Phrase: "5021-5024"

Phrase: "[Abstract/Free FullText"

Phrase: "] Huang,"

Phrase: "J."
Processing 00000000.tx.513: H., and Liao, W. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Liao,"

Phrase: "W."
Processing 00000000.tx.514: S-L. 

Phrase: "S-L."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439394:s l [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.515: (1994) Mol. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.516: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.517: Biol. 

Phrase: "Biol."
Processing 00000000.tx.518: 14, 4475-4484 [Abstract] Ray, A., and Ray, B. 

Phrase: "14,"

Phrase: "4475-4484"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Ray,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086894:ray [Fish]
  1000   C0851346:ray [Natural Phenomenon or Process]
  1000   C2314876:ray [Fish]

Phrase: "A.,"

Phrase: "and"

Phrase: "Ray,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086894:ray [Fish]
  1000   C0851346:ray [Natural Phenomenon or Process]
  1000   C2314876:ray [Fish]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.519: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.520: (1994) Mol. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.521: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.522: Biol. 

Phrase: "Biol."
Processing 00000000.tx.523: 14, 4324-4332 [Abstract] Baumann, H., Morella, K. 

Phrase: "14,"

Phrase: "4324-4332"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Baumann,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Morella,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1213504:Morella [Plant]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.524: K., Campos, S. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Campos,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.525: P., Cao, Z., and Jahreis, G.P. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Cao,"

Phrase: "Z.,"

Phrase: "and"

Phrase: "Jahreis,"

Phrase: "G.P."
Processing 00000000.tx.526: (1992) J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.527: Biol. 

Phrase: "Biol."
Processing 00000000.tx.528: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.529: 267, 19744-19751 [Abstract/Free FullText] Nishio, Y., Isshiki, H., Kishimoto, T., and Akira, S. 

Phrase: "267,"

Phrase: "19744-19751"

Phrase: "[Abstract/Free FullText"

Phrase: "] Nishio,"

Phrase: "Y.,"

Phrase: "Isshiki,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kishimoto,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Akira,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.530: (1993) Mol. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.531: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.532: Biol. 

Phrase: "Biol."
Processing 00000000.tx.533: 13, 1854-1862 [Abstract] Ratajczak, T., Williams, P. 

Phrase: "13,"

Phrase: "1854-1862"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Ratajczak,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Williams,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.534: M., DiLorenzo, D., and Ringold, G. 

Phrase: "M."

Phrase: ","

Phrase: "DiLorenzo,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Ringold,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.535: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.536: (1992) J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.537: Biol. 

Phrase: "Biol."
Processing 00000000.tx.538: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.539: 267, 11111-11119 [Abstract/Free FullText] Juan, T. 

Phrase: "267,"

Phrase: "11111-11119"

Phrase: "[Abstract/Free FullText"

Phrase: "] Juan,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.540: S-C., Wilson, D. 

Phrase: "S-C., Wilson,"

Phrase: "D."
Processing 00000000.tx.541: R., Wilde, M. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Wilde,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.542: D., and Darlington, G. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Darlington,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.543: J. 

Phrase: "J."
Processing 00000000.tx.544: (1993) Proc. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.545: Natl. 

Phrase: "Natl."
Processing 00000000.tx.546: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.547: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.548: U. 

Phrase: "U."
Processing 00000000.tx.549: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.550: A. 

Phrase: "A."
Processing 00000000.tx.551: 90, 2584-2588 [Abstract] Ron, D., Brasier, A. 

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "2584-2588"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Ron,"

Phrase: "D."

Phrase: ","

Phrase: "Brasier,"

Phrase: "A."
Processing 00000000.tx.552: R., McGehee, R. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "McGehee,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.553: E., and Habener, J. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Habener,"

Phrase: "J."
Processing 00000000.tx.554: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.555: (1992) J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.556: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.557: Invest. 

Phrase: "Invest."
Processing 00000000.tx.558: 89, 223-233 [Medline] [OrderarticleviaInfotrieve] Stephens, J. 

Phrase: "89,"

Phrase: "223-233"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Stephens,"

Phrase: "J."
Processing 00000000.tx.559: M., and Pekala, P. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Pekala,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.560: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.561: (1991) J. 

Phrase: "(1991"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.562: Biol. 

Phrase: "Biol."
Processing 00000000.tx.563: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.564: 266, 21839-21845 [Abstract/Free FullText] Stephens, J. 

Phrase: "266,"

Phrase: "21839-21845"

Phrase: "[Abstract/Free FullText"

Phrase: "] Stephens,"

Phrase: "J."
Processing 00000000.tx.565: M., and Pekala, P. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Pekala,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.566: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.567: (1992) J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.568: Biol. 

Phrase: "Biol."
Processing 00000000.tx.569: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.570: 267, 13580-13584 [Abstract/Free FullText] McKnight, S. 

Phrase: "267,"

Phrase: "13580-13584"

Phrase: "[Abstract/Free FullText"

Phrase: "] McKnight,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.571: L., Lane, M. 

Phrase: "L., Lane,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.572: D., and Gluecksohn-Waelsch, S. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Gluecksohn-Waelsch,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.573: (1989) Genes & Dev. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Genes & Dev."
Processing 00000000.tx.574: 3, 2021-2024 1995 by The American Society for Biochemistry and Molecular Biology, Inc.

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "2021-2024 1995 by The American Society"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0037455:society [Organization]
   748   C0596070:American [Population Group]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Inc."

